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Abstract 
Aim: To investigate the barriers and facilitators identified within the various stages of 
implementing the Healthy Living Pharmacy (HLP) project and the limitations to its 
sustainment within community pharmacy.  
Scope: The HLP project is a Department of Health commissioned initiative to enhance the 
potential contribution of community pharmacy towards improving the health of their local 
communities.  
The research was conducted between November 2011 and January 2017 in Portsmouth - the 
HLP project pilot site. A literature review on the development of community pharmacy 
activities and implementation of services provided a contextual basis.  
Semi-structured interviews with community pharmacy staff and subsequent framework 
analysis informed by implementation theory was employed to investigate the study aims. A 
sustainability strategy in the form of an online networking platform aiming to support the role 
of the Healthy Living Champions (HLCs) was designed and implemented. Its evaluation, 
including social network analysis revealed the effectiveness of this intervention.   
Results: The findings identified the Healthy Living Champions’ (HLCs’) contribution and an 
emerging community of practice (CoP) as critical factors in the apparent successful 
implementation of the project. Despite the introduction of a HLC Facebook group, which 
demonstrated potential to serve as a virtual community of practice (VCoP), the sustainability 
of the HLP proved challenging. Ultimately, poor integration of community pharmacy into the 
wider NHS as well as contractual issues and commissioning constraints, resulted in the HLP 
project demonstrating poor potential for long-term sustainability.   
Conclusions and contribution to the knowledge of the subject: This study is one of the first 
to successfully employ and report on the use of implementation theory to investigate the 
adoption and sustainability of innovation within UK community pharmacy. The findings 
elaborate on those of a recent NHS publication reporting on the challenges of providing 
clinical services in community pharmacy; and provide important lessons for consideration in 
planning and developing future community pharmacy innovations.  
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Chapter 1 Introduction to the thesis 
 
1.1 Origins and development of the thesis 
This chapter provides an introduction to the research study, including the origins and development of 
the PhD.  
Each of the themes introduced will be briefly described and then further discussed with reference to 
the literature in Chapter 2.  
Despite a number of opportunities that have been made available to community pharmacy, it was 
described by the Conservative party spokesman in 2009, as the country’s “most under-utilised 
national resource in the delivery of services to National Health Service (NHS) patients”1.  
Studies have been carried out to investigate the success of delivering specific public health services 
from community pharmacy and factors affecting service delivery and health outcomes2, 3. Despite 
these studies, the extended role of the community pharmacy team has not been developed, delivered 
and embraced by the profession as rapidly as one might expect4. 
The Government’s expectations of the profession and the evidence base for community pharmacy’s 
potential contribution to improving the health of the public have been key drivers for the development 
of the Healthy Living Pharmacy (HLP) project5.  
The HLP project was created to build upon the roles conducted from community pharmacies and 
attempts to utilise the potential of community pharmacy teams to establish additional key services 
for the local community6.  
This research aims to explore the success or failure of the HLP initiative as a sustainable model for the 
delivery of public health services within community pharmacies.  
 
1.1.1 The United Kingdom community pharmacy market  
Community pharmacies in the United Kingdom (UK) are operated and run as private businesses 
independent of the NHS. They are able to sell products and services directly to their 
patients/customers7. Community pharmacies are able to supply Prescription Only Medicines and 
advice to customers based on a contract with the NHS, where the bulk of their remuneration is largely 
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based on the volume of prescriptions dispensed, rather than services provided8. Within the UK, the 
community pharmacy market is made up of a number of multiples (greater than 200 outlets), large 
chains (more than 20 outlets but less than 200), small chain of pharmacies (20 outlets or less but more 
than 5) and independent contractors (5 outlets or less), with multiples and large chains accounting for 
approximately 50% of the market9.  
Community pharmacies are located in a variety of settings ranging from health centres, high street 
locations, edge of town shopping centres, and rural communities5. Each of these pharmacies is 
required to employ a pharmacist to legally operate. Community pharmacists are employed directly by 
a pharmacy company, work independently on a non-contractual basis, or own and operate an 
independent pharmacy themselves.  
In England there are over 10,500 community pharmacies10. These community pharmacies are open at 
convenient times, including evenings and weekends, allowing access for people who work a wide 
range of hours. It has been shown that 89% of the population in England can access a pharmacy from 
home within a 20-minute walk. Importantly, in areas of highest deprivation, this value increases to 
almost 100%11.  
 
1.1.2 The state of community pharmacy in United Kingdom 
The UK Government (2010 - current) has committed to providing a health service that is based around 
the needs of the people12. It has focused on prevention programmes that help to keep people healthy, 
making general healthcare more accessible and introducing programmes that reduce health 
inequalities. The Government has recognised that health and social care will need to work together, 
along with new providers from the public and private sector, to deliver its vision for health outlined in 
‘The NHS Plan’13. 
A number of opportunities are available for community pharmacists to become more involved in 
delivering NHS commissioned public health services, which promote self-care and improve the 
management of long-term conditions. Such services include Medicines Use Reviews (MUR)14  and the 
New Medicines Service15.  Legislative changes have occurred to help community pharmacists extend 
their role, such as the legislative ability of pharmacist prescribing16 and supervision requirements17. 
The new community pharmacy contract18, introduced in 2005, included a change in the way in which 
community pharmacists are remunerated; funds traditionally earmarked for the dispensing role of 
community pharmacists were reallocated to patient facing roles.  
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These changes in health policy have provided community pharmacists the opportunity to develop and 
deliver a wider range of public health services19.   
 
1.1.3 Change within UK community pharmacy  
Despite changes in health policy, and the opportunities this has presented for community pharmacy, 
the implementation and delivery of new services in England has been slower than expected4. The 
structure of community pharmacy within England, may help to explain some of the issues around the 
slow development of public health services on behalf of the NHS4.  
Problems with the implementation and delivery of services within community pharmacy have been 
experienced not only in England, but also at an international level. A number of studies have identified 
some of the barriers, facilitators and motivators affecting service delivery within community 
pharmacy4, 20-30. These included: public demand and attitudes, pharmacist characteristics and 
attitudes, training, operational aspects of service delivery, remuneration, pharmacy environment and 
healthcare professional relationships. These factors, amongst others, are explored in Chapter 2.  
The HLP concept originally described a commissioning framework. It was created by NHS Portsmouth 
Primary Care Trust (PCT) in 2009, to build upon the role of community pharmacies and establish them 
as a key provider of public health services for their local community31. It aspires to do this through a 
consistently high standard of delivery for locally required public health services that include: advice 
and interventions as well as regular health promotion activities2.  
The project’s accreditation criteria were designed to support community pharmacies in developing 
three ‘enablers’ that have been identified to underpin the delivery of services32. These are:  
 Workforce development, which requires a staff member to become a Health Living Champions 
(HLCs) (members of the pharmacy team who have undertaken specific additional training); 
 On site premises fit for delivery of the service;  
 Engagement with other stakeholders (e.g. General Practitioners, social care and public health 
professionals).  
 
 
 
 
1.2 Aim and objectives 
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Aim 
The overall aim of this study was to investigate the potential for the HLP project to provide a platform 
for community pharmacy’s sustained involvement in public health initiatives.  
 
Objectives 
Following a review of the literature regarding the development and implementation of community 
pharmacy services, the following objectives explored the implementation and sustainability of the HLP 
project through the opinions and experiences of members of the community pharmacy team. 
1. To investigate the implementation of the HLP project within the community pharmacies 
within Portsmouth. 
2. To design, implement and evaluate an evidence-based strategy to enhance the 
implementation process and support the sustainability of the HLP project within the 
community pharmacies in Portsmouth. 
3. To investigate the sustainability of the HLP project in community pharmacies within 
Portsmouth. 
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1.3 Structure of the thesis 
The results from the study are presented over a series of chapters, describing the research activities.  
Results and discussion sections for each chapter are included, as findings from early chapters have 
informed the direction of further research. 
Figure 1.1 offers a diagrammatical representation of the structure the thesis will follow. The contents 
page provides a more detailed content and the location of each of the chapters.  
Figure 1.1 The structure of the thesis 
 
 
 
Chapter TWO: Review of the literature 
 Chapter THREE:  
The 
implementation of 
the HLP project in 
Portsmouth’s 
community 
pharmacies 
Chapter FOUR: 
 
 The Healthy 
Living Champions’ 
Network 
Chapter FIVE:  
Supporting the 
Healthy Living 
Champions’ 
community of 
practice 
 
Chapter SIX: 
Investigating the 
sustainability of 
the HLP project in 
Portsmouth’s 
community 
pharmacies 
Chapter SEVEN: Thesis discussion 
Chapter EIGHT: Conclusion  
Chapter ONE: Introduction to thesis  
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Chapter 2 : Review of the literature 
 
This chapter of the thesis reviews the literature relevant to this study. It explores the Government’s 
health services strategy and its impact on community pharmacy activities, and analyses the success of 
public health initiatives within community pharmacy. The chapter further reviews the role of the 
pharmacy team in the provision of health services and recognises the potential for enhanced 
responsibilities. 
This review demonstrates the impact of the changing political environment on community pharmacy, 
and the increasing number of opportunities available for community pharmacy to contribute towards 
the improving the health of the public.  
 
2.1 Community pharmacy 
In the UK, community pharmacies are a resource within primary care33, used by customers in different 
ways and at different points in care pathways34.  It has been known for many years that the majority 
of illness episodes are not presented to general medical practitioners (GPs)35. As alternatives to 
seeking medical advice for the management of symptoms or minor illness, members of the public may 
do nothing, they may seek advice from a pharmacy or elsewhere, they may self-treat with medicines 
or they may use a non-pharmacological approach36.  
In brief, the major health-related activities performed in community pharmacies are the dispensing of 
prescribed medicines, providing advice alongside sales on non-prescription medicines, providing 
advice on action to take regarding the treatment of minor ailments and the provision of services that 
improve the health of individuals37. 
Community pharmacy presents an unusual healthcare environment that provides a number of 
benefits as a setting for these activities38. Venues such as walk-in centres and GP surgeries are clearly 
established as non-retail spaces, thereby patients are obliged to obtain a recommended medicine 
from a second venue following an appointment e.g. community pharmacy or retail outlet.  Whereas 
the pharmacy represents a different type of space; one in which there is a combination of commercial 
retail elements with health products and advice. The organisation of space within community 
pharmacies reflects this mixed retail/healthcare role. The front part resembles a shop where 
customers can select goods that are both health and non-health related, while the dispensary and 
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shelves holding the medicines which can only legally be obtained from a pharmacy (Pharmacy-
medicines), are located behind the pharmacy counter. Although the front area is primarily a retail 
environment, there is also a significant healthcare dimension to this space because patients collect 
prescribed medicines, and pharmacists, dispensing assistants and medicines counter assistants 
(MCAs) give advice on medicine use. 38 
With extended opening hours and no appointment needed for advice, community pharmacy can be 
more accessible than other settings. In England, an estimated 1.6 million people visit a community 
pharmacy each day and, an average person will visit a community pharmacy 14 times over the course 
of a year39. Importantly, community pharmacies often occupy a geographic position in the heart of 
communities40. This gives community pharmacies access to a range of individuals in both good and 
poor health, and to those that may not have contact with any other healthcare professionals. Research 
has recognised that the public is trusting of advice received from community pharmacies41. 
Furthermore, a review of the evidence has confirmed the potential of pharmacy in the area of 
delivering public health initiatives, and suggests that pharmacy teams can indeed make a positive 
contribution to public health3. This is discussed in the following sections of this chapter.  
 
2.2 The development of the public health role in community pharmacy 
A recognised role in health promotion was one of the first ways community pharmacy contributed to 
public health42. Health promotion includes the provision of services or advice that improve the health 
of individuals and communities, and empower people to have increased control over and to improve, 
their health41.  
As early as 1981, pilot schemes have been introduced to explore the potential of community pharmacy 
as sites for the provision of healthcare information and advice43. Increasing health inequalities and the 
realisation that the existing health and welfare provision was not delivering a service to meet demand 
nor expectation were key drivers to initiating these pilots44. In November 1987, the Government 
published its programme for improving primary healthcare, Promoting better health45. This document 
recognised the potential role for community pharmacy in delivering health promotion and 
consequently included a recommendation that pharmacies be used to display health education and 
health promotion material.  
As this public health role came to be more prominent within UK community pharmacies, the area 
became more researched. The initial published studies often reported very positive conclusions about 
a future role in health promotion46-49. However, these findings were derived from small studies, 
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involving few pharmacies in specific geographical areas. An example of which included a qualitative 
evaluation of a cholesterol screening programme delivered within four community pharmacies in an 
area of Birmingham50.   
A significant initiative in the development of the pharmacist’s health promotion role was the Barnet 
High Street Health Scheme, introduced in 199151. For the first time, pharmacists were provided 
training and ongoing support for their health promotion role. This included seven days of accredited 
training in health promotion knowledge and communication skills together with ongoing support for 
the health promotion role51, 52. The scheme received publicity in both the pharmaceutical press53 and 
the national media, and as a result, similar schemes were introduced elsewhere54. A later survey in 
1994 found that nearly 60 per cent of family health services authorities had some sort of health 
promotion activity in their pharmacies, and that most had been influenced by the Barnet scheme52. 
More specifically it was reported that the scheme prompted pharmacists to make more appropriate 
use of health promotion materials and spend less time dispensing medicines and more time talking 
and advising patients.52.  
However, it should be noted that the project targeted developing the health promotion role of the 
pharmacist and was not inclusive of the whole pharmacy team. In addition the analysis revealed, that 
since pharmacists were not paid to undertake the health promotion activities, a number of 
pharmacists were not motivated to participate.55,56 
In the 1990s the emphasis on health promotion turned to a role in harm reduction; focusing on 
smoking cessation services57, promotion of sensible attitudes to drinking and drug misuse services58 .  
 
2.3 Defining the public health role of community pharmacy  
Anderson et al. conducted a comprehensive review of the peer-reviewed and non-peer-reviewed UK 
research relating to the contribution of community pharmacists to improving the public’s health 
during the period 1990-20023.  
The report demonstrated that community pharmacists can make an important contribution to health 
improvement in the areas of smoking cessation59-61 and emergency contraception and provided the 
clearest evidence of the effectiveness and cost-effectiveness of services provided by community 
pharmacists62. The non-peer reviewed literature further identified evidence of community 
pharmacists’ public health role in relation to the primary healthcare team and on user perspectives of 
sensitive health topics such as head lice management63 and drug misuse services64, 65.   Further to this, 
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the authors made recommendations for the widespread implementation in pharmacies of these 
public health services.  
The review also reported that despite studies identifying community pharmacists’ involvement in 
other areas of health improvement, the authors were unable to determine the efficacy of these 
interventions, primarily because the evidence base was limited or the methodological quality was 
poor. Furthermore, the authors concluded from the published evidence that pharmacists tended to 
take a reactive rather than proactive approach to health improvement initiatives.  
This review in its context of developing evidence of the public health contribution of community 
pharmacists, was later challenged in a critical review of public health in pharmacy by Jesson and 
Bissell42. The report re-analysed the evidence and identified that few of the 43 published UK papers in 
the 2002 review were based on any theoretical framework or models of behaviour change.  Jesson 
and Bissell noted that in many studies, the determining factor for positive service outcomes was the 
training provided to pharmacists to deliver health promotion and argued that these interventions 
were as much about pharmacy development as public health. It was also recognised that the public 
health agenda, where health inequalities or neighbourhood regeneration and renewal were the 
context, were not reported on, suggesting that this was almost certainly because of the absence of 
such studies.  
The authors also concluded that although pharmacists’ attitudes towards health promotion/education 
were largely positive, most successful interventions were linked to medicinal merchandise in some 
way, such as smoking-cessation products, emergency contraception supply or provision of drug 
misuse services.  
Further reviews of community pharmacy public health interventions were conducted by: Anderson et 
al. (2006)66, Dent et al. (2007)67, Sinclair et al. (2008)68, Anderson et al.(2009)69, Watson et al. (2009)70, 
Strang et al. (2010)71, Gordon et al. (2011)72, Agomo (2012) 73, Brown et al. (2012)2 and Watson et al. 
(2012)74. These reviews reported on community pharmacy’s contribution to improving public health 
or the contribution to improving specific public health issues.  
The authors of the majority of these reviews employed the UK National Service Framework hierarchy 
of evidence to rank the individual studies included75. (See Table 2.1) 
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Table 2.1 UK National Service Framework hierarchy 
 
 
The identified review articles relate to studies conducted during the period from August 2002 until 
August 2012 and include both international and UK studies. An overview of the quality of the studies 
included in the reviews is shown in Table 2.2.  
 
 
 
 
 
 
 
 
 
Evidence from research and other professional literature  
A1 Systematic reviews which include at least one randomised controlled trial (RCT) e.g. systematic reviews 
from Cochrane or NHS Centre for Reviews and Dissemination  
A2 Other systematic and high quality reviews which synthesise references 
B1  Individual RCTs 
B2 Individual non-randomised, experimental/intervention studies 
B3  Individual well-designed non-experimental studies, controlled statistically if appropriate. Includes 
studies using case control, longitudinal, cohort, matched pairs or cross-sectional random sample 
methodologies, and well-designed qualitative studies, well-designed analytical studies including 
secondary analysis 
C1 Descriptive and other research or evaluation not in B (e.g. convenience samples) 
C2 Case studies and examples of good practice 
D Summary review articles and discussions of relevant literature and conference proceedings not 
otherwise classified 
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Table 2.2 Overview of the quality of studies included in the reviews identified 
Theme Number of reviews 
identified 
References Quality of studies included 
in the reviews 
Smoking cessation 
services 
5 Dent et al. 2007 
Sinclair et al. 2008 
Anderson et al. 2009 
Agomo 2012 
Brown et al. 2012 
B1, B2, B3, C1, C2, D 
B1 
B1 
B1 
B1, B3, C2, D 
Emergency 
Hormonal 
Contraception 
4 Anderson et al. 2006 
Anderson et al. 2009 
Agomo 2012 
Brown et al. 2012 
B1 
B3 
B1 
A2, B1 
Prevention and 
management of 
drug abuse, misuse 
and addiction  
6 Watson et al. 2009 
Anderson et al. 2009 
Strang et al. 2010 
Agomo 2012 
Brown et al. 2012 
Watson et al. 2012 
C1 
B3 
C1 
A2, B3 
B3, C1 
C1, D 
Healthy eating and 
lifestyle advice 
4 Anderson et al. 2009 
Agomo 2012 
Gordon 2011 
Brown et al. 2012 
B3 
B1, B2, B3, C1, C2, D 
B1, B2, B3, C1, C2, D 
B2 
Chronic disease 
management 
1 Brown et al. 2012 A1, A2, B1, B2 
Infection control 
and prevention 
3 Anderson et al. 2009 
Agomo 2012 
Brown et al. 2012 
C1, B3 
B2, D 
B2 
Minor Ailment 
Scheme  
1 Brown et al. 2012 B2, B3, C2 
 
The review articles revealed that community pharmacists were involved in a wide range of roles in 
public health. The seven dominant themes were smoking cessation services (5 reviews), provision of 
emergency hormonal contraceptives (4 reviews), prevention and management of drug abuse, misuse 
and addiction (6 reviews), healthy eating and lifestyle advice (4 reviews), chronic disease management 
(1 review), infection control (3 reviews) and minor ailment scheme (1 review).   
The review papers reporting on community pharmacy contribution to smoking cessation indicated 
that community pharmacy-based stop smoking services run by trained pharmacy staff were effective 
and cost-effective in helping individuals to quit smoking. The studies included in the reviews were of 
high levels of evidence (RCTs).  
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Three of the four reviews reporting on the provision of emergency hormonal contraceptives indicated 
good evidence that community pharmacy Emergency Hormonal Contraception services provided 
timely access to therapy and were highly rated by women who used them.  
Six review papers detailing the community pharmacy role in the prevention and management of drug 
abuse, misuse and addiction included studies of varying quality. Watson and Blenkinsopp70 reporting 
on studies of moderate quality, identified the involvement of community pharmacy in the 
management of alcohol misuse. The review concluded that there was little empirical evidence of 
effectiveness of community pharmacy-based services for alcohol misuse.  
Moderate quality evidence on community pharmacy-based supervised methadone administration 
services showed that high attendance was achieved and it was acceptable to users. There is evidence 
from one review71, that the introduction of supervised methadone dosing resulted in substantial 
declines in death from overdoses of methadone in Scotland and England. However, the data used 
were not community pharmacy specific.  
Pharmacy-based needle exchange schemes have been found to achieve high rates of returned 
injecting equipment and were cost effective. It should be noted that this evidence was based on 
descriptive studies2, 74 rather than a cost-analysis evaluation.  
Four review papers included studies of moderate to good quality relating to the involvement of 
community in healthy eating and lifestyle advice2, 69, 72, 73. All the identified reviews pointed to the fact 
that although community pharmacy-based weight reduction programmes appear to show promise, 
there is insufficient evidence to indicate the effectiveness of community pharmacy contribution.   
Brown et al.’s report included six reviews in the area of chronic disease management and prevention. 
There was good quality evidence to support community pharmacy input into chronic disease 
management. This included a report indicating strong evidence of improvements in lipid levels that 
were sustained for at least one year in both primary and secondary prevention of coronary heart 
disease76. A cardiovascular pharmacy service evaluation revealed strong evidence of significant 
reduction in systolic blood pressure but a limitation of this service was that the patients recruited into 
the service required regular reviews in order for a reduced systolic blood pressure to be maintained77. 
There was also good quality evidence that enhanced medicines management in patients with heart 
failure recently discharged from hospital led to reduction in hospitalisation; however this did not lead 
to a reduced rate of mortality2. 
Evidence that community pharmacists can make an important contribution to the management of 
diabetes in terms of screening, improved concordance with medication and reduced blood glucose or 
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HbA1c was strong. Interestingly, community pharmacists were also effective in contributing to 
diabetic patients achieving weight reduction2. 
Brown et al.2 found good evidence that community pharmacy interventions can improve respiratory 
function and medication adherence in patients with asthma. This was in contrast to the weak evidence 
for community pharmacy services targeting sufferers of chronic obstruction pulmonary disorder and 
osteoporosis screening services.  
Two of three reviews identified moderate evidence from the United States of America (USA) for 
community pharmacy-based provision of a range of vaccinations2, 73. Although this exercise did not 
identify UK papers on immunisation and vaccination, there has since been published reports 
evidencing UK community pharmacists contribution to increasing the season influenza vaccination 
uptake78, 79. There is also evidence that community pharmacy-based chlamydia testing and treatment 
services increased customer access and detected positives for referral; however uptake of a UK 
nationally funded Chlamydia screening programme by community pharmacies was poor with 
implications for the prospects of disease control2,69.  
Brown et al.2 suggested that there is good evidence that minor ailment services have facilitated the 
transfer of an appreciable amount of the minor ailment care burden from GPs to community 
pharmacies but strong evidence for beneficial effect on patient health seem to be lacking.  
 
2.4 Recognition of the potential for community pharmacy to improve public health and 
the community pharmacy contract. 
The potential contribution of community pharmacy to public health has been increasingly 
acknowledged through Department of Health (DoH) publications and Government papers; these are 
reported below.   
The DoH publication, Primary care delivering the future (1996)80 recognised community pharmacy’s 
public health activities as an area where innovative local practices existed, and called for national 
development of these initiatives. It proposed that pharmacists should be the first port of call for both 
advice and over-the-counter (OTC) medicines for treatment and that this would increase pharmacists’ 
contribution to improving public health. The report also stated that pharmacists should be actively 
promoting the health of people, contributing to the local achievement of health targets, and 
encouraging the principle of self-care and individual responsibility for health.  
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Further to this, the White Paper, The New NHS: Modern, Dependable (DoH 1997)81 emphasised the 
need for local collaborative working in the NHS to reduce inequalities in health and to improve health 
as well as reinforcing the need for health promotion. The need for local collaboration was emphasised 
in the 1998 White Paper, Our Healthier Nation82. This report focused on improving the health of the 
population as a whole by increasing the longevity and the number of years people spend free from 
illness. The paper called for local areas to develop health improvement plans and services to 
effectively deliver appropriate healthcare with explicit mention of pharmacies as important settings 
for health promotion.  
Reports of the Government’s considerable focus on public health became primarily directed at 
developing capacity within the public health workforce and reducing inequalities in health83, 84.  
A number of key policy documents outlined the areas in which the public health role of pharmacists 
should be developed further. For example, the Health Committee Inquiry into Public Health 
recommended that ‘the Government takes steps for community pharmacists to play a more active role 
in public health’85. The Government strategy document for outlining the future direction of pharmacy, 
Pharmacy in the Future 86, recognised that the skills and expertise of the pharmacist could be further 
utilised. According to the strategy, this could be achieved through community pharmacy becoming 
more integrated within the NHS, through working more flexibly as part of a multidisciplinary 
healthcare team and through playing a greater role in supporting self-care.  
Tackling Health Inequalities: A programme for Action (2003)87 highlighted the importance of 
community pharmacy settings and services in addressing health inequalities.  The report went on to 
state that community pharmacists have a vital role to play in improving the public’s health by giving 
advice, specifically on how to quit smoking, offering exercise on prescription, identifying patients at 
risk of heart disease and providing services for substance users. A Vision for Pharmacy in the New NHS 
(2003)37, recognised the untapped contribution that pharmacists can make to the public health 
agenda. The ‘vision’ made a commitment to develop a pharmaceutical public health strategy by 2005, 
integrating pharmacy and the wider public health agenda and workforce.   
In 2005, the statutory provisions governing pharmaceutical services supplied to the NHS were 
restructured and a new pharmacy contract was introduced which incorporated a range of new 
services88. The new community pharmacy contractual framework identified three levels of service: 
nationally agreed essential services, to be provided by all community pharmacy contractors; nationally 
specified advanced services, requiring pharmacists and their premises to be accredited for the 
purpose; and enhanced services to be commissioned and funded by primary care trusts89. The 
inclusion of public health in the essential service element through promotion of healthy lifestyles and 
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involvement in national and local health campaigns recognised the importance of public health and 
the contribution that can be made by community pharmacy40. 
In January 2005, the DoH published two key documents90, 91. The first provided information on 
developing policy on support for self-care, to empower people to treat themselves appropriately and 
avoid unnecessary taking of medicines90. Community pharmacists were recognised as a source of 
advice for self-care, and innovative pharmacy schemes for minor ailments were quoted as examples 
of good practice within the report. The second document focused on providing support for people 
with long-term conditions91, in which pharmacists were also recognised as playing an important role 
in helping people to manage their conditions better. In March 2005, the DoH released their delivery 
plan for ‘Choosing Health’92, and shortly following this, ‘Choosing health through pharmacy’93 was 
published. This resource was developed to maximise the contribution of community pharmacists, their 
staff, and the premises in which they worked, to improve health and reduce inequalities.   
“We want to build on pharmacy’s strengths, to develop and further extend health improvement 
services, working closely with the wider public health team and expanding their role as advocates for 
health.”    
Melanie Johnson MP, Parliamentary Under Secretary of State for Public Health93 
‘Choosing health through pharmacy’93 set out the contribution that pharmacy could make to delivering 
‘Choosing health’92. This included: signposting, ‘stop smoking’ services, sexual health services, drug 
misuse schemes, obesity programmes, identifying individuals with risk factors for disease, and helping 
people to manage long term conditions.  
In January 2006, the white paper ‘Our health, our care, our say’ was released94. Prior to publication, 
the DoH conducted a consultation exercise with over 40,000 people to understand what local people 
wanted out of their NHS service. The consultation showed the public wanted to see a wider range of 
professionals (particularly practice nurses and pharmacists) involved in health improvement, disease 
prevention and the promotion of independence95. They also wanted pharmacists to have an increased 
role in providing support, information and care. This white paper outlined four main goals for the NHS: 
better prevention services with earlier intervention, more patient choice, more on tackling inequalities 
and access to community services, and more support for people with long-term conditions. A number 
of opportunities were mentioned for pharmacy involvement, including a desire to encourage 
innovative providers from the independent and voluntary sectors to work together. A number of 
innovative pharmacy services were mentioned within the paper, including community pharmacy 
screening services. In response to this consultation, the DoH published a document in February 2006 
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to support people with long-term conditions to self-care91. This document was a self-help guide to 
help organisations deliver local strategies to empower people with long-term conditions to manage 
their own care, with the support of doctors, nurses and pharmacists.   
From the above documents, it is clear that the Government recognised the need for health and social 
care to work together alongside new healthcare providers, to reduce inequalities in health and to 
improve health. Furthermore, it is evident that the Government recognised the potential for 
community pharmacy to become more involved in delivering NHS services that promote self-care and 
improve the management of long-term conditions. The new pharmacy contract was intended to help 
establish this role for community pharmacy and provide a vehicle for funding and remuneration for 
the delivery of services.   
Despite the Government legislation and policy changes within the health service environment, the 
extended role of the community pharmacist has not been developed, delivered and embraced by the 
profession as rapidly as one might expect4. The following section of this chapter reviews the literature 
to help identify factors that may be responsible for this.  
 
2.5 Is community pharmacy the right setting for public health initiatives?  
A number of factors are thought to affect the delivery of services in community pharmacy, and these 
have been reported in the literature. Appendix 2.1 outlines details of the studies reporting on the 
barriers and facilitators of delivering services within community pharmacy. The summary provided 
also identities the methodologies employed and the limitations identified in each of the studies.  
It should be noted that the results presented in Appendix 2.1 are limited to studies conducted within 
the UK. Although the barriers and facilitators identified from similar studies conducted outside the UK 
tend to be similar in nature, each country has different community pharmacy systems, staffing 
structures, remuneration and funding systems, health systems, level of support and pharmacist roles.  
Ten studies have been identified that looked at factors affecting service delivery within the UK. The 
first of these was reported in 1995 by Mottram et al.22 who conducted a mail survey with a sample of 
community pharmacists in Liverpool to try to identify activities that represented the extended role, 
the extent to which they had been implemented and any constraints that had been experienced. The 
authors found that pharmacists had adopted activities such as health promotion and pregnancy 
testing that could be administered with minimal inconvenience to the traditional role, and that 
required little financial commitment. It was recognised that many aspects of the extended roles (such 
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as diagnostic testing) required considerable expense and time to set up and run; for which funding 
was not provided by the Government. Patients themselves were unwilling to pay for extended services 
from the community pharmacy, especially when they received them elsewhere at no cost.  
In 1996 Tann el al. 21 explored the hypothesis that the successful implementation of the wider role of 
the pharmacist was related to enablers in the work environment, as well as characteristics particular 
to ‘Leading Edge Practitioners’ (LEPs). Within the study LEPs were found to initiate more actions, to 
be more patient centred, be effective networkers, more focused on staff development, and more 
effective influencers. Barriers to implementation identified by the LEPs included lack of finance, time 
and space within the pharmacy. The authors suggested the gap between policy and practice, as well 
as the time lag in implementation of services could be reduced by focusing on LEPs to pilot and 
implement changes to pharmacy practice.  
In 1998, Bell et al. 24 conducted interviews with a sample of community pharmacists in Northern 
Ireland to ascertain their attitudes and opinions towards the concept of pharmaceutical care and its 
implementation. The degree of implementation of pharmaceutical care was restricted, and although 
all of the pharmacists questioned believed that they were involved with pharmaceutical care, this was 
primarily focused on patient education about their medicines. None of the pharmacists interviewed 
were involved in diagnostic or monitoring services. The authors found that the pharmacists were keen 
to develop their role, but identified a number of barriers, which impeded this. This included lack of 
time, remuneration, private counselling area, access to patient medication records, low public 
expectation of the pharmacy profession, and lack of inter-professional relationships. Proprietors of 
independent pharmacies displayed a higher degree of business orientation and were particularly 
concerned about lack of remuneration. The facilitators identified were the opposites of the barriers, 
and included having a private consultation area, developing professional relationships, increasing 
general public perception of the pharmacy, and having access to patients’ medication records. The 
location of the pharmacy was also considered important in developing a loyal customer base, with 
those pharmacists working near GP practices having particularly good relationships with GPs.  In 1999, 
Bell et al.23 investigated whether lack of time to implement pharmaceutical care was a barrier to the 
routine provision of extended patient care services. A self-reported work sampling study was 
conducted with a sample of community pharmacists in Northern Ireland to investigate how they used 
their time. Staffing levels with the pharmacy were found to significantly influence the pharmacists’ 
involvement in a number of activities. The authors also found that pharmacists working in 
environments with a high prescription turnover devoted significantly less time to counselling patients. 
Almost a quarter or the pharmacists’ time was dedicated to non-professional activities that could have 
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been performed by other members of staff. The authors concluded that improved time management 
and better use of trained support staff could improve the ability of pharmacists to integrate 
pharmaceutical care services into their routine practice.  
Following a systematic review to develop questionnaire statements, Tully et al.25 assessed the 
motivators and barriers to the implementation of a prescription monitoring and review service led by 
community pharmacists that was delivered with either the pharmacy or GP practice. The authors used 
a two-part Delphi survey and measured the attainment of consensus as to whether the statements 
represented motivators or barriers. There were high levels of agreement that providing a prescription 
monitoring and review service would improve both public and GP perceptions of pharmacists, help 
develop relationships with patients, and give pharmacists professional fulfilment. Other motivators 
included improving patients’ clinical parameters and adherence. Key barriers to the implementation 
of these services included their time consuming nature, locum difficulties, the prohibitive cost of 
providing the service, and the unwillingness of pharmacy owners or GPs to fund services. It was also 
noted that services would be hindered by not having access to the patients’ medical record, and if 
pharmacists did not have a cooperative working relationship with their local GP. The authors also 
discovered within the free text comments that internal rivalries, and the structure and culture of the 
profession may also represent barriers to the implementation of these services. They concluded that 
community pharmacists were motivated to participate in prescription monitoring and review schemes 
by a complex set of personal, professional and altruistic reasons. The authors recommend that for 
these services to be successful, adequate remuneration structures, internal rivalries, and the structure 
and culture of the profession itself would need to be considered.  
In 2000, Rutter et al.26 reported on their study to investigate community pharmacy managers’ 
perceptions of their role in providing healthcare. Interviews were conducted with pharmacy managers 
within one area of a UK national pharmacy chain. Although participants shared the vision of wanting 
to play a more integral role in the healthcare of patients, a number of barriers and obstacles were 
identified. These included a lack of awareness amongst healthcare professionals and the general 
public regarding pharmacists’ skills and attributes, the legislative restriction on pharmacists remaining 
on the premises, and the current remuneration structure. There was a call for professional bodies to 
intervene and campaign to improve the perceived role of the pharmacist. It was also recognised that 
empowering staff through the skill mix initiative would help to free up the pharmacists’ time and 
provide them with more opportunities to interact with patients.  
In 2001, Ruston27 conducted a study to identify the characteristics of community pharmacists that 
influenced the adoption of an extended role in order to inform ways in which they could organise the 
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pharmacy business to achieve successful re-professionalisation. Ruston found that involvement was 
low in extended activities, which required skills not traditionally associated with community pharmacy 
(such as specialist screening services), whereas activities such as health promotion and advice giving 
were well established. The barriers identified within the study included shortage of time, insufficient 
remuneration, shortage of staff, and lack of contact with other healthcare professionals. Fostering 
levels of autonomy, promoting uptake of post-registration activities to increase knowledge, skills and 
confidence, establishing formal links with other healthcare professionals, and identifying ways for the 
pharmacist to delegate pharmacy supervision while absent from the pharmacy were some of the 
facilitators identified within the study. Although Ruston looked at the percentage turnover of NHS 
prescriptions, type of pharmacy, and provision of private consultation area, she concluded that 
pharmacist involvement in the extended role was more to do with the professional orientation than 
the settings in which they worked,  
In 2001, Krska and Veitch28 interviewed potential policy makers and innovative practising pharmacists 
in Scotland to obtain their views on a systematic approach to pharmaceutical care and the factors 
important in its development. Many of the participants expressed views on the need for 
remuneration, training, physical resources, relationships with GPs, repeat dispensing systems, and 
improvement to existing computer systems to facilitate pharmaceutical care. The perceptions of 
patients as well as other healthcare professionals were also viewed as important, and the majority 
considered that there was a need to educate patients on the role of the pharmacist.  
Further to this, studies have examined the factors affecting service delivery in community pharmacy 
from the perspective of commissioners in more detail29, 96 . In 2003, Blenkinsopp and Celino29 
conducted a postal survey with pharmaceutical advisors and chief pharmacists from the Primary Care 
Trusts (PCTs who were the local commissioners of pharmacy services), to establish current and 
planned community pharmacy services, and to identify barriers for development. The majority of the 
PCTs were found to be commissioning additional NHS services within community pharmacies, 
although there was variability in the number of services commissioned. Those PCTs with less than 
three services were found to be less likely to employ someone to develop community pharmacy, and 
tended to take a fairly opportunistic approach to development with limited planning. In contrast, 
those commissioning more than seven services, tended to employ someone to develop community 
pharmacy, and took a planned approach to development. Local relationships and leadership issues 
tended to be the main drivers and barriers to service development. In 2006, Bradley et al. 96 conducted 
a survey to identify factors which PCTs considered to be barriers and drivers to the commissioning of 
services from community pharmacies. Access to funding, lack of staff capacity at the PCT and 
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impending reconfiguration were found to be the major barriers, whilst the new pharmacy contract 
and local relationships with the PCTs were found to be the main drivers. The majority of PCTs 
questioned were engaged with local pharmaceutical committees and local pharmacists to consider 
service opportunities for community pharmacy.  
UK literature reviews4, 20 have reported challenges for developing the role of the community 
pharmacist, and have provided recommendations for future practice. A report commissioned by the 
Royal Pharmaceutical Society of Great Britain (now the Royal Pharmaceutical Society)4 to investigate 
how service delivery and organisation of community pharmacy were developing in the new 
environment, concluded that the challenges facing pharmacy were not unique to the profession, and 
mirrored those that had confronted organisations and professionals operating in the legal and banking 
sectors. The systematic literature review identified 324 papers of relevance, from which a number of 
common threads were recognised as essential to the future shape of community pharmacy. These 
included the need for community pharmacists to work in partnership with other healthcare 
professionals, the development of the skills of community pharmacy staff, changes to the process of 
remuneration, and the reconfiguration of the pharmacist’s role to enhance professional satisfaction. 
In 2004, Tann and Blenkinsopp20 conducted a review of policy and research findings to recommend 
actions that PCTs could take to increase the likelihood of success when implementing innovation in 
community pharmacy. The recommendations included establishing a local team to review existing 
pharmacy services against local needs, identifying funding for new services, identifying innovator and 
early adopter pharmacists, engaging and supporting local pharmacists, and recognising the need to 
negotiate with pharmacy chains regarding decisions about innovation as well as local pharmacists.  
Further to the aforementioned papers focusing mainly on the views of pharmacists and 
pharmaceutical advisors, Eades et al.97 conducted a systematic review of articles reporting the views 
of customers, as well as pharmacists, on the provision of public health activities.  
Customer attitudes towards community pharmacy’s public health role were largely positive. It was 
reported that customers found the pharmacy a convenient setting and felt it appropriate for 
pharmacists to provide public health services. Customers viewed pharmacists as appropriate providers 
of public health advice but there were mixed views on the pharmacist’s ability to do this; some 
customers perceiving pharmacists as drug experts and unsure of their expertise in providing general 
health advice. 
However, it was also recognised that most pharmacy customers included in these studies reported 
that they had never been offered public health services by their pharmacist and did not expect them 
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to be offered. Despite this, it was revealed that satisfaction was found to be high in those who had 
experienced public health services 97. 
The report identified that most pharmacists viewed public health services as important and part of 
their role. This suggests that the changing role of community pharmacy from traditional dispensing 
activities to greater involvement in health improvement is largely accepted, and the importance of 
providing these services is understood. However, the review indicates that the public health role is 
still considered secondary to medicine related roles, such as dispensing. Pharmacists viewed public 
health activities as less important than traditional roles and were less confident in providing these. 
Less positive views were also held by some pharmacists in relation to certain public health services; 
particularly services for drug misusers. These findings are consistent with those of previous systematic 
reviews on this topic3, 66.    
This review recommended further pharmacist training in a number of public health services. This 
finding is consistent with those from previous reviews where training was found to have a positive 
effect on pharmacists’ attitudes to participate and level of participation in public health activities3, 98.  
A significant weakness of the studies included in the Eades et al. review, however, was that the 
majority of the research focussed on the views of the pharmacist’s role; the inclusion of the views of 
other community pharmacy staff were either not considered or not reported on. Often the first point 
of contact for pharmacy customers is not the pharmacist; other pharmacy staff can play a vital role in 
offering public health services and carrying out initial screening99.  
 
2.6 Community pharmacy support staff  
In the last 20 years, pharmacy has witnessed a shift in role from traditional dispensing activity to more 
patient-focused ‘pharmaceutical care’ 100, 101. Policy makers have sought to broaden the role of 
community pharmacy so that it becomes a point of primary healthcare for the local community102 and 
reduces the general practice workload 86, 103, 104. More recently, community pharmacy has been 
increasingly targeted as a resource for widening access and choice to primary care105. Consequently, 
pharmacists now offer increasing levels and ranges of clinical, diagnostic and public health services. 
For this range of services to be sustainable and developed further, the need for pharmacists to work 
effectively with and delegate to, other members of the pharmacy team (often referred to collectively 
as ‘pharmacy support staff’) has been identified 106, 107.  
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These developments have prompted growing interest in optimising skill-mix within community 
pharmacies. Skill-mix refers to the mix of staff and the balance of different levels of responsibility108. 
The community pharmacy team is complex and diverse109 and there are no set requirements for the 
composition of pharmacy support staff.  
Pharmacy support staff comprise of pharmacy technicians (PTs), accuracy checking technicians (ACTs), 
dispensing assistants (DAs) and medicines counter assistants (MCAs).  
The roles of dispensary support staff have been defined in the literature and are summarised in Table 
2.3.  
Table 2.3 The roles of pharmacy support staff defined in literature108 
Staff type Training Role 
Medicines counter 
assistant (MCA)  
 
A person who has satisfactorily completed or 
is undertaking an accredited programme of 
training for work in support of the sale of non-
prescription medicines, the receipt of 
prescriptions, the handing out of completed 
dispensed items and the provision of advice 
on health matters.  
Involved in the sale of over the 
counter medicines, working under 
the supervision of a pharmacist is 
community pharmacy  
Dispensing assistant 
(DA) (other common 
terms: dispenser, 
pharmacy assistant) 
A person involved in a range of pharmacy 
support activities covered by the 2005 
minimum competence requirements 
Involved in a range of duties, 
working under the supervision of a 
pharmacist. Assists the pharmacist 
and PT with the dispensing process 
Pharmacy technician 
(PT)  
 
A person who holds a Pharmacy Services 
Scottish/National Vocational Qualification 
(S/NVQ) level 3 qualification or a qualification 
that has been previously recognised by 
employers as a valid qualification for 
pharmacy technicians.  
Working under the supervision of a 
pharmacist. Involved in the 
preparation and supply of 
medicines and other healthcare 
products and the provision of 
guidance on taking medicines to 
patients 
Accredited/accuracy 
checking technician 
(ACT) 
Accredited/accuracy checking qualification.  Check the accuracy of dispensed 
items (e.g. right medication has 
been selected, the dosage is as 
prescribed) 
  
The Government89 and the professional body110 believe that effective use of pharmacy support staff 
and role expansion will enable pharmacists to take on extended role activities to support patients with 
their medicines and general health.  
Pharmacy support staff have been recognised to play an integral role in the delivery of primary care, 
and are often the first (and commonly the only) contact community pharmacy customers make when 
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collecting prescriptions, seeking advice or purchasing OTC medicines99. They also play an important 
role in supporting the pharmacist in their dispensing and checking roles, thus freeing up time for 
pharmacists to spend on clinical tasks.111, 112  
A small body of work has been published aimed at understanding the role and contributions of support 
staff in community pharmacies in the UK. Existing research is relatively small scale and much of it has 
focused on the role of MCAs in providing advice to patients about the purchase of appropriate OTC 
medicines108. Other studies have explored the impact of pharmacy technicians (PTs) on pharmacists' 
workload113. 
Early research (pre-contract change) conducted by Mullen et al.114 explored the role of support staff 
within community pharmacies. They found a series of distinct working patterns to be present in the 
community pharmacies included in the study. While some of these working patterns were efficient, 
they found cases where staff worked beyond their qualification level or in contrast, felt disempowered 
because more senior staff were reluctant to delegate work. The authors made recommendations to 
seek to utilise the skills of pharmacy technicians more appropriately. A more recent study, however 
has reported a willingness of pharmacists to delegate work to support staff115.  
In 2008 Schafheutle et al.108 reported on DoH commissioned research. They aimed to collect 
information on pharmacy support staff, develop a demographic profile of the group and their roles, 
obtain data on their background, education and qualifications, and explore their training aspirations 
and career ambitions.  
The study revealed that the vast majority of support staff employed within the community pharmacies 
surveyed, were female and approximately one-third of them worked part-time. The authors identified 
two distinct groups of support staff. The first comprised mature women with few formal qualifications 
and no background in science. They did not necessarily plan a career in community pharmacy and 
were less likely to have obtained a dispensary qualification or, indeed, did not want to undertake 
further training. The second group were younger support staff, often with some background in 
science, such as GCSEs or A-Levels in scientific subjects.  This group had often obtained a dispensary 
qualification (DA or PT) and were attracted by the opportunities for further training, formal 
qualifications and career progression.  
The study also reported that many of the respondents were long-standing members of staff who were 
satisfied with their jobs and generally intended to remain with their current employers. This finding is 
of significant importance since it has been reported that staff attitude and ethos are known to affect 
both success of treatment116 and user’s choice of where to access healthcare services117. Furthermore 
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in the author’s opinion, poorly-informed staff or those with negative attitudes may limit the uptake of 
pharmacy services by customers, negating one of the most beneficial features of community 
pharmacies – that of accessibility.  
There are a small number of studies reporting on pharmacy support staff’s attitudes and involvement 
in service provision. Sheridan and Cronin, reported that support staff have a generally positive attitude 
towards being involved in service provision and many who are currently providing services are happy 
to do so118. A later study examined the involvement and attitudes of 1975 UK community pharmacy 
support staff in the delivery of services to drug misusers. The study revealed positive attitudes of 
support staff towards the provision of services for drug misusers, and a willingness to undertake 
service specific training119. However, of the pharmacy support staff providing services to drug 
misusers, less than one-quarter had undertaken training. The research did not report on the reasons 
for this but earlier studies have identified the following barriers to pharmacy staff training114,120; 
insufficient time in the staff working day, no relevant courses available locally, training held during 
staff’s free time, too far to training venue, insufficient staff level in the workplace, financial cost to 
employer/pharmacy department, and staff undertaking training felt isolated and unsupported, 
particularly when completing distance-learning training.  
Significantly, research exploring the attitudes of pharmacists towards support staff has identified that 
pharmacists have problems delegating to appropriate members of staff 14.  Despite being willing to 
delegate parts of the dispensing process121, it has been reported that pharmacists continue to carry 
out tasks, which could be performed by technicians or ACTs 19, 121-125. Bradley et al.113 provide possible 
explanations for this in their study exploring pharmacist opinion for greater utilisation of pharmacy 
support staff including community pharmacists’ reluctance to relinquish control and concerns about 
knowing and trusting the competencies of support staff.  
Recommendations to policy makers and professional bodies have surfaced from various related 
studies; factors such as staffing levels, skill-mix and the culture of the pharmacy should be taken into 
consideration when extending the role and services in community pharmacy 126, 127.   
2.7 The HLP project 
The White Paper: Pharmacy in England: building on strengths, delivering the future5, described the 
role community pharmacy could play in supporting public health through becoming healthy living 
centres. Recommendations were made to increase pharmacy’s contribution to promoting better 
health, prevention and early detection of disease and managing patients with long-term conditions.  
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The development of the concept of the “healthy living centres” was commissioned by the DoH to 
Portsmouth PCT. The project was named ‘The Healthy Living Pharmacy project’.  Table 2.4 outlines 
the aspects considered in the project’s design128.  
Table 2.4 Supporting research employed to inform the design of the HLP model128 
Review of the national evidence for the effectiveness of community pharmacy interventions 
Development of specifications, performance measures and accreditation options for the delivery of services 
and components included in the model 
Identification of indicators that may be employed to differentiate progress within the model 
Identification of outcome criteria that may be employed to evaluate the effectiveness of the model  
Exploration of the needs, expectations and perceptions of the profession, other healthcare professionals and 
the public have of community pharmacy 
Understanding the barriers to change and appropriate facilitators  
Identifying appropriate specifications for premises and a comprehensive accreditation framework 
 
The HLP model is based on a tiered framework that is designed to quality assure the delivery of specific 
services to meet the local public health demands2. It consists of three levels of advancing service 
provision, each level underpinned by several key principles. Firstly, the services are tailored to local 
health needs with the aim of reducing health inequalities by improving health and wellbeing outcomes 
in their communities. Secondly, a HLP builds on existing core pharmacy services (Essential and 
Advanced) with a series of Enhanced Services. Finally, the delivery of services is supported by three 
enablers: workforce development, with the introduction of health living champions (HLCs); premises 
fit for purpose, with a dedicated health promotion area; and local stakeholder engagement, including 
local GPs and members of the public.  
NHS Portsmouth arranged a stakeholder engagement event in August 2009 designed to involve all the 
community pharmacy teams across the city in the development of the HLP initiative. Attendees were 
encouraged to contribute their ideas of ‘What a HLP would look like” and which health and well-being 
services would be accessible to the customers using these pharmacies. An informed model for HLP 
was launched in December 2009, through publication of a local HLP prospectus32.  
Community pharmacies were invited to apply to be Level 1 HLPs, which required participation in the 
following services: wellbeing and self-care including active health promotion campaigns, optimising 
medicines including delivering targeted respiratory Medicines Usage Reviews (MURs) and providing 
enhanced services including smoking cessation and at least one other enhanced service.  
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The full accreditation criteria are detailed in Table 2.5.  
Table 2.5 Accreditation criteria Level 1 HLP129 
Criteria: A HLP 
 Consistently delivers a range of health and well-being services to a high quality. Every interaction in 
the pharmacy should be seen as an opportunity for a health promoting intervention, ‘making every 
contact count’.  
 Has achieved defined quality criteria requirements and met productivity targets linked to local health 
needs e.g. the number of successful Stop Smoking quits at 4 weeks 
 Has a team that proactively promotes health and well-being and proactively offers brief advice in a 
range of health issues such as smoking, physical activity, sexual health, healthy eating and alcohol.  
 Has a minimum of one Health Champion (also known as Healthy Living Champion), who has achieved 
the Understanding Health Improvement Level 2 Royal Society of Public Health award. The HLC is 
proactive in promoting health and wellbeing messages, signposts the public to appropriate services 
and enables and supports the team in demonstrating the ‘ethos’ of an HLP.  
 Has premises that are fit for purpose for promoting health and wellbeing messages as well as 
delivering commissioned services. The consultation room should be equipped appropriately 
depending on the services offered. 
 Engages with the local community and other health and social care professionals  
 Is recognisable to the public through the display of the HLP logo 
 Leadership training undertaken by an individual involved in a leadership or management position so 
that they can support the development of the pharmacy team and change from providing reactive 
to proactive health interventions.  
 
Comprising the ‘workforce development’ enabler, a non-pharmacist member of the pharmacy team, 
must become a qualified Healthy Living Champion (HLC). This is an individual with an interest in the 
area of public health and a commitment to the HLP concept; they are required to undertake an 
attendance-based qualification in understanding health improvement, as accredited by the Royal 
Society for Public Health130. The HLC has a role in cascading information about health and wellbeing 
onto the rest of the pharmacy team and signposting individuals to appropriate services and 
resources131. 
Further to this a minimum of one member of the pharmacy team is required to attend a leadership 
training course provided by the PCT, which involves elements of effective time management, and 
development of delegation and consultation skills.   
2.8 Demography of Portsmouth  
Portsmouth is a port city on the south coast of England. It holds a population of approximately 207, 
000 people.  This equates to 5,100 people living in every square kilometre, which is eleven times more 
than the regional average. The city is predominantly white in terms of ethnicity, with 84% of the 
population belonging to this ethnic group.132  
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The following data were extracted from the 2012 Health Profile of Portsmouth133,  
 The health of people is generally worse than the England average. Deprivation is higher than 
average and about 9,200 children live in poverty.  
 Life expectancy for men is lower than the England average. Life expectancy for men is 10.8 
years lower and 6.1 years lower for women in the most deprived areas of Portsmouth than in 
the least deprived areas. Approximately 45% of this difference is due to vascular disease- a 
major priority in the city.  
 Levels of teenage pregnancy and smoking in pregnancy are worse than the England average.  
 More than 1,300 people are problem drug users.  
 Estimated levels of adult ‘healthy eating’ and smoking are worse than the England average.  
 Rates of sexually transmitted infections, smoking related deaths and hospital stays for alcohol 
related harm are worse than the England average. 
 Priorities in Portsmouth include reducing harm caused by alcohol, reducing smoking, teenage 
pregnancy, substance misuse and tackling health inequalities.   
Faced with these significant public health challenges, health commissioners in Portsmouth saw that 
community pharmacists could play a larger role in promoting healthy living and improving delivery of 
related services32.  
At the time of introducing the HLP project, there were 32 community pharmacies in Portsmouth134. 
The breakdown of these pharmacies include 19 multiples (greater than 200 outlets), 1 large chain 
(more than 20 outlets but less than 200), 6 belonging to a small chain of pharmacies (20 outlets or less 
but more than 5) and 6 independent contractors (5 outlets or less). These figures reflect the 
community pharmacy market makeup within Great Britain135.  
Pharmacy contractors are required to provide the essential services set in the NHS Pharmaceutical 
and Local Pharmaceutical Regulation 2013, and may choose to provide one or more of the advanced 
services set out in the Pharmaceutical Services Advanced and Enhanced Services Directions 2013. The 
2013 directions also set out the enhanced services, which may be commissioned from pharmacy 
contractors 18. 
Before 1st April 2013, Primary Care Trusts (PCTs) commissioned enhanced services from pharmacy 
contractors in line with the needs of their population. From 1st April 2013, those public health 
enhanced services previously commissioned by PCTs transferred to local authorities. The remaining 
enhanced services may be commissioned by the NHS Commissioning Board, also known as NHS 
England.  
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In 2009, at the time of the HLP pilot, the commissioning of pharmacy services was managed by 
Portsmouth PCT. Services were commissioned from community pharmacies depending on the health 
need within the local area; and the capability and reliability of the pharmacy to deliver the services. 
Portsmouth PCT agreed to support the HLP pilot, committing to the following32 :  
 Support (with the provision of back-fill and co-facilitating) members of the pharmacy to 
become HLCs 
 Providing training for the delivery of the smoking cessation scheme 
 Providing leadership training for pharmacy managers and pharmacists on developing the 
workforce and primary care management 
 Providing training on delivering medicines reviews specific to patients with respiratory disease 
 Delivering regular communication through HLP newsletters 
 Recognising community pharmacy’s achievements though the HLP project; including 
accreditation awards and sharing case studies of good practice 
 Engaging the public and other healthcare professionals in promoting the project.  
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2.9 Evaluation of the HLP project 
In order to explore the success or failure of the HLP initiative as a sustainable model for the delivery 
of public health services within community pharmacies, this project investigated the following broad 
research questions:  
 What were the experiences and views of community pharmacy staff on the implementation 
process of the HLP project within the community pharmacies in Portsmouth?  
 
 As perceived by the community pharmacy staff, what were the major influences and specific 
factors associated with implementing the HLP project within the community pharmacies in 
Portsmouth?  
 
 As perceived by the community pharmacy staff, can an evidence-based intervention 
contribute to the sustained involvement of community pharmacies in the HLP project?  
 
 As perceived by the community pharmacy staff, can the HLP project facilitate the sustained 
involvement of community pharmacies in activities to promote the health of their local 
communities?  
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Chapter 3 : The implementation of the HLP project in 
Portsmouth’s community pharmacies 
 
3.1 Introduction 
This chapter begins by describing the reasons for the need to evaluate the HLP project. The literature 
discussing the implementation of health innovations in various settings is then explored and 
contextualised in relation to the implementation of the HLP project.  Through the use of semi-
structured interviews, the implementation of the HLP project is investigated from the perspective of 
various pharmacy staff. These data are then analysed with reference to the theoretical models of 
implementing innovation in healthcare settings.  
The process of evaluation is guided by the Generic Implementation Framework (GIF)136, an overarching 
framework that collates and illustrates the core implementation concepts. Specific models or theories 
are employed to tailor the GIF to evaluate each concept. This chapter provides further details of the 
GIF and outlines the models or theories selected to evaluate each concept.  
 
3.1.1 The need to evaluate the HLP project  
The shift in community pharmacy services has resulted because of factors such as increased 
prevalence of drug-related morbidity and mortality137, escalating costs of healthcare delivery due to 
demographic changes and technological advancements and increased customers’ demands, 
preferences and expectations138,  as well as the subsequent healthcare policy to address these issues. 
The new roles for pharmacists have evolved in parallel with evidence-based medicine139; further to 
this there is a significant body of evidence that demonstrates that medicine use in practice is less than 
optimal to the detriment of patient outcomes140-142. As new professional services and practices evolve, 
there is a need to demonstrate evidence of their benefit and to identify strategies to promote their 
embedding in every day practice138, 139, 143.  
Often what is needed is local evidence that demonstrates the need for a new service or different 
method of service delivery138, 144, 145. Such evidence is provided through pharmacy practice research 
which can inform policy through demonstrating the value or feasibility of the potential new roles and 
services144, 146-148. This places pharmacy practice research as a driver for establishing new pharmacy 
services and innovative delivery approaches by justifying the need, effectiveness and the value of 
these innovative practices138, 144, 148. Therefore, pharmacy practice research is essential to the 
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advancement of the pharmacy profession and provides the evidence of benefit for new and existing 
practice143, 144, 147.  
The 2013 Royal Pharmaceutical Society (RPS) report, Now or never: Shaping pharmacy for the future39, 
concluded that pharmacy faced a significant challenge in making a case (and hence being 
commissioned and funded) for the provision of a greater degree of patient services aimed at improving 
the use of medicines and helping address wide NHS-wide service problems . The report went on to 
state, that it was vital that pharmacy as a profession found clear and accessible ways of expressing 
what it can and should be giving by way of additional patient services. 
In line with this, recent figures from the Health and Social Care Information Centre show that the 
number of local enhanced services provided by community pharmacies has been falling since the start 
of 2010, sharply reversing an earlier upward trend149. This may suggest that community pharmacy is 
not fully capitalising on its highly-trained professional workforce, local and accessible premises, and 
understanding of local communities in offering commissioners a range of pharmaceutical services that 
can contribute to the solution for the wider NHS concerns. Alternatively, it has also been proposed 
that since the change in the commissioning structure of local enhanced services from Primary Care 
Trust (PCT) to Clinical Commissioning Groups (CCG) and Local Authorities (LA), the complexity of 
commissioning has been more complex and can act as a barrier for the integration of community 
pharmacy services alongside general practice150.   
The HLP project offers an innovative framework for the delivery of additional services, including 
disease prevention services and the promotion of healthy living. An evaluation of this framework is 
necessary to identify its ability to move the profession forward towards a future focused on care 
delivery, and influencing care commissioners, as recommended by the aforementioned RPS report39. 
 
3.1.2 The implementation of the HLP project 
The HLP project was developed in Portsmouth in 2009 with support from the DoH, the Director of 
Public Health for Portsmouth and the Local Portsmouth Pharmaceutical Committee.  
A research team, based at Portsmouth University, conducted a systematic analysis of international 
published research on the potential for and impact of delivery of HLP services, which informed the 
initial Portsmouth HLP framework. This work allowed research evidence to inform the services to be 
offered in the framework and how these services could be delivered2.  
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The implementation of the HLP project included appropriately up-skilling members of the pharmacy 
workforce and promoting the initiative to both the public and other health providers. An overview of 
the Portsmouth HLP implementation strategy was published in a Portsmouth HLP prospectus32.    
 
3.1.3 Defining professional services in community pharmacy  
The transition of community pharmacy practice from a focus on dispensing to one that embraces 
professional pharmacy service delivery is complex151. The area of implementing innovative health 
services has been researched to identify optimal implementation strategies that may be considered 
to inform future design and commissioning of professional pharmacy services.  
Moullin et al. argued that in order to fully appreciate the factors which contribute to the successful 
implementation of a pharmacy service, a broader definition of what constitutes a professional 
pharmacy service is needed, that acknowledges the wider role that community pharmacies play in 
healthcare152. The following definition was proposed: 
A professional pharmacy service has been defined as an action or a set of actions undertaken in or 
organised by a pharmacy, delivered by a pharmacist or other health practitioner, who applies their 
specialised health knowledge personally or via an intermediary, with a patient/client, population or 
other health professional, to optimise the process of care, with the aim to improve health outcomes 
and the value of healthcare152.  
This definition contributes to a holistic understanding of the role and value of community pharmacies 
within a healthcare system, both working as an independent entity and as a collective network. 
Furthermore, applying this definition facilitates the recognition of community pharmacy professional 
services as being diverse in their design and complex in their implementation. Significantly, this 
definition acknowledges that a professional pharmacy service is not restricted to being delivered by a 
pharmacist, but also may be performed by other health practitioners, thereby recognising the role of 
non-pharmacist members of the pharmacy team. Moreover, a pharmacy service must involve the 
application of specialised health knowledge, which appreciates the requirement for appropriate 
training and education153, 154. Finally, the definition asserts that an interaction takes place either 
personally or via an intermediary; in either case this highlights the necessity to be able to communicate 
effectively with a wide spectrum of people in order to deliver community pharmacy services.  
Since the activities included in the HLP project require specialist health knowledge, interaction with 
customers and are delivered by ay member of the pharmacy team, it can be concluded that those 
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services delivered through the HLP project, can be classified as pharmacy services. Thus, in the 
pursuing sections of this chapter, the HLP project will be discussed in the context of an innovation 
within a healthcare setting.   
 
3.1.4 Innovation in healthcare 
Innovation is defined as the intentional introduction and application of ideas, processes, technologies, 
medicines, and services155 that are perceived to be ‘new’ to the relevant unit of adoption156. Adoption 
here is defined as the decision to make use of an innovation by individuals, groups or organisations156. 
Implementation relates to putting innovations into routine practice156, 157. It has been argued that 
adoption of innovation requires changes in behaviours and characteristics, on the part of the 
individual or organisation, should external changes (either individual or organisational) be responsible 
for driving the process158.  
Innovation research has three key elements: context, content and process159, 160. Context is further 
categorised into elements which are internal and those which are external. Internal context relates to 
organisational conditions ‘external’ to the individual160, for example, motivation for change and 
availability of resources. Conditions outside the organisation are referred to as ‘external contexts’155, 
160; these may include public demand and Government policies.  Content refers to identifying features 
of innovations that are likely to be associated with the innovation adoption decision by the adopting 
unit, for example the cost of introducing the innovation and the potential training required160.  The 
phases through which a system or individual adopts an innovation and the key players involved, relates 
to the ‘process’160, 161. 
It has been proposed that an understanding and appropriate management of these key elements is 
critical to the successful implementation of an innovation162. Further to this, it has been reported that 
healthcare practitioners’ failure to successfully adopt innovation is commonly linked to poor 
consideration of contextual and process dimensions of practice change155, 163. The use of theoretical 
models can be used as implementation frameworks to identify the key elements of innovation 
adoption that should be considered. 
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3.1.5 Models and frameworks for change  
It is widely recognised that resistance to change is a common phenomenon164. Numerous 
interventions found to be viable in health services research studies fail to translate into meaningful 
patient care outcomes. In fact, it has been reported that two-thirds of organisations’ efforts to 
implement change fail165. Barriers to implementation may arise at multiple levels of healthcare 
delivery; the patient level, the provider team or group level, the organisational level, or the 
market/policy level166. Health services researchers are increasingly recognising that as well as 
evaluating the summative end point health outcomes, research into the formative evaluation to assess 
the extent to which implementation is effective in a specific context has a critical role167. In recognising 
the factors contributing to successful implementation, it has been argued that intervention benefits 
can be optimised, sustainability of the intervention can be prolonged, and dissemination of findings 
into other context can be enhanced168.  
Many implementation theories to promote effective implementation have been described in the 
literature.  The application of these theoretical models in innovation adoption research allows 
researchers to systematically collect, analyse and/or interpret appropriate data in evaluating the 
adoption of innovation161.  
A comparison of the published models exposes similarity, however there is not one single model that 
encompasses all of the core concepts of the implementation process. Moullin et al.’s systematic 
review of implementation frameworks of innovations in healthcare136 identified that numerous and 
potentially disparate implementation and knowledge translation frameworks are being developed 
and used. The differences in the frameworks included disparate terminology and classification 
concepts. With this, it was realised that implementation frameworks vary in their orientation and that 
it is plausible, by design or otherwise, that not all frameworks targeting a particular innovation cover 
all implementation concepts. However, it was recognised that consistent elements may be 
distinguished. Moullin et al.136 concluded that implementation may be summarised as involving: (1) 
an innovation, and (2) a process, influenced across (3) contextual domains/levels by (4) factors (5) 
strategies (6) evaluations. These concepts were defined as the following:  
 Process of implementation – This was recognised to be a process divided into a series of 
stages or steps (e.g. exploration, preparation, operation, sustainability) 
 
 Contextual domains – Defined as groups or levels of influence and identified as the 
constituents within the factors, strategies and evaluations. This means that there are sets 
of factors that have an influence at various levels of the implementation process; and 
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specific strategies and evaluations can be applied to each level accordingly. (e.g. 
intervention characteristics, outer setting, inner setting, characteristics of the individuals 
involved) 
 
 Three elements – Throughout each stage of the implementation process, three 
fundamental elements were considered: 
1. Factors: Variable that may affect the implementation process. Also termed facilitators 
and barriers or determinants of practice.   
  
2. Strategies: Targeted efforts (method, technique or activity) designed to enhance the use 
and integration of an innovation into routine practice.   
 
3. Evaluations: Measures of the effects of implementation including process evaluation of 
course and factors; formative evaluation of strategies, and summative evaluation of 
implementation and innovation outcomes.  
Moullin et al.136 proposed a Generic Implementation Framework (GIF) to depict the core concepts of 
implementation. (Figure 3.1)  
Figure 3.1 Generic Implementation Framework (GIF)136 
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The GIF endeavours to serve as a general, overarching framework that groups and delineates the 
principal implementation concepts, so that it may be applied across disciplines. Illustrated though the 
use of double arrows and overlapping circles, the authors point out the non-linear and recursive 
nature of the implementation process. Further, the model recognises that the implementation process 
can be split up into various stages and/or steps. The focal point of the model is the innovation to be 
implemented and encompassing the innovation are the contextual domains, which can affect the 
process of implementation. At each stage and for each domain of the implementation process, there 
are factors, strategies and evaluations that need to be considered due to their potential impact on the 
course of implementation.  
The authors point out that the GIF is not a new framework, yet rather a composite of  what is 
represented in most, if not all, other frameworks and that employing the GIF acts as checklist to 
guarantee that the specific implementation framework(s) selected encompass the core 
implementation concepts.  
 
3.1.6 Rational for use of the Generic Implementation Framework (GIF)  
The GIF has been employed in this study since its skeletal structure permits the adoption of multiple 
theories to facilitate and cater for the investigation of each implementation element136. Considering 
that the pharmacy practice literature is yet to report on the specific factors, strategies and evaluations 
encountered during the various stages of the implementation process of an innovation, the GIF serves 
as a model to capture and map this data in an articulate format.   
To tailor the GIF to evaluate the implementation of the HLP project, it is therefore necessary to identify 
implementation theory that is aligned with research in pharmacy practice.  
In the following sections, the implementation of the HLP project is discussed with reference to the 
GIF. The processes of implementation, domains, factors, strategies and evaluations cited in the 
literature that are most relevant to innovation within pharmacy practice, will be explored. Specific 
detail of findings from studies investigating the implementation of interventions within community 
pharmacy will be included to add further context.  
Table 3.1 outlines the frameworks and models relating to the various concepts included in the GIF that 
will be described in the following sections.  
  
 49 
Table 3.1 The frameworks and models to be considered in evaluating the implementation of the HLP 
project 
GIF concept  Framework to be considered for evaluating the 
implementation of the HLP project 
Process of implementation  
(i.e. stages in the implementation 
process)   
 Greenhalgh et al.169, Moullin et al.136 
Contextual domains  Damshroder et al.170 
Factors  Damshroder et al. 170, Royal Pharmaceutical Society39  
Strategies  Powell et al.171, Roberts et al.172 
Evaluations  Procter et al.173 
 
3.1.6.1 The Generic Implementation Framework (GIF) processes of implementation and 
domains 
The process of implementation and domains has been discussed by Greenhalgh et al.’s systematic 
review of innovations in service oraganisations169.  In this report, Greenhalgh et al. proposed and 
articulated an evidence-based model for considering the diffusion of innovations in health service 
organisations (Figure 3.2) 
The model recognised many of the cited themes in the literature such as the detailed description of 
innovation attributes that may contribute in identifying whether successful implementation is likely; 
the significant role of social influence and the networks through which it operates; the complexity and 
unpredictability of the process of implementation; organisational attributes that promote or 
discourage innovation; and the challenging-to-research process of assimilation and implementation 
as routine.  
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Figure 3.2 Conceptual model for considering the determinants of diffusion, dissemination, and 
implementation of innovations in health service delivery and organisation, based on a systematic 
review of empirical research studies169 
 
Greenhalgh et al.169 included the implementation stages within their conceptual framework (diffusion 
and dissemination, adoption/assimilation, and implementation) and detailed the implementation 
activities which take place at each stage. However, there are stages identified in further studies which 
are not alluded to in the Greenhalgh et al. model. The pre-implementation stage of ‘development’, 
(which includes innovation creation, refinement and impact evaluation)174; and post-implementation 
stage of ‘sustainability’175. Moreover, based on a systematic review of implementation frameworks of 
innovations in healthcare136, Moullin et al.136 proposed that diffusion and dissemination be combined 
under the heading of ‘communication’ and described this stage as the process by which people share 
information about a new innovation to increase awareness. They also suggested that the 
adoption/assimilation phase be divided into two sub-stages of ‘exploration’, which details the 
innovation-decision process, whereby the end-user(s) appraise the innovation to decide whether to 
adopt; and ‘preparation’ which describes the course of preparation prior to use. Implementation or 
operation refers to the stage whereby the innovation is in use and is in the process of being integrated 
into routine practice through active and planned approaches.  
 51 
The implementation stages that were considered in evaluating the implementation of HLP are those 
initially proposed by Greenhalgh et al. and since adapted by Moullin et al. for use within a healthcare 
context (Table 3.2).  
Table 3.2 Stages and activities of the implementation process as articulated by Moulin et al.136   
Stages of implementation  
Development This stage comprises of identification or creation, synthesis, refinement of an innovation 
through knowledge transfer.  
Communication The process by which people learn and share information about a new innovation to 
increase awareness. This may occur through diffusion, a passive untargeted and 
unplanned means or through dissemination using planned strategies via determined 
channels.  
Exploration The innovation-decision process whereby the end-user(s) appraise the innovation 
concluding with a decision to either accept/adopt or reject. Involves progression though 
awareness, knowledge, persuasion, opinion and decision regarding the innovation.  
Activities include assessment of relative advantage, compatibility, community, complexity, 
risk, augmentation/support, task issues and knowledge. A decision whether or not to 
adopt is then made. 
Preparation The course of preparation (this may apply to the innovation, individuals, organisation, local 
environment and external system) prior to innovation use.  
Activities include: planning procedures, organising supporting conditions, training, 
community awareness and recruitment, team communication, staff arrangements, 
rearrange workflow, research requirements, assign leader.  
Operation  Innovation is in use and is in the process of being integrated into routine practice through 
active and planned approaches.  
Activities include: improvement, adaptation, monitoring, goal setting, ongoing training, 
integration tactics, teamwork, staffing, maintain customer demand, modification of plans 
and procedures.  
Sustainability Process of maintaining the innovation through continued use, integrated as routine 
practice and yielding persistent benefits.  
Activities include: obtaining feedback adaptation/reinvention, seeking diverse funding 
streams, communication, and improvement.  
 
Since the publication of Greenhalgh et al.’s conceptual model, it has been cited in multiple 
implementation science studies. Damschroder et al.170, attempted to establish a Consolidated 
Framework for Implementation Research (CFIR). The CFIR specifies a list of factors within general 
domains that are believed to influence implementation based on the strength of their support in the 
literature.  Damshcroder et al.’s CFIR provided further theoretical and practical support for the 
conceptual model proposed by Greenhalgh et al. Further, through their findings, Damschroder et al. 
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were able to categorise and refine the content of the Greenhalgh et al.’s conceptual model to 
emphasise the domains and factors that reflect a professional consensus within healthcare settings.  
The CFIR is composed of five major domains: intervention characteristics, outer setting, inner setting, 
characteristics of the individuals involved in implementation, and the process by which implementation 
is accomplished. The authors point out that these domains interact in complex ways to influence the 
effectiveness of the implementation process within healthcare settings.   
The first major domain relates to the characteristics of the intervention. Damschroder et al. recognised 
that when interventions are introduced to a setting, they require adaptation in order to promote 
acceptance by individuals who will be affected and a strategy to engage individuals is needed to 
enhance their implementation. The authors noted that interventions within healthcare are often 
complex and multi-faceted, with many interacting components, such is the case of the HLP project, 
which comprises of a diverse accreditation criteria (service delivery, workforce development and 
engagement with local stakeholders).  
The CFIR distinguishes between inner and outer settings. The outer settings are those features of the 
external environment that might influence implementation. This could include the economic, political, 
and social context within which an organisation resides. Since the HLP project is a Department of 
Health commissioned programme, the national and local commissioning setup and local health 
inequalities pose significant external influences.   The inner setting includes features of the 
implementing organisation that might influence implementation, including the structural, political and 
cultural contexts through which the implementation process will proceed. The inner contexts 
therefore, represents many of the organisational structures, cultures, inputs and resources, and 
processes and practices that characterise everyday practice and influence implementation, these may 
vary from one pharmacy to the next.  
Importantly, it was noted that it can often be challenging to differentiate between inner and outer 
settings and this will be dependent upon the context of the implementation. 
The fourth major domain is the individuals involved with the intervention and/or implementation 
process. The CFIR acknowledges the influence of individuals’ contribution, recognising that they are 
carriers of cultural, organisational, professionals and individual mind-sets, norms, interests and 
affiliations. In this study, the influence of the community pharmacy staff with regards to 
implementation of the HLP project will be investigated. 
The implementation process is the final domain whereby it has been recognised that successful 
implementation usually requires an active change process to achieve individual and organisational 
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level use of the intervention as designed. This domain therefore includes strategies or tactics that 
might influence implementation of the HLP project (e.g. engaging appropriate individuals in the 
implementation process and use of the project) 
The CFIR has since been utilised in pharmacy practice research to map implementation factors over 
the various stages of implementation176, 177. In investigating the implementation of the HLP project, 
the CFIR five domains were used within the GIF to provide a pragmatic structure that unifies key 
factors from published implementation theories.  
 
3.1.6.2 The Generic Implementation Framework (GIF) factors  
From published implementation theories, Damschroder et al. identified a series of significant factors 
that may be encountered during various levels of implementation; these were proposed to be 
essential in supporting the five domains. Many of these factors were described in Greenhalgh et al.’s 
conceptual model; however the CFIR organises the factors into the five domains and also includes 
factors supported in related research.  
These factors have been cited in recent work examining the implementation of complex health 
interventions within community pharmacy177, 178 and will be utilised within the GIF to provide a 
theoretical framework in understanding the factors that may influence the process of implementation 
of the HLP project. Table 3.3 details the CFIR factors170. 
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Table 3.3 The Consolidated Framework for Implement Research (CFIR) factors identified to influence 
the successful implementation of an intervention170. 
Domain 1: Intervention – characteristics of the intervention itself 
 Intervention source: Perception about whether intervention is externally or internally developed 
 Evidence Strength & Quality: Perception of the quality and validity of evidence supporting the belief 
that the intervention will have desired outcomes 
 Relative Advantage: Perception of the advantage of implementing the intervention versus an 
alternative solution 
 Adaptability: Degree to which an intervention can be tailored to meet the needs of an organisation 
 Trialability: Ability to test the intervention on a small scale, and to reverse course if warranted 
 Complexity: Perceived difficulty of implementation  
 Design Quality & Packaging: Perceived excellence in how the intervention is bundled and presented 
 Cost: Cost of the intervention and costs associated with implementing the intervention 
Domain 2: Outer Setting – factors external to the organisation 
 Patient Needs & Resources: Extent to which patient needs are accurately known and prioritised by the 
organisation 
 Cosmopolitanism: Level of connectedness and networks with other organisations 
 Peer Pressure: Competitive pressure to implement an intervention 
 External Policy & Incentives: external strategies to spread interventions, including policy and 
regulations, mandates, recommendations and guidelines, etc. 
Domain 3: Inner Setting - characteristics of the organisation implementing the intervention 
 Structural characteristics: Age, maturity, or size of the organisation 
 Networks & Communication: Nature and quality of webs of social networks and the nature and quality 
of formal and informal communications within an organisation 
 Culture: Norms, values, and basic assumptions of a given organisation 
 Implementation climate: Relative priority of implementing the current intervention versus other 
competing priorities 
 Readiness for Implementation: Access to resources, knowledge, and information about the intervention 
Domain 4: Individuals - characteristics of the individuals involved in implementation 
 Knowledge and Beliefs about Intervention: Individual staff knowledge and attitude towards the 
intervention  
 Self-efficacy: An individual’s belief in their capabilities to execute the implementation  
 Individual State of Change: Phase an individual is in as he or she progresses toward skilled, enthusiastic, 
and sustained use of the intervention 
 Individual Identification with Organisation: Individuals’ perception of the organisation and their 
relationship and degree of commitment to the organisation 
 Other Personal Attributes: Personal traits such as tolerance of ambiguity, intellectual ability, 
motivation, etc. 
Domain 5: Process – processes of implementation 
 Planning: Planning for the implementation 
 Engaging: Engaging individuals in implementation processes 
 Executing: Executing the implementation plan 
 Reflecting & Evaluating: Reflecting and evaluating the progress of implementation 
 
Importantly, there is similarity between those factors discussed in the CFIR and the factors identified 
to affect the implementation of innovation in community pharmacy. These factors have been well 
documented and were summarised in the 2013 RPS report of the Commission On Future Models Of 
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Care Delivered Through Pharmacy39. The report discussed the reported barriers to implementing 
innovation and new models of care involving pharmacy (Table 3.4); pharmacy being marginalised 
within the NHS affects can be seen as their level of connectedness and networks with other 
organisations (cosmopolitanism); poor public understanding, lack of leadership and inadequate 
commissioning are linked to the external policy and incentives responsible for developing strategies 
to increase awareness of interventions and the failure of the profession to influence such policies. The 
lack of a structured development pathway and profession isolation may be linked to inner and outer 
settings as well as individual characteristics such as the individual state of change, the implementation 
climate and external incentives.   
Table 3.4 RPS reported barriers to implementing innovation in community pharmacy39 
Reported barrier 
Pharmacy is marginalised within the NHS 
Poor public understanding of the role of pharmacists 
Pharmacy lacks leaderships and consistent vision 
Pharmacy needs a more structured development pathway 
Community pharmacists are often professionally isolated 
Pharmacy services are not well commissioned 
 
3.1.6.3 The Generic Implementation Framework (GIF) strategies 
To overcome recognised barriers to the implementation process, researchers have proposed 
theorised facilitators as well as reporting on tested strategies employed to enhance implementation. 
In the area of community pharmacy, the concept of developing strategies to facilitate change is a less 
well-developed area. Roberts et al. conducted a review of the literature to investigate the specific 
facilitators of change in the implementation of community pharmacy services172.  
The identified facilitators were split into two categories:  individual and organisations. (Table 3.5)   
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Table 3.5 Facilitators of change in community pharmacy172 
Individual facilitators 
 Pharmacist competence 
 Education and training for pharmacy assistants 
 Education and training for pharmacists 
 Communication skills 
 Motivation 
 Leadership skills 
 Professional satisfaction 
 Pharmacists’ knowledge of community pharmacy 
services 
 Pharmacists’ attitudes towards services 
 Pharmacists’ confidence in ability to provide 
services 
 Autonomy 
 Attitude of pharmacy staff 
Organisational facilitators 
 Physical environment e.g. adequate 
space/privacy and workflow 
 Culture of the pharmacy 
 Remuneration/incentives 
 Sufficient and qualified staff/manpower 
 Use of pharmacy technicians 
 Delegation of tasks 
 Innovative practice orientation  
 Customer demands/expectations 
 Relationships with doctors 
 Equipment and technology e.g. computers 
 Access to patient information/records 
 Documentation system 
 Profile within local community 
 Attention for special patient groups 
 Use of protocols 
 
 Interaction with other pharmacists 
 Support for management 
 Access to reference literature 
 Pharmacist-customer relationship 
 Marketing 
 Support from professional organisations and/or 
Government 
 Low script volume 
 Legislation requiring or supporting provision of 
services 
 Attitude/perception of doctors 
 Attitude/perception of customers 
 Examples from leading practitioners 
 External advisors or mentors 
 Evidence of benefits of services 
 
Further to this, Powell et al.179 presented a list of implementation enabling strategies based on a 
review of the healthcare literature which has since been refined following expert 
recommendations171. The compilation is grouped into six key implementation processes: planning, 
educating, financing, restructuring, managing quality, and attending to the policy context. The authors 
suggest that their findings can serve as a reference to stakeholders who wish to implement clinical 
innovations in healthcare.  The facilitators identified by Roberts et al. resonate strongly with Powell et 
al.’s findings, however they were not mapped to the specific phases of the implementation process, 
as articulated by Powell et al.  
Roberts et al. also identified that despite recognition of these facilitators, researchers and 
commissioners have continued to focus on remuneration as the single most important factor in 
introducing innovation in community pharmacy with little consideration to other factors. 
Furthermore, the authors highlight that a large majority of studies reporting on the implementation 
process of community pharmacy services have involved ‘leading edge’ practitioners (also termed 
 57 
‘early adopters’), giving rise to the concept that these innovative pharmacists may themselves be 
facilitators.   
The literature which discusses designing strategies to achieve these facilitators acknowledges that 
implementing pharmaceutical care programmes that attempt to address individual factors in isolation 
will not be successful180. Change management research supports this notion in recognising that an 
understanding of social trends and forces affecting an organisation is essential in facilitating effective 
change management 181.  
Powell et al.179 list of implementation enabling strategies was used to aid in recognising and 
understanding the strategies employed to overcome barriers encountered during the implementation 
process of the HLP project. 
 
 3.1.6.4 The Generic Implementation Framework (GIF) evaluations 
The topic of how to conceptualise and evaluate successful implementation is one that has been 
discussed in the literature182, 183. It has been reported that studies of implementation use widely 
varying approaches to measure how well an innovation is implemented. Some infer implementation 
success by measuring clinical outcomes at the customer or patient level, while others measure the 
actual targets of implementation, quantifying for example the desired provider behaviours associated 
with delivering the innovation.  Proctor et al.173 distinguished the concept of implementation 
outcomes from service system outcomes and clinical treatment outcomes. The authors argue that in 
making this distinction, it is possible to assess that if an innovation fails, whether the failure occurred 
because the intervention was ineffective in the new setting, or if a good intervention was deployed 
incorrectly. In reviewing and discussing the literature, the authors formed a working taxonomy of 
implementation outcomes: acceptability, adoption, appropriateness, feasibility, fidelity, 
implementation cost, penetration and sustainability. Using these implementation outcomes, it is 
proposed that the success of implementation may be modelled and tested thus facilitating the design 
of informed strategies to increase provider acceptance, improve penetration, reduce implementation 
costs, and achieve sustainability of the innovation being implemented.  
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3.1.7 Summary of models to be used within the GIF in evaluating the implementation of 
HLP  
Sections 3.1.6.1 to 3.1.6.4 have discussed conceptual models that may be used to tailor the GIF for 
the evaluating the implementation of the HLP project.  
The conceptual models selected for guiding the evaluation the various elements of the GIF in this 
study are summarised in Table 3.6.  
Table 3.6 The conceptual models selected to use within the GIF for guiding the evaluation of the HLP 
implementation. 
 
3.1.8 Aim and objectives 
The work undertaken in this chapter aimed to explore the implementation process of the HLP within 
Portsmouth’s community pharmacies. The concepts of the Generic Implementation Framework (GIF) 
were used in order to tailor a set of frameworks for the implementation process.  
The research had the following objectives:  
 To identify the extent was the HLP project implemented in Portsmouth’s community 
pharmacies. 
 To investigate the reported implementation activities undertaken within the pharmacies. 
 To identify the reported challenges encountered in the implementation of the project and 
how do these compare to those included in Damschroder et al.’s CFIR. 
 To identify the strategies were employed to enhance the implementation process. 
 To identify the influences associated with the implementation of the project.  
 
GIF concept Framework to be considered for evaluating the implementation of the 
HLP project 
Process of implementation  Greenhalgh et al., Moullin et al.  (Exploration, preparation, operation, 
sustainability)  
Contextual domains 
(influences) 
Damschroder et al.’s Consolidated Framework for Implementation 
Research (CFIR) (Intervention characteristics, outer setting, inner setting, 
characteristics of the individuals involved, process by which 
implementation is accomplished.)  
Factors 
  
Those listed under the domains within Damschroder et al.’s Consolidated 
Framework for Implementation Research (CFIR) 
Strategies Powell et al. list of implementation enabling strategies  
Evaluation  Proctor et al. working taxonomy of implementation outcomes 
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3.2 Methodology 
The research aims signal the endeavour to explore experiences and views, which stem from an 
observable, objective reality, this study is situated within the critical realist paradigm. Critical realism 
highlights how, similarly to positivism, critical realism acknowledges an objective and intransitive 
reality which occurs independently of our knowledge. Forming part of this reality are the people, 
structures, norms, events and mechanisms within society which have independent and causal 
powers184.  
Critical realism is appropriate for this study as it views reality as complex and multiple rational; it 
recognises the significant role of agency and structural factors that influence human behaviour, which 
can be explained through the use of qualitative research methods. Critical realism postulates that 
there is an intransitive world that is real, and a transitive take on the world through the perceptions 
and theories that individuals develop about it. The transitive ‘reality’ is a human construction- 
influenced by factors such as individual values and ideas, interactions, experiences and contexts, 
which inevitably influence what is perceived and understood of ‘reality’185.   The focus of a critical 
realist approach therefore involves investigating the mechanisms and structure underlying perceived 
events and identifying significant relationships or tendencies between phenomena. Adopting a critical 
realist approach acknowledges that causal mechanisms are facilitated or hindered by human agency, 
and the time and social context in which they operate; therefore in order to determine “what works 
best, for who and under what circumstances?” it is essential to view an individual’s experience within 
those facilitating and constraining contexts in which they exist. Examination of data collected by 
various qualitative methods such as semi-structured interviews or questionnaires can be used to 
facilitate this approach186.  
This following sections review the methodology and methods that were applied throughout the 
research reported in this chapter of the thesis. A summary of the approaches to data collection and 
generation, analysis and interpretation of findings are presented along with reasons for the selection 
of such approaches as well as their shortcomings, where appropriate.  
3.2.1 Methods overview  
This study gathered the views of various community pharmacy staff working from Portsmouth’s 
community pharmacies in order to evaluate the research questions in Section 3.1.7. These pharmacy 
staff included pharmacy owners, pharmacy managers, employee pharmacists, pharmacy technicians, 
dispensers and medicines counter assistants.  
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The study followed a qualitative evaluation research approach, where data were collected from one-
to-one semi-structured interviews. These interviews were transcribed verbatim and subject to 
framework analysis; a pragmatic approach for considering practice related questions and providing an 
intuitive means of organising qualitative data. Evaluation research is action orientated and conducted 
to determine value or impact, with a view to making recommendations for improvement184, and as 
such is conducted  within the political and organisational context of the appropriate setting185, 186. The 
research method aims to represent the range of perspectives of those who are directly involved in the 
implementation and delivery of the HLP project and places emphasis on ascertaining relationships 
between activities and outcomes185.  
In the following sections, the methodologies selected to carry out this study are discussed including 
their rationale and associated practicalities. Figure 3.3 illustrates an overview of the study 
methodology.  
 
Figure 3.3 Overview of study methodology to investigate the implementation and early perceived 
outcomes of the HLP project. 
 
 
3.2.2 Rationale for adopting qualitative design  
On assessing the problem under investigation, it was deemed that a methodology of qualitative design 
was the most suited to this study. Qualitative methods have been identified to be especially useful in 
establishing relationships between events and how study subjects perceive them to be187. This can be 
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applied to the work conducted in this chapter, whereby an innovation was the focus of the research, 
about which very little is known. Individuals were interviewed to explore their experiences and 
perceptions regarding the implementation of the HLP within community pharmacy. The literature 
suggests that in order to optimise opportunities for exploring views of individuals and to describe and 
analyse the culture and behaviour of groups that qualitative designs should be employed188-192. It can 
be argued that programme implementation involves a social element, making it necessary to 
investigate the social context in which it occurs to understand patterns and outcomes. Furthermore, 
due to qualitative methods considering the full account of the many interaction effects that take place 
in a dynamic setting, they are particularly appropriate for evaluating healthcare service delivery, 
where the methods chosen must be capable of dealing with complexities193, 194.  
Extensive healthcare research utilises qualitative designs and its use in successfully addressing specific 
problems within pharmacy practice have been reported195-197. Qualitative methods have enabled the 
evaluation of education and training initiatives based on the views of different stakeholders and to 
gather information on perceived relevance, improvements in the knowledge and skills base, changes 
in practice, overall value and acceptability198-202.  
There are critics of qualitative methodology, who have labelled it as ‘unscientific’ or ‘anecdotal’, as 
findings may be based on subjective accounts203, 204 and that they may provide context to what people 
say as opposed to what they do204. However, in order to allow for the qualitative research to be 
undertaken in a transparent way, so that findings are valid and reliable, a number of strategies can be 
deployed. Such measures have been adopted throughout the stages involving qualitative 
methodology in this research204.  
 
3.2.3 Rationale for the choice of data collection method  
One-to-one interviews199, 205-207 have been used widely in healthcare and pharmacy practice research 
in order to provide rich insights into people perspectives. They usually use an ‘in-depth’ approach 
which allows participants enough time to develop their own accounts of the issues important to 
them204. In semi-structured approaches, the researcher uses a pre-determined agenda, based around 
the research questions, and allows the participant to determine the kind of information produced as 
per the importance to them204. 
 The rationale behind employing one-to-one, semi-structured interviews was that the participants 
were either in full-time or part-time employment at various locations across the city of Portsmouth 
and therefore group interviews would have been very difficult to arrange. It was found that 
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interviewing participants at their place of work was the only practical way to make participation 
possible. The use of one-to-one, semi-structured interviews enabled a focused and in-depth 
exploration of single ideas24, 208. In addition, data collected through one-to one had the potential to 
overcome group polarisation expected in group discussions and group dynamics which have silenced 
individual voices24, 209. 
 
3.2.4 Rationale for use of framework analysis 
Framework analysis has been applied to similar qualitative research in the field of pharmacy practice 
research where the experiences of healthcare professionals are being investigated176, 210-212. It has 
been argued that using a framework technique facilitates a more structured method of data collection 
and analysis whereby a deductive approach can be taken initially (based on pre-set aims and 
objectives) and then a more inductive approach (through interpretation of original accounts and 
observations)195. Also, framework analysis promotes the identification of relationships between 
various thematic sections to help organise emerging patterns and form explanations.  
A significant benefit framework analysis offers this particular study, where there was a large volume 
of data collected, is that it helps to organise the data through summarising narratives within charts 
and condensing discourses, whilst maintaining a link to the original data. (References were made to 
the original data using NVivo software213.) 
The analysis encompasses five key stages: familiarisation of data; identification of a thematic 
framework; indexing; charting; and mapping and interpretation (Table 3.7).  
Table 3.7 The five stages of the framework analysis method for data management 
Stage Descriptions 
1. Familiarisation of data Reading and re-reading transcripts 
2. Identification of a 
thematic framework  
Generating codes, concepts and themes based on research aims 
3. Indexing  Systematic application of the coding framework 
4. Charting Creating charts with participants across rows and themes down columns 
to provide a picture of the data to be viewed by others 
5. Mapping and 
interpretation  
Filling in the corresponding cells for row x column with quotes, 
interpretation and/or summaries 
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Data from transcripts are labelled, sorted and compared once the researcher is thoroughly ‘familiar’ 
with it. Themes emerge during this familiarisation process and then are ‘indexed’. The indexed 
material is then synthesised to define the framework.  
 
3.2.5 Literature review  
Prior to carrying out the study, a review of research and policy literature was conducted to investigate 
previous studies reporting on the implementation and delivery of community pharmacy services 
(Chapter 2). The literature was accessed through the University of Portsmouth library resources and 
facilities. Additional literature was obtained via inter-library loans. A search of online resources was 
supplemented by a manual search and following references in material accessed, which included key 
pharmacy and healthcare databases and web pages. The literature review comprised of three parts: 
firstly, literature relating to the implementation of change and innovation in pharmacy practice, 
secondly to the delivery of services in community pharmacy, and thirdly to specific published literature 
and grey literature around the contextual background of the HLP project. Initially, there was an 
attempt to limit the literature review to material from the last ten years, however, the fact that some 
texts of historical interest proved useful in the understanding of contextualising recent policy changes 
– led to an extension of this timeframe to the last 15 years. This was particularly the case for articles 
and documents that described the evolution and development of community pharmacy services. A 
list of databases searched and key terms used can be found in Appendix 3.1.  
Learning derived from the literature was used in establishing a background for this study and 
identifying important issues for the topic under investigation. This informed the design of the research 
questions, interview guide and analysis of the data obtained.  
 
3.2.6 Data collection  
3.2.6.1 Sampling and recruitment  
In order to identify study subjects, purposive sampling was used, where recruitment is context 
based208, and sampling allows participants to be chosen from sampling based on participant 
demographics or other characteristics. This strategy is supported in qualitative studies214 as it enables 
selection of a wide range of participants who have the potential to provide rich, relevant and diverse 
data pertinent to the research question195.  
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The sample population were those staff employed within Portsmouth’s community pharmacies. These 
staff fell into one of two groups; there were staff who were either, aware and actively involved in the 
HLP project through undertaking or planning the activities as set out in the HLP criteria; or there were 
staff who had consciously decided not to participate in the project. This included both pharmacist and 
non-pharmacist members of the community pharmacy team. No limits were placed on the number of 
potential participants since it was recognised that the process of implementation has its specific 
challenges to individual pharmacies and has the potential to impact pharmacy staff in different ways; 
thereby it was deemed that additional data may generate new information.   
The rationale for including non-pharmacist staff was to not exclude those community pharmacies 
which did not have a regular employed pharmacist, since at the time of the study, national statistics 
indicated that 24% of the community pharmacy workforce was locums215.  
Furthermore, the literature had indicated a significant contribution of non-pharmacist staff in the 
implementation of innovation within community pharmacy108.  
A list of the community pharmacies, which fell within the Portsmouth City commissioned area was 
obtained from the commissioner’s office (Portsmouth Primary Care Trust now Portsmouth CCG) 
Participants were recruited through telephone contact made by the author to each community 
pharmacy. Potential study participants were invited to participate verbally; whereby the author 
explained that the study sample included both pharmacist and non-pharmacist staff and was not 
limited in the number of participants. A date for the researcher to conduct the interviews at the 
pharmacy was arranged. A study information sheet and consent form, which included details about 
the project, was sent by mail prior to visiting the pharmacy, once an appointment had been made. A 
copy of this information sheet and consent form are shown in Appendix 3.2.  
 
3.2.6.2 Interview design  
A semi-structured interview schedule was developed to guide the interview process since the main 
purpose of employing qualitative interviewing is to reduce the potential for predetermined responses 
and to explore emerging ideas216. This type of schedule does not constrain the interview process as it 
permits the use of alternative wording and the use of prompts in order to aid understanding and 
obtain full responses216, 217. If used appropriately, this method can also contribute towards respondent 
validation218, in that the moderator may request to clarify meaning to reduce the potential for 
misinterpretation219. The interview schedule was designed to be non-directive with the inclusion of 
informal open-ended questions to explore the views and experiences of the participants within the 
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HLP project.  Funnelling220 was used to sequence the questions, whereby interviewees were initially 
asked broad questions to elicit general views, this was then followed by prompts in order to generate 
discussion, establish more specific concerns or determine a context for participants to express their 
views221. Consistent with the qualitative methodologies, the interview guide was developed to follow 
an iterative process rather than a linear one, in which questions were used in a flexible way, and 
refocused in light of participants’ responses, with the interviewer investigating significant and 
noteworthy communication which changed or developed. Consequently, the interviews conducted 
were focused and systematic, whereby flexibility was combined with structure218 and thereby 
facilitating the robust analysis of the data and enhanced validity222.  
Four topic areas were included in the interview schedule. The literature discusses that between four 
and nine topic areas may be considered in the design of an interview of one-hour duration223. However 
it was deemed that breadth and depth of topic exploration was of greater significance to investigate 
and therefore the decision was made to limit the interview guide to four topic areas. A maximum one-
hour interview was deemed most appropriate because participants would likely be put off by an 
interview longer than this and the interviews were scheduled to take place during operating hours 
and in some pharmacies multiple participants were scheduled for interviews. Secondly, the researcher 
was mindful that with longer interviews the ability to obtain a complete set of data from each 
participant is put at risk by interviewer and participant fatigue224.  
The initial design of the interview schedule was set around four key elements of the implementation 
process.  A question to provide participants the opportunity to add anything to what had been covered 
in the interview was also included. This initial version of the schedule underwent a pilot and was 
amended to emphasise the focus on areas of particular importance and to remove questions that did 
not contribute towards achieving the aims of the study. More details about the pilot interview can be 
found in Section 3.2.6.3. The questions included in the interview schedule are provided below and the 
final version of the interview schedule is shown in Appendix 3.3.  
 
 
 
Interview schedule:  
 
Section 1: Addresses the exploration stage of the implementation process 
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1. Can you tell me how and why you decided to engage/not engage in the HLP project..  
Section 2: Addresses the preparation stage of the implementation process 
2. After deciding, what were your next steps?  
Section 3: Addresses the operation stage of the implementation process 
3. What challenges have you faced to get to where you are with HLP and how have you 
overcome these challenges?  
4. What qualities or attributes do you think are present in this pharmacy that have enabled it 
to progress with HLP and how have these been supported?   
5. What does it feel like to work here? What has changed to accommodate the HLP project?  
6. What skills have you developed in order to be able to successfully deliver the HLP role?  
7. What sort of benefits do you get from being an HLP and how have you recognised this?  
Section 4: Address the sustainability stage of the implementation process 
8. Would you describe HLP as routine day-to-day practice in your pharmacy? What barriers do 
you face to sustain HLP activities or increase the range of services you offer here?  
 
9. Any other comments.  
3.2.6.3 Interview pilot 
The pilot interview involved a community pharmacist, working in a pharmacy working towards HLP 
accreditation. The purpose of conducting the pilot was to observe whether the questions elicited the 
desired breadth and depth of response224 . 
The length of the pilot interview was 48 minutes; during this time the participant appeared motivated 
and provided thorough responses to the questions posed.  Moreover, this was found to be an 
adequate amount of time for exploration of the key topics areas included in the schedule. Therefore 
the interview schedule was kept largely unchanged with only minor amendments made to a number 
of the prompts to provide further clarity, consequently it was deemed appropriate to include these 
data in the analysis.      
 
3.2.6.4 Interviews 
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No incentive was provided for participation in this study. Prior to each visit to a community pharmacy, 
a telephone call was made to check whether participants were present and able to undertake the 
interview. The interview schedule was employed to conduct one-to-one face-to-face interviews in a 
suitable quiet place in the pharmacy, where interruptions would be avoided; predominantly in the 
pharmacy consultation room or staff room. To ensure confidentiality and allow the interviewee to 
speak freely about their views, a request was made to the other pharmacy staff not to enter the 
consultation room or staff room whilst the interview was taking place.    
The interviews began with a short introduction and explanation about the study and its purpose, and 
an opportunity for study participants to ask questions about the research. Even though an information 
sheet was sent to each participant prior to the interview, the researcher began each interview with 
reiterating the nature and purpose of the research, reaffirming confidentiality and then sought the 
participant’s permission to record the interview. The participant was then requested to sign a consent 
form agreeing to participate. Interviewees were requested to speak honestly in providing their 
opinions. It was made clear that there were no correct answers and that participants could withdraw 
their involvement at any point. Before each interview, participants were requested to complete a 
short questionnaire to obtain information of their demographics and place of work; this information 
would be used in the analysis of the data. Once the participant had completed the questionnaire and 
handed it to the researcher, the audio recorder was switched on and the interview commenced.  
Following the interviews, the researcher thanked the participants for their involvement and briefly 
described the next phase of the research. To ensure consistency, an interview checklist was used; this 
is provided in Appendix 3.4.    
After each interview, field notes were made summarising the researcher’s overall impression of the 
interview and any initial thoughts in apparent key themes. These notes were used to aid analysis of 
the audio recording transcripts.  
 
3.2.6.5 Audio recording and transcription 
Participants were informed that they would not be identified in any of the study’s output; thereafter 
written consent was obtained prior to conducting each interview. The form used to obtain consent 
can be found in Appendix 3.2. A digital audio recording device (OLYMPUS DS-80) was used to ensure 
high sound quality. It has been argued that such recording devices may be perceived as intrusive and 
act as a barrier in participants feeling relaxed to respond honestly225. However in the context of this 
study where multiple interviews were conducted, such a recording device was deemed indispensable. 
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In this study, the researcher perceived through observing the participant’s behaviour that the 
presence of the recording device was largely ignored and therefore its effects on their responses were 
believed to be minimal.  The audio files from the digital recorder was downloaded to a password 
protected laptop and labelled with an appropriate reference code. Later the audio file was transcribed 
verbatim by the author using NVivo QSR 9 software. A second member of the research team checked 
the transcriptions for accuracy. Care was taken to include all verbal communication and non-verbal 
gestures in the transcriptions. To ensure anonymity, identifiable information within the transcript was 
removed and a relevant participant reference number was assigned to each of the participants.   
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3.2.7 Data analysis 
 
3.2.7.1 Overview of data analysis  
The data set was subject to framework analysis in a way consistent with previous qualitative studies176, 
226-229. The process of Framework Analysis was iterative, rather than comprising five sequential stages, 
and involved successive analyses over several months. The five stages and associated practical details, 
are summarised in Table 3.6.   
The first phase of the framework methodology was familiarisation of the raw data by listening to the 
audio, to confirm accuracy of the transcripts, and to note key ideas and recurrent themes. Secondly, 
the stages of the implementation process were used as the overarching themes (according to the 
definitions provided in Table 3.2) and were input into a framework matrix. The data were then coded 
under the appropriate theme. For example, often, during the implementation process, innovation 
champions are appointed within a leadership role; the literature recognises this as an implementation 
activity170 that takes place during the preparation phase of implementation. Thus in a process referred 
to as indexing, this activity may be categorised as such, [activity: assign leader], under the overarching 
preparation theme within the framework matrix.  
Within the framework matrix, each column is a theme (in this study, the stages of implementation 
shall be used as themes) and each row a case (study participant)230. For the purpose of simplifying the 
data in this study, each case represented a single community pharmacy, rather than a single 
respondent. To facilitate this, the data from interviews of staff employed at the same pharmacy were 
combined.  
Thematic analysis was performed on the data under each stage of implementation to identify the 
steps/activities and influences on the process of implementation230, 231. This analysis was performed 
by open coding the transcript line-by-line, using a constant comparison approach of the interviews, 
until each interview’s data were coded across all applicable implementation stages and the key 
activities and influences in the implementation process emerged.  
Additional codes were added as the data extraction continued, allowing the framework to be 
developed further231. The interpretation of the chart was used to confirm the implementation process, 
the influences and their relationships230, 231.  
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A secondary analysis was performed to examine the discussed factors, strategies and evaluations- 
implementation concepts included in the Generic Implementation Framework. Established 
implementation frameworks, as cited in section 3.1.6, were referred to support this analysis.   
Factors were assessed at each stage of implementation using the CFIR170.   
The reported strategies utilised to overcome implementation challenges were considered using the 
Powell et al.’s list of implementation strategies171. 
 
3.2.8 Ethical approval 
This research received a favourable opinion from the Portsmouth NHS Local Research Ethics 
Committee (ref 10/H0501/6) 22/01/10 (Annexe 1). 
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3.3 Results  
The purposive sampling meant that the participants of the study included both pharmacist and non-
pharmacist staff in all of the community pharmacies in Portsmouth. This strategy resulted in good 
representation of the various types of pharmacies located in the city (Tablet 3.8). Staff from 32 of 36 
community pharmacies in Portsmouth consented to be interviewed; those pharmacies in which staff 
declined to participate in the study had shown no engagement with the HLP project. The number of 
community pharmacy staff interviewed was determined by convenience and availability, since many 
community pharmacy staff are employed on a part-time basis; additionally the demands on pharmacy 
staff time vary according to customer needs which often do not follow distinct trends. In total, 38 
interviews were conducted with pharmacy staff between November 2011 and February 2012, as 
detailed in Tables 3.8 and 3.9. In some pharmacies, both the pharmacist and the HLC or another 
member of pharmacy-support staff were interviewed. Two HLCs were employed by pharmacies that 
were working towards achieving their HLP-accreditation by demonstrating adequate service provision 
and staff training (this is defined as ‘aspiring to HLP-status’ in the identifier to following quotations).    
The interviews ranged in length from 20 to 35 minutes. 
Table 3.8 The type of pharmacy at which interviewed staff were employed 
Pharmacies Totals HLP accredited (HLP) Non-HLP accredited 
Independents 11 7 4 
Multiples 21 10 11 
Total 32 17 15 
 
Table 3.9 Details of the job role of the staff interviewed 
Staff HLP accredited 
pharmacy (HLP) 
Non-HLP accredited 
pharmacy (nHLP) 
Total 
Pharmacist (P) 14 11 25 
HLC  9a 2b 11 
Non-HLC support staff  0 2c 2 
Total 23 15 38 
a Consisting of three medicines counter assistants and six dispensing assistants 
b Consisting of one medicines counter assistant and one dispensing assistant 
c Consisting of two medicines counter assistants 
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The findings indicated that all of the pharmacies had undertaken activities to indicate that the process 
of implementing the HLP project had been initiated. As indicated in Table 3.8, 17 of the 32 pharmacies 
had achieved HLP accreditation, with other pharmacies working towards achieving the accreditation 
criteria. However, the findings reveal that those pharmacies in which a greater number and more 
diverse implementation activities were reported, had not all achieved HLP-accreditation (i.e. the 
number and diversity of implementation activities reported did not always correlate to HLP-
accreditation). For example within particular pharmacies, it was reported that specific activities had 
been undertaken that are recognised within the literature to take place within the operation phase of 
the implementation process, such as goal setting and modifying procedures but not all pharmacies 
reporting these activities had achieved HLP accreditation. Whereas, other pharmacies in which 
respondents did not report any implementation activities that would indicate that the operation phase 
has been reached, may have achieved HLP-accreditation. To explain this observation, one must be 
familiar with the specific HLP-accreditation criteria (see Table 2.5, Chapter 2). For example, HLP-
accreditation required the pharmacy to have a minimum of one trained HLC; this posed a challenge to 
some pharmacies. Respondents from community pharmacies that employed pre-dominantly part-
time staff, or who relied on a small team of full-time staff, discussed their difficulty in releasing staff 
to attend the training, due to the consequent staff shortage this would result in. Therefore, there were 
pharmacies who had achieved the majority of the criteria and were offering HLP services routinely but 
were not able to achieve the HLP-accreditation.  
The individuals interviewed spoke predominantly about the pharmacy services affiliated to the HLP 
criteria32, but mention was made to other areas of the HLP criteria including engagement with the 
local community through setting up health promotion activities and introducing a designated area in 
the pharmacy to promote HLP services.  
It was also evident that pharmacies with a highly motivated HLC appeared to be at an advantage 
compared to those who had not yet appointed a HLC or where the HLC was not conducting the 
ascribed role, either due to work demands or personal factors such as lack of buy-in. Generally such 
pharmacies emerged more knowledgeable of the HLP project and were more aware of newly 
introduced HLP services.  
 
3.3.1 Process of implementation  
Four implementation stages emerged from the data, exploration, preparation, operation and 
sustainability. This was made evident through interviewee’s discussion of the range of activities they 
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had undertaken since the introduction of the HLP project. These activities were categorised and are 
summarised is Table 3.10.  
 
 
Table 3.10 Resulting stages and activities of the implementation process of the HLP project in 
Portsmouth’s community pharmacies. 
Exploration 
 Organisation fit assessment (implementation climate)  
 Value assessment (relative advantage)  
 Intervention assessment (complexity) 
 Organisational capacity assessment (supporting conditions and staff capacity)  
 Community fit assessment 
 Decision  
Preparation 
 Assign leader (HLC) 
 Research requirements 
 Rearrange workflow  
 Staff arrangements  
 Team communication (buy-in and foster climate)  
 Community awareness and recruitment  
 Training  
 Organise supporting conditions  
 Plan service procedures  
Operation 
 Modification of plans and procedures 
 Maintain patient demand 
 Staffing 
 Teamwork, team input and internal communication 
 Integration tactics 
 Ongoing training 
 Goal setting  
 Monitoring 
 Adaptation  
 Improvement 
Sustainability 
 Monitoringa 
 Adaptationa 
 Improvementa 
aFew pharmacies had reached sustainability, these activities appeared only in a few pharmacies who had a 
culture of community pharmacy service engagement prior to adopting the HLP project.  
 
Analysis across the cases of the framework matrix revealed a pattern, whereby those pharmacies 
where a greater number of implementation activities were considered and discussed seemed to 
demonstrate an apparent greater integration of the HLP project.  
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The interpretation of the framework matrix also identified that there was movement back and forth 
between stages and differences in the order of performing implementation activities. Examples to 
demonstrate this was at one particular pharmacy in which a member of staff was put forward for the 
HLC role and attended the HLC training in order to gather more information about the project; 
following this the pharmacy team made a decision to adopt the HLP project. Secondly, there were 
respondents who had reported activities indicating that the pharmacy had reached the operation 
phase of the implementation process yet would also be undertaking preparation implementation 
activities simultaneously, particularly in the case where a new HLP-service was launched or a member 
of staff left the pharmacy.  
It was also apparent from the interviews that pharmacies did not necessarily complete all of the 
activities before progressing to the next stage of the implementation process. An example to 
demonstrate this was a pharmacy where it was reported that staff had been set individual targets for 
service provision (operation activity) but were yet to assign a HLC (preparation activity). 
 
Exploration 
An exploration stage emerged in the interviews, which was often informal in that there was no set 
structure or systems, and lacking objective assessment. A decision to participate in the HLP project 
was subsequently made, often by the pharmacist; but in most cases the pharmacist initiated an 
opportunity for a joint discussion and the decision was made by the pharmacy team [activity: decision].   
“From the start we all agreed that we have to get involved (in the HLP project), we are always looking 
to do whatever we can to help the customers who come into this pharmacy and this was just another 
way that we could offer more services and help more people” HLC employed in an HLP accredited 
pharmacy.  
During the exploration stage, the HLP project was assessed by the pharmacy staff, to identify what 
could be the potential benefits of involvement, including financial, business (such as increasing 
customer loyalty and rapport), customer and/or professional [activity: value assessment (relative 
advantage)]. In many cases, the potential benefits of involvement were balanced against the 
complexity and requirements for implementation of the project. That is, pharmacies assessed the HLP 
project in terms of the degree of change [activity: intervention assessment (complexity)] and their 
capacity to deliver (cost of resources, staffing levels, training) [activity: organisational capacity 
assessment]. 
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“It was an easy decision to make, the services would be an additional revenue stream which didn’t 
require big investment and I, myself enjoy that part of the job a lot more (providing community 
pharmacy services) than the checking (clinically and accuracy checking prescriptions), and so do my 
staff” Pharmacist employed in an HLP accredited pharmacy.  
 
Significantly, the most frequently mentioned consideration was the community’s needs whereby 
interviewees felt that the HLP project was aligned with the pharmacy’s objectives and vision [activity: 
organisational fit assessment] and therefore had a duty to their community to implement the HLP 
project [activity: community fit assessment]. Personal interest was also frequently reported as 
contributing to the decision to adopt the project, particularly with the pharmacist respondents, 
exemplified by the following:    
 “We do have lots of our local customers that would need the extra services and we already offer most 
of the services so it wouldn’t be a big change” HLC employed in an HLP accredited pharmacy. 
 
Preparation  
After deciding to adopt the HLP project, in most cases a staff member was assigned to attend the HLC 
training and to be responsible for disseminating information back to them team; this was done both 
formally and informally [activity: assign leader]. This person was most often a medicines counter 
assistant (MCA) or a dispensing assistant (DA) who had expressed an interest in the role and were 
motivated to undertake the training, or was contracted to full-time hours. The HLC’s reported carrying 
out activities including conducting training, recruiting customers, providing the HLP services and 
overall driving the implementation effort. Another activity was to investigate the various 
documentation and requirements of the various HLP accreditation criteria [activity: research 
requirements] and making the required changes in the pharmacy, such as arranging a health 
promotion stand and updating the pharmacy’s sign-posting resources [activity: organise supporting 
conditions].  
“Because I worked the most hours and am here on the most days, XXXX (the pharmacist) asked if I 
would go on the training (HLC training)……. They showed us what we need to do to get accredited and 
it was my job to go back to the pharmacy and basically share that information with everyone else and 
make sure everyone knows what to do” HLC employed in an HLP accredited pharmacy.  
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“It was my job to keep everyone up to date with how we are doing with our services and other bits 
(accreditation criteria) and then me and XXXX would set up the stand in the pharmacy, making sure its 
tidy and there’s plenty of leaflets and making sure we know what we are talking about (regarding 
health information on the health promotion stand)” DA employed in a pharmacy aspiring to HLP-status  
Planning strategies of recruiting customers and delivering services was generally carried out by the 
HLC [activity: plan service procedure]. The majority of pharmacies considered logistical issues of 
introducing the HLP project into the pharmacy; but this was particularly significant for the pharmacies 
which did not routinely offer community pharmacy services and pharmacies with fewer staff, or 
predominantly part-time staff. Logistical considerations included convenient access to the private 
consultation room, the workflow of the dispensary or in some cases the layout of the pharmacy 
[activity: rearrange workflow]. As an example, two pharmacies undertook structural rearrangements 
within the pharmacy whereby a second consultation room was introduced to conduct HLP services.  
“We moved the shelving in the shop around to make space for the health promotion stand and make 
it easier to get to the consultation room because we thought we’d probably use it more for the services” 
HLC employed in a pharmacy aspiring to HLP-status 
“We did say to start off with, that XXXX (the HLC) would run the services and if there was customers 
asking we would get XXXX from the back (dispensary) to come talk to them (the customer) and then 
we’d see how it went, but afterwards we decided to move the computer (used for dispensing) nearer 
to the counter, so that XXXX could overhear us and come and take over if the customer wanted to talk 
about one of the services ” DA in a HLP-accredited pharmacy 
Staff was a prominent consideration; this included adapting the roles and responsibilities of staff, 
assessing whether staff numbers were adequate (to facilitate provision and manage existing work 
demands) and recruiting staff if new staff were required [activity: staff arrangements]. There was wide 
variability in the level of team input and teamwork [activity: team communication (buy-in and foster 
climate)]. Internal communication channels comprised of informal meetings or one-to-one 
conversations but in many cases interviewees reported a lack of internal communication and 
discussed this as a barrier to furthering implementation.  
“I think there should be some sort of regular communication where we can all say what we think and 
give our ideas to make things work better because we all see things from different perspectives and 
maybe I can have an idea that nobody has thought of (regarding HLP activities) but it doesn’t really 
happen” MCA in a HLP-accredited pharmacy 
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“We have dispensary meetings on Thursday mornings when it’s a bit quiet and we can talk about who 
(pharmacy staff) should be doing what (staff arrangements) and if we’ve noticed things that can make 
the services run better or if somebody isn’t doing the paperwork properly (relating to HLP services)”  
HLC employed in an HLP accredited pharmacy 
The activity that was most frequently discussed was training in order to prepare staff for delivering 
HLP services and to understand the objectives of the HLP project [activity: training].  
“We’ve had to send staff away for training days, which hasn’t always been easy to cope with, because 
we are a small team….. I feel that we do need more staff, especially if we are doing more services” 
Pharmacist in a pharmacy aspiring to HLP-status.  
While another consideration were strategies to promote awareness within the community and local 
health network so to enhance customer interest and potential recruitment [activity: community 
awareness and recruitment]. These activities were initiated and developed by the HLP project team 
and supported by pharmacies.  
 
Operation  
Challenges began to arise as pharmacies began to offer the HLP services and work towards meeting 
the accreditation criteria. The provision of services required the recruitment of customers; as time 
passed, recruitment became increasingly challenging. A common contributory factor for this was that 
in most pharmacies, a core group of regular customers was initially recruited to receive various HLP 
services, such as smoking cessation and respiratory medicine usage review; however after this initial 
recruitment, it was reported that maintaining the same level of demand for services became more 
difficult. This challenge of maintaining demand is recognised in the implementation literature [activity: 
maintain patient demand]. To tackle this, a series of activities were put in place by pharmacy teams, 
including reviewing the dispensary procedure to help in identifying suitable customers who may 
benefit from HLP services, adapting the specific language and approach used to recruit customers, 
delegating recruitment to specific members of staff and using prompts to remind staff.  
“It does depend on the patients as well, its not just the staff not communicating properly. Sometimes 
patients aren’t willing to commit to anything new or change anything (regarding the challenges of 
recruiting patients to HLP services)” HLC employed in an HLP accredited pharmacy 
“We’ve done a few little things to try and get more customers to join…..XXXX (the dispenser) will mark 
on the script (NHS prescription) if the person (customer) is asthmatic (to target a respiratory Medicines 
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Usage Review) or she’ll write on top (of the prescription) that the person’s got a note on the computer 
to check their blood pressure because it was a little bit high or that she was on the stop smoking scheme 
so we can ask them about that too” From a MCA employed in a pharmacy aspiring to HLP-status 
“Now, if someone comes in for a cough syrup or a bad chest, we always ask if they’re a smoker, and 
then XXXX (the HLC) has told us a few tips about what to say to get them interested in joining the stop 
smoking (service)” MCA employed in a pharmacy aspiring to HLP-status 
All participants discussed staffing issues with regards to the implementation of HLP [activity: staffing].  
Reference was made to the morale, confidence, enthusiasm, and skill of staff in service provision and 
in approaching and recruiting customers into HLP services.  
“It hasn’t always been easy to motivate the staff, I try my best but you have to have strong leadership 
and that should come from the pharmacist or the manager; if they don’t get involved and support it 
and help you then it’s easier for other staff not to get involved and learn more” HLC in a pharmacy 
aspiring to HLP-status  
“The training (HLC training) was excellent; because we were all finding out feet with the whole thing 
(HLP project), it meant that we (the staff present at the HLC training) all had similar questions and 
having that time to meet up with the other champions (HLCs) to talk about things and to help each 
other was invaluable…. I think that’s what motivated us more than anything else” HLC in HLP 
accredited pharmacy 
A number of participants detailed their strategy of redefining staff roles and responsibilities in order 
to further the process of implementation [activity: teamwork team input and internal 
communication].  The majority of pharmacies introduced strategies to change existing habits and to 
enhance the integration of HLP activities into day-to-day practice [activity: integration tactics]. For 
example, it was reported that pharmacy staff did not have a proactive approach to customer 
recruitment to pharmacy services and initiating conversations around health and well-being was not 
common practice. The strategies employed to change this comprised of introducing prompts for staff 
(such as asking about smoking status on the sale of cough medicines), making incentives available 
(including staff recognition awards) and undertaking performance reviews. In addition, on-going 
training for staff was raised as a key activity for supporting continued involved in delivering HLP 
services [activity: on-going training].  
“When I said that I wanted to do the training, me and XXXX (the pharmacist) sat down and discussed 
how we can try best use my expertise, because I am a dispenser and don’t really have that much to do 
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with the customers…… XXXX (the pharmacist) suggested we get XXXX (the MCA) trained as a dispenser 
so I can have more time with the customers” HLC in HLP accredited pharmacy 
“Job satisfaction; I’m using more of my skills in a productive way to improve the health of my local 
community and that is really what I got into pharmacy for: to feel I am contributing and making a 
difference to people’s health” Pharmacist in a pharmacy aspiring to HLP-status 
“We had weekly targets (HLP services) that we put on the wall, and there were prizes for whoever got 
the most or whoever got their target…… it did work to get us going which was good” HLC in a pharmacy 
aspiring to HLP-status 
“The training we go to helps, because there’s so much to remember and there’s always something 
new…. When you go there (HLC networking meetings) and meet the other champions, you learn from 
what they are doing and there’s always a talk by someone to explain the services with more details 
(service practitioner e.g. a member of the local Alcohol Intervention team).” MCA in a pharmacy 
aspiring to HLP-status 
Goal setting was prevalent in pharmacies (n=17) whereby teams set weekly service targets, for 
example, to recruit two customers to the smoking cessation programme [activity: goal setting]. Some 
pharmacies revealed that Key Performance Indicators (KPIs) had been developed for individual staff 
members, while others had worked together to agree on pharmacy team targets. However, a minority 
(n=4) of pharmacies were against the idea of introducing goal setting since they believed that self-
motivation was sufficient and the concept of setting targets was not consistent with the ethos of the 
HLP project.  
There were two pharmacies, who were yet to achieve HLP accreditation, which had introduced formal 
monitoring systems to keep track of the level of service provision; in each case this was arranged by 
the pharmacy owner [activity: monitoring]. Recognising customer feedback was identified as 
important in improving staff morale and motivation, and was thereby perceived to enhance the 
implementation efforts and service provision as well to assess the relative advantage of the project. 
There were also reports of informal monitoring of service procedures; this included recording the time 
to carry out individual services. Based on the monitoring, a minority of pharmacies decided to adapt 
the service; such as making arrangements for the service to be conducted using an appointments-
based system [activity: adaptation]. Finally, there were individuals who made minor amendments or 
improvements to the services in an attempt to improve efficiency or effectiveness, for example, 
pharmacies introduced sending a text message reminder to customers to attend their smoking 
cessation or weight management appointments [activity: improvement].  
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“We do hear about how well we are doing when XXXX (pharmacy owner) comes down with the figures 
and tells us how many services we’ve done (HLP services), and he says well done and is really 
supportive” HLC in a HLP accredited pharmacy 
“We were finding that our smokers (customers enrolled on stop smoking programme) wouldn’t always 
turn up for their appointments and that meant we couldn’t claim them as a quitter. So we used the 
pharmacy phone to send out reminder texts which seemed to work really well” HLC in a HLP accredited 
pharmacy 
 
Sustainability  
The analysis revealed that only a small number of pharmacies had reached the sustainability stage of 
the implementation process; that is on-going provision of HLP services, the maintenance of supportive 
conditions for the delivery of HLP activities (e.g. staff capacity, service adaptation, monitoring) and 
consistent service outcomes. Indicators of sustainability were evident only in those pharmacies that 
had previously been delivering many of the services prior to adopting the HLP project; interestingly 
the majority of respondents reporting such activities were not HLP accredited.   
“I know we need to get a champion trained up (HLC) (in order to achieve HLP accreditation), but a lot 
of the services we already offered for quite some time, so it wasn’t too hard to take on a little bit more 
because everybody knows what to do and we all help each other….. I think that’s how we’ve been able 
to maintain good figures (in delivering HLP services)” MCA employed in a pharmacy aspiring to HLP-
status.  
“We collect patient feedback from the customers who’s gone through the services, and they are 
generally really happy. That can help with staff morale and help motivate staff so they can see the 
impact they are having” Pharmacist employed in an HLP accredited pharmacy 
“The services have needed slight tweaks to fit in with how we do things here…… we soon realised that 
the health checks took a lot longer than we thought they would and it meant that we were left short 
at busy times in the shop (pharmacy)…… that’s when I decided it’ll be best to have appointments 
instead” Pharmacist employed in an HLP accredited pharmacy 
It was identified that within these pharmacies, internal communication was routine, whereby regular 
staff meetings were held to raise concerns or to share ideas of how internal processes can be 
improved. It was also evident that within these pharmacies, respondents reported strong leadership 
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and support (in terms of resources) from managerial level personnel (managers/ owners/ organisation 
management). 
“We have managed to do really well with the project, we’ve got a really good team; and owners who 
listen to us and let us do what we think is best. If we tell them we need more hours (staffing-hours) 
then they’ll support us and they do that because they care about the customers and they know how 
difficult it is for people round here (local community)” HLC employed in a HLP accredited pharmacy.  
 
3.3.2 Implementation influences/domains  
The thematic analysis also identified five recurring influences that appeared to be present in the 
various implementation stages, which have been mapped to Damschroder et al.’s CFIR domains170: 
 direction and impetus, (inner setting) 
 internal communication and planning, (inner setting and process by which implementation is 
accomplished) 
 staffing, (inner setting and characteristics of individuals involved) 
 community fit (outer settings)  
 and support (inner and outer settings).  
Depending on whether or not these individual influences were present within the various stages of 
the implementation process determined their impact; furthermore their presence resulted in both 
positive and detrimental effects on HLP implementation. Using staffing as an example; enhanced staff 
capacity was a positive influence on the progression of pharmacies in implementing the HLP project; 
whereas some pharmacies reported that a lack of trained and motivated staff inhibited the adoption 
of change and thereby acted as a barrier to implementation.   
The direction and impetus of the pharmacy, which encompassed the vision, ambition and motivation 
of the pharmacist in addition to the leadership and support provided by management (manager, 
owner or company management), was identified as a prominent influence. In many cases, it was this 
influence which appeared to be an initial precondition for the implementation process and an 
important aspect for continued progress through the implementation process. 
“Having a pharmacist who is interested and motivated and wants to get involved, makes all the 
difference. A motivated pharmacist will give staff the encouragement and freedom to do what they 
are trained to do.” Pharmacist employed in a HLP accredited pharmacy 
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“We see the pharmacy as an ideal environment to help support patients with healthy living- the 
principles that HLP are built on really. What we are try to achieve is…. to not just be there for help with 
people’s medicines but also to be able to give them advice and support on their general health” 
Pharmacist employed in a HLP accredited pharmacy 
Leadership from the pharmacist and/or management needed to include support, motivation and 
encouragement, where this was lacking, the implementation of the HLP project did not progress as 
quickly and the implementation activities reported were fewer. The role taken up by the HLC was also 
a significant one as an internal leader, contributing to influencing change within the pharmacy staff. 
This was achieved through supporting staff performance and encouraging involvement in the HLP 
activities.    
“The HLC role has changed the way I do my job; she motivates the staff, watches them with customers 
and give them feedback…. I think that’s the best thing the HLP has done (introduce the HLC role” 
Pharmacist employed in a HLP accredited pharmacy 
Secondly, internal communication and planning, which included input from all team members and 
teamwork, was a recognised influence. It was observed that some pharmacies had little or no 
communication regarding services and the implementation of the HLP project, whereas other 
pharmacies had a process of shared decision-making where staff, often lead by the HLC, were able to 
contribute their ideas to the implementation planning during formal or informal meetings. It was 
reported that internal communication had an impact on the culture and ethos within the pharmacy, 
which had an impact on the overall implementation effort.  
“I am envious of some of the pharmacies…. When we meet up (at the HLC training) and hear about 
how everybody else is doing and what they get up to (with the HLP project)….. In other pharmacies, it 
seems that everyone (pharmacy staff) is involved and make decisions together. Sometime I feel that I 
am the only one doing anything about it (HLP involvement) and if I didn’t, nobody else would (other 
staff within the pharmacy” DA employed in a pharmacy aspiring to HLP-status  
“I do think that we would do so much better (with HLP activities) if we made plans and everybody know 
what we all were supposed to be doing… we are so busy, we don’t really talk about it (HLP activities), 
we just come in and do our best…. I don’t think it’s the best way to do it (HLP implementation) but we 
just don’t have the numbers (staff within the pharmacy)” MCA employed in a pharmacy aspiring to 
HLP-status 
Staff was the third influence which covered staff capacity (enthusiasm, morale, confidence, skill) and 
was an influence present in all stages of the implementation process, particularly discussed in relation 
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to activities within the operation stage of the implementation process. Selecting appropriate staff for 
the HLC role and staff members’ beliefs regarding their involvement in the project were important 
influences. For example, staff who did not see the value in services, appeared to struggle with 
implementation.  
“Motivation is always difficult to create no matter what…… a change of skills from being retailers into 
offering services and healthcare advice. It’s always difficult to get people to change how they work and 
it seems we have more success with younger, more dynamic member of staff.”  Pharmacist employed 
in a HLP accredited pharmacy 
“The HLCs have been a revelation; there confidence to approach and talk to customers, and the 
enjoyment they get out of it (delivering HLP services) is something I’ve not seen before in community 
pharmacy…. They pretty much run the project themselves, getting everybody trained and making sure 
we have all the consumables for the services; they even have started to call up customers who haven’t 
turned up to their appointments (for HLP services, e.g. smoking cessation). They are brilliant” 
Pharmacist in a HLP-accredited pharmacy  
Community fit (i.e. the suitability of the HLP project within the context of the local community) was an 
influence present throughout the implementation process. In the exploration stage, pharmacy staff 
considered the health inequalities of the local community; and existing accessible health resources, 
as motivators in their decision to participate in the HLP project. 
“We know that we are in a deprived area of Portsmouth (the location of the pharmacy), we see all 
sorts of things on a daily basis (presenting complaints of customers), and we know that we have to do 
our bit to help…. We’ve been here twenty odd years…. Customers come in here for everything” HLC in 
a HLP accredited pharmacy 
Further in the implementation process, community fit became a more prevalent influence as 
pharmacy staff became more conscious of the impact of community awareness, perception and 
demand.  
“We have our regular customers and they help to spread the word (about the HLP services offered), 
but I think more needs to be done to raise awareness in the community… there’s no point in having all 
these services and nobody using them (in response to reduced demand of HLP services).” MCA 
employed at HLP-accredited pharmacy.  
The final underlying influence was support, which included having a professional network, 
management support and support from the HLP project team. This support affected a number of 
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implementation activities, including challenges establishing favourable connections with local services 
providers (for example with local GPs) as well as the lack of networking events for pharmacists 
involved in the HLP project, which respondents felt could have contributed to developing strategies 
to improve public awareness and made customer recruitment easier.  
“I think the training does need to continue; the PCT’s help has made HLP successful, so whenever 
anything new is launched, we need that to be backed up with the PCT’s help especially with getting the 
local GPs onboard and making them aware of what we are doing…… you know how it is in community 
pharmacy, if it’s not ‘Okayed’ with the GPs, then patients get suspicious (referring to GPs’ endorsement 
of community pharmacy initiatives).”  Pharmacist employed in a pharmacy aspiring to HLP-status. 
 “This is a brand new initiative and we very much need the public on board…..surely, it makes a lot of 
sense for the local pharmacists to get together and discuss ways we can take this forward…. But the 
PCT doesn’t provide those opportunities” Pharmacist employed in a HLP accredited pharmacy. 
A lack of support for developing a service procedure that did not disrupt workflow and poor service 
commissioning was discussed in relation to the NHS health check service, which was reported to 
require up to one hour of staff time and respondents felt the reimbursement did not reflect the time 
required to conduct this service.  
In contrast, the PCT support in the provision of training HLCs and providing reports of service provision 
at the HLC meetings was largely indicated to be a positive influence on implementing the HLP project.  
“The whole champion idea is amazing and the champions meetings are brilliant…. They give me so 
much energy and I get so much good advice (from HLCs employed in other pharmacies) that I can bring 
back here (to the pharmacy) and use for running our services (HLP services)” HLC in a HLP accredited 
pharmacy 
“I think the HLC role has been a revelation, its given individuals the confidence and the ability to go up 
to customers and start conversations about their health issues… it’s something I really did not expect” 
Pharmacist in a HLP accredited pharmacy.  
 
3.3.3 Secondary analysis: factors, strategies and evaluations   
The data were subjected to secondary analysis whereby a list of implementation factors relating to 
the process of implementing the HLP project was developed and were mapped to the CFIR170 (as 
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defined in Table 3.3). In each of the implementation stages, a variety of factors were identified. 
Appendix 3.5 provides the analysis of factors that were recognised at each stage of implementation.  
Factors relating to the characteristics of the HLP project (innovation domain) were particularly evident 
within the exploration stage, during which pharmacies undertook an informal analysis to decide on 
their involvement in HLP. Staff perceptions of the potential advantages to the pharmacy and to the 
customers, the difficulty of implementation, and potential cost were considered in the adoption 
decision. In the preparation stage, factors linked to the pharmacy (inner setting) appeared frequently, 
but the majority were also identified during all stages.  
The needs and subsequent demand of the pharmacy’s customer population for HLP services were 
discussed as dominant outer setting factors.  
The factors relating to the staff, (knowledge and beliefs about HLP; individual state of change; 
motivation) were prevalent across the implementation stages.   
To promote adoption and enhance integration of the HLP project, pharmacies adopted various 
implementation strategies. A significant number of pharmacies faced challenges in fully implementing 
the HLP project and achieving accreditation, yet, out of the 73 discrete implementation strategies as 
described by Powell et al.179 , 44 were evident in the narrative provided by at least one pharmacy 
(Appendix 3.6).  
The analysis revealed that evaluations of any form were lacking or informal. There was evidence that 
most pharmacies had monitored the number of services they were providing (sometimes linked to 
economic outcomes) and feedback from customers was obtained for specific HLP services. However, 
performance, implementation or clinical evaluations were absent.  
 
 
3.4 Discussion  
The work carried out in this chapter aimed to investigate the implementation of the HLP project in the 
community pharmacies within Portsmouth. Through the employment of the GIF, the implementation 
process of the HLP in Portsmouth’s community pharmacies was investigated.  
Figure 3.4 and Table 3.11 illustrate the implementation concepts specific to the implementation of 
the HLP project, identified within this study.  
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Figure 3.4 Framework for the implementation of HLP in community pharmacy 
 
 
 
Table 3.11 Outline of the specific GIF implementation concepts recognised to apply to the HLP project 
Implementation stages Exploration, preparation, operation, sustainability  
Influences/domains Direction and impetus, internal communication and planning, staff, community fit, 
support 
Factors As recognised using the CFIR (Appendix 3.5)  
Strategies 44 of those identified by Powell et al. (Appendix 3.6) 
Evaluations Largely lacking, customer feedback was collecting in few pharmacies.  
 
These findings describe the stages involved in the implementation of the HLP project within 
community pharmacy. They recognise the general influences of the implementation process and 
identifying the specific factors reported to be present at each stage of the process. Further, the 
findings also reveal the strategies employed by community pharmacy teams in an attempt to enhance 
the integration of the HLP project into routine practice.  
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Figure 3.4 also illustrates where pharmacies were undertaking implementation activities associated 
with more than one implementation stage concurrently (depicted by the overlapping outer circles) 
and where pharmacies had moved back and forth between different stages of the implementation 
process (depicted by the double-headed arrows).    
A further finding, not illustrated in Figure 3.4, is that of the disconnection between HLP-accreditation 
and extent of HLP-implementation. In contrast to what one might expect, in some cases respondents 
from pharmacies aspiring to HLP-status reported a greater number of implementation activities within 
the operation and sustainability phases than reports from HLP-accredited pharmacy respondents. This 
is consistent with findings of previous studies, which demonstrate that implementation activities and 
influences are complementary and integrative, whereby strength in one area may rectify a 
shortcoming elsewhere183, 232. 
Although the implementation process of innovation within community pharmacy is yet to be reported 
on in the literature; previous individual studies have identified the various factors, facilitators 
(strategies) and influences of implementing community pharmacy services.  
The RPS reported barriers of implementing innovation in community pharmacy39 (Table 3.4) 
acknowledges poor public understanding of the role of pharmacists, lack of leadership, professional 
isolation and poor commissioning of pharmacy services; all of which resonate with the findings in this 
study. For example the findings of this study demonstrated that the local community’s awareness, 
perception and demand for HLP services influenced the process of implementing HLP – this can be 
linked to the poor public understanding of the role of pharmacist. A lack of leadership from the 
pharmacist and/or management, which included support, motivation and encouragement was 
reported by a number of respondents within this study, which made the implementation of HLP more 
challenging. An absence of opportunity to network with other pharmacists involved in the HLP project 
and lack of favourable connections with other local health providers mentioned in this study, reflect 
the professional isolation and lack of integration of community pharmacy.  
Importantly, the influences of HLP implementation identified in this study (direction and impetus, 
internal communication and planning, staff, community fit, support) can all be linked to the HLC role 
within the pharmacy. This was evident in reports that that the HLCs adopted a leadership role within 
the pharmacy, supporting staff performance, encouraging involvement in the HLP activities and 
directing internal communications to allow staff to contribute ideas to the implementation planning. 
The introduction of the HLC role was also reported to have had a positive influence in supporting the 
implementation process.  
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The reported strategies employed in this study (Appendix 3.6) are reflected in the list of individual and 
organisation facilitators of change in community pharmacy172 as compiled by Roberts et al. (Table 3.5). 
This included facilitators of education and training for pharmacy staff; enhancing communication skills 
and enhancing motivation, as discussed in this study. Similarly, organisational facilitators such as 
adapting the physical environment, introducing incentives, delegation of tasks, managing customer 
demand/expectations and innovative practice orientation were evident within this study. All of which, 
Robert et al. makes mention.  
Activities related to monitoring are recognised as significant factors within implementation 
research175, 233; but in the present study they were observed to be lacking. This finding is consistent 
with studies published in other disciplines234, 235. Evaluation of outcomes and monitoring of staff 
performance, with regards to fidelity and quality measures, which the literature reports are more 
evident in innovations that have achieved sustainability,  were largely absent in all of the pharmacies 
but were beginning to emerge.  
 
Implications of the study  
This is the first study to examine the process of implementation of the HLP project. These findings can 
contribute considerably to the development and evaluation of innovation within community 
pharmacy in the UK.  Further, these findings identify specific strengths and areas of the HLP project 
which can be reviewed within the local context, to enhance the implementation process and promote 
sustainability. 
 
Strengths and limitation of the study 
Despite the validity of the findings against the relevant literature presented, a number of limitations 
associated with the process of conducting and analysing the qualitative interviews were identified. 
These limitations involve the characteristics of the sample used, the methods followed to recruit 
participants, analysis of the interview transcripts and the validity of the results.  
Regarding the characteristics pf the sample, it was initially intended the use of a purposive sample to 
increase the validity of the results across the population of community pharmacy staff. However, a 
convenience sample was used instead, as recruiting participants on arrival at the pharmacy was a 
challenging process, with a large number of potential participants unable to afford the time away from 
their work duties. Choosing a purposive sample would have allowed for the choice of participants to 
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be more selective, involving selecting the most adequate sample for the purposes of the research and 
considering variables such as gender, age or professional role. This is a more complex sampling 
technique than the one used in this research, incurring more time, effort and costs, but would have 
ensured a higher variability in the participants and validity of the results.  Instead, using a convenient 
sample was more cost-effective and less time-consuming, involving the selection of participants by 
their availability and willingness to participate, without considering specific variables or characteristics 
that may have had an impact on the quality of the data collected. Despite being considered as less 
reliable in terms of the data collected, the convenience sample used for this research was still 
considered as valid, as the participants selected belonged to the population-target, and were 
therefore able to produce meaningful results.  
Another likely limitation associated with conducting the interviews was the inexperience of the 
researcher in conducting qualitative interviews. Piloting the interview schedule provided an 
opportunity for the researcher to practice and gain experience , however given the limited time frame, 
only one pilot interview took was undertaken which  was consequently included in the data analysis. 
As a result, it is likely that the earlier interviews were not as rich in terms of the data collected, and 
that the quality of data improved progressively as the research gained more experience. This potential 
limitation was recognised prior to conducting the interviews and therefore the interview checklist 
(Appendix 3.4) was designed and adopted on commencing data collection in order to ensure 
consistency.  
In qualitative research, there is no standard and established method capable of capturing absolute 
truth, since it is more interested in the quality and meaningfulness of the results rather than the 
attempt at generalising the results. Regardless of the sample characteristics and the method of 
analysis used, qualitative research involves small samples, and bias and error will always occur as a 
consequence. Therefore reflexivity and or a reflexive awareness of the problematic status of the 
author’s own claims to knowledge is an important element in the research process and may influence 
the reported outcomes. The approach taken in this research assumed that the role of the research is 
important in the construction of the whole process of the research, from the development of the 
broad area of research and the initial questions, through the design, undertaking and analysis. 
Consequently steps were taken as described in Section 3.2, to emphasise participation, conceptual 
rigour and philosophical coherence as means of establishing quality and relevance.  
In this chapter, framework analysis has demonstrated its use as a methodology for implementation 
research. Using the implementation stages of the GIF as overarching themes, thematic analysis of the 
data was performed under each stage. It could be argued that interviews be designed and coded using 
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themes from an implementation factor, strategy or evaluation, as this may elicited further insight; 
however, this was not considered at the time of developing this study.  
It may also be suggested that adopting framework analysis may inhibit the development or refinement 
of conceptual models; however efforts were made to conduct detailed thematic analysis of the data 
so as to recognise further themes.  
Finally, this work focussed on the implementation of the HLP project within community pharmacies in 
Portsmouth; a city in south England where one commissioning body was involved in the management 
of community pharmacy services. However the findings suggest that the approach taken within this 
study would also be beneficial in other areas of the UK.  
Further work  
The HLP project encompassed the delivery of a range of community pharmacy services and activities. 
This included services whose focus were on medication usage, such as respiratory medicines usage 
review and monitoring services, in addition to services focussed on promoting healthy lifestyles, such 
as screening and tackling local public health issues.  
Further work exploring the implementation process of specific services may have revealed a distinct 
set of activities and considerations associated with different services.  
Further to this, since this study was conducted little over 12 months since the introduction of the HLP 
project into Portsmouth’s community pharmacies, the literature recommends that sustainability of 
public health interventions should be assessed no sooner than one year after the initial funding source 
to set up the initiative ends236. Therefore, in a later chapter the pharmacies shall be re-visited to 
investigate the sustainability of the project.  
   
 
3.5 Conclusion  
 
The literature acknowledges the paucity of theory cited in implementation research. However, this 
study provides an example of where a conceptual framework can be employed to provide a structure 
for assessing implementing innovation.  Moreover, this study is the first to report on the employment 
of implementation literature in the context of community pharmacy practice.  
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Through utilisation of the Generic Implementation Framework, the various implementation concepts 
could be identified with and articulated to provide a detailed evaluation of the HLP implementation 
process.  
The implementation influences, factors and strategies identified within this work are broadly 
consistent with specific reports within the pharmacy practice literature. The HLC role was significantly 
implicated in successful implementation of the HLP project.  In the next chapter, this finding will be 
explored and reported on further.  
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Chapter 4 : The Health Living Champions’ Network 
 
4.1 Introduction:  
An evaluation of the HLP project demonstrated a positive impact on community pharmacy services in 
Portsmouth121. The conclusions derived from the work conducted in Chapter 3 and subsequent 
publication121 identified the HLC contribution to the apparent success of the project.  
In Portsmouth, it was reported that a ‘pharmacy community’ was created121, whereby the HLCs 
formed a networking group and met periodically. HLCs reported that these meetings acted as a source 
of motivation to engage in HLP activities121. The local commissioner, therefore, continued to facilitate 
and fund networking meetings. The aim of this was an attempt to sustain enthusiasm around HLP 
activities and support the role of the HLC with education and professional development.  
Meetings were arranged by the local pharmaceutical advisor (PA) and back-fill for attendees was 
commissioned through the local commissioners. Meetings were held at a local community centre on 
a Wednesday afternoon, when many of the local GP services close for training and the subsequent 
demand for prescription services in the community pharmacy decreases. 
HLCs were notified of forthcoming meetings through postal invitation addressed to the community 
pharmacy of employment and where possible through the community pharmacy email.  
An informal agenda for the meetings was arranged by the PA, whereby time was allocated for the 
HLCs to network amongst themselves. The PA would deliver an update on current levels of activity in 
commissioned HLP services and discussed any HLP developments, for example, plans to introduce 
further commissioned services. The final part of the session was allocated for a presentation delivered 
by an invited practitioner affiliated to one of the services delivered through the HLP project, for 
example, a member of the local drugs intervention team or the local sexual health team. The focus of 
the presentations was to describe the specific activities of the service, detailing their particular area 
of expertise as well as promoting an understanding of the potential referral pathway from community 
pharmacy through signposting appropriate customers. 
These meetings were initiated in February 2011, following the first group of HLCs successfully 
completing their HLC qualification in Understanding Health Improvement as accredited by the Royal 
Society of Public Health130. The local commissioners continued to fund and facilitate meetings; with 
the number of attendees increasing as further individuals enrolled and successfully completed the HLC 
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qualification. At the time that this study was conducted, November 2013, there were 33 qualified HLCs 
employed in Portsmouth’s 32 community pharmacies. 
In this chapter, the research focussed on exploring the role of HLCs and investigating the significance 
the HLCs attribute to attending HLCs meetings. 
 
4.1.1 The ‘Champion’ concept  
Chapter 2 of the thesis explored the limited literature on the role and contribution of community 
pharmacy support staff. Further to this, in describing the introduction of the HLP project and the 
associated accreditation criteria, the HLC role was introduced.  
The concept of introducing champions into an organisation has been reported in the literature; indeed 
the champion role within community pharmacy has also been investigated.  
Greenhalgh et al.169 defined champions as “individuals who dedicate themselves to supporting, 
marketing, and ‘driving through’ an innovation”. Champions have been referred to by a variety of 
terms such as change agents, opinion leaders, sponsors, and internal entrepreneurs169, 237. Greenhalgh 
et al. explained that champions are not necessarily opinion leaders as they may or may not support 
an innovation. 
The concept of champions was implied in Rogers’238 seminal research on diffusion of innovations in 
which he described the “change agent” as an individual who “influences clients’ innovation-decisions 
in a direction deemed desirable by a change agency”.   
The role of champions is relatively new to pharmacy, although it has been studied extensively in the 
management and medical literature239-241. The influence of medical opinion leaders in the diffusion 
and adoption of medical innovations has been recognised for almost half a century242. The literature 
suggests that when implementing change, leadership needs to involve change agents as local 
champions or clinical opinion leaders to influence the practice of their peers243. Clinical opinion leaders 
tend to be those individuals who are “respected sources of information”244 and are able to exert 
influence over others’ decision making, not as innovators but as early adopters who are well 
integrated with their peers. These are informal leaders who are neither authority figures nor working 
in administrative roles, but practitioners who “walk in their [colleague’s] shoes”242. They influence 
patterns of practice, potentially leading to high quality care and patient outcomes, and they may 
accelerate the uptake of knowledge245. 
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The literature on the role of champions within a pharmacy setting in promoting innovation is scarce 
and the nature of their role seems to be diverse; however where the role has been reported on, the 
evidence indicates a positive contribution in facilitating the adoption of innovative practices. For 
example a 2011 study by Berry et al. describing the feasibility of an ‘Asthma Friendly Pharmacy’ 
community pharmacy innovation, identified that a pharmacist champion at each participating 
community pharmacy was critical to developing initial enthusiasm for the model, planning a site-
specific workflow, orienting staff, and reinforcing procedures to encourage long-term behaviour 
change246. Similarly, a recent UK-based initiative, ‘A Carer-Friendly Pharmacy’247, attributed the 
appointed carer champion to the success of the initiative. The carer champion is a pharmacy member 
of staff who takes on the role to lead and facilitate carer referrals and act as a contact point for external 
agencies, such as the local carers centre and GP practices to support a multi-disciplinary approach.  
Westrick et al. reported that the effectiveness of a ’service champion’ was key to the sustainability of 
a community pharmacy-based immunisation service. The role encompassed activities to continuously 
promote the service within the pharmacy. The authors also recognised their significant role in the 
implementation of the service in a way that was compatible with the host pharmacy; this was 
highlighted as a significant facilitator in the pharmacy adopting the immunisation service248. 
In the same way, a study by Melczak et al. recognised the value of an ‘innovation champion’ in 
implementing an innovative patient outcome measure in the context of a community pharmacy 
medicines management service. The ‘innovation champion’ was identified as the individual who was 
particularly enthusiastic about the intervention, and as someone likely to lead the further 
development of innovative practices throughout the professional community249.  
Finally, Shoemaker et al.250 identified the critical role of a ‘change champion’ in community pharmacies 
adopting and implementing health literacy tools. This individual was described as someone who took 
responsibility to use and understand the tool. The authors recognised that the change champion was 
able to identify the advantages of adopting the intervention. It was observed that the change 
champion anticipated that the intervention would provide valuable information and improve 
customer care and satisfaction and be professionally beneficial. It was concluded that the contribution 
of the change champion facilitated the pharmacy team’s decision to adopt the tools. Further to this, 
Shoemaker et al. recognises the alignment of their findings with Rogers’ Diffusion of Innovations 
model238 in describing the significance of ‘change champions’ in organisational capacity and 
anticipating the relative advantage of innovation in the process of adopting and implementing 
innovation. 
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In addition to the aforementioned examples, a study conducted by the University of Manchester251 
reviewed the commissioning and delivery of services from community pharmacy in England. The 
authors identified that collaborative innovations (such as a locally commissioned pharmacy service) 
often relied on a central person, such as a pharmaceutical advisor within the commissioning 
organisation, to champion the innovation and influence others to adopt it. This was made evident 
when an individual championing an innovation left the role; contractors consequently dropped out 
and activity levels fell. Soon after this, commissioners perceived the innovation to be unsuccessful. 
The authors also reported on the important role ‘innovator pharmacists’ and ‘champions’ working 
within community pharmacies play in driving the development of commissioned services. 
Despite this, the introduction of champions within pharmacy has been largely overlooked in the UK.  
The Pharmaceutical Journal reported in 2011, that the role of pharmacy assistants in promoting and 
delivering public health services had been largely ignored and described the advantages of pharmacy 
assistants taking up a ‘public health champion role’. The article reported that pharmacy assistants 
frequently had a long association with the users of the pharmacy and the fact they frequently come 
from the local community they work within. It is suggested that this could help in establishing an 
understanding of customers’ circumstances, which the pharmacist may lack.252  
Further to this, researchers have continued to study the potential of champions in the adoption of 
innovation.  Doucette et al. 151 in investigating pharmacy entrepreneurial orientation and its effects 
on the provision of innovative pharmacy services, suggested that in order to foster innovation, 
managers should appoint ‘champions’ who are given a level of autonomy to assist in developing 
promising pharmacy service concepts. A ‘Champion’ in this context were described as someone who 
develops an idea and pushes it forward for evaluation and if acceptable, guides implementation. The 
authors also emphasised that in order for champions to be successful, they either need their own 
authority or close support by the pharmacy’s decision makers 253. 
Garcia-Cardenas et al. chose to use Roberts et al.’s model of implementing community pharmacy 
services254 in informing the design of a community pharmacy medication review service. Roberts et 
al.’s model recognised that organisational structure of the pharmacy, lack of an internal 
implementation champion, and lack of priorities and goals, as major barriers in the pharmacy 
hindering the implementation of innovation. Garcia-Cardenas et al. facilitated the nomination of an 
internal champion, to support and drive the implementation of the medication review service. The 
internal champion set priorities and goals with clear expectations in regards to work performance and 
results of the service to the community pharmacy team. The appointment of an internal champion 
was one element comprising an innovative approach for the implementation, which according to the 
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evaluation, supported the implementation process of the service (measured by the time taken to 
integrate the service into routine practice; and the number of patients recruited and rate of follow-
up)254.  
The concept of an internal pharmacy champion was also identified by Moullin et al., in an earlier study 
in the development of a theoretical implementation model for community pharmacy. The individual 
appointed to this role took charge of the implementation team during the implementation of a 
pharmacy service. Further to this, it was the role of the internal champion to analyse barriers and 
facilitators and subsequent tailoring of the intervention255. 
Coakes et al.256 drew on extant research in supporting the notion that innovation is facilitated and 
supported by innovation champions. However, Coakes et al. furthered the discussion in identifying 
innovation champions as ‘special people’, with particular personality types and psychological profiles. 
The research concluded that in order for innovation champions to succeed in championing innovations 
in organisations, they needed both procedural and resource support, and social and cognitive support. 
The authors recognised that the influence of innovation champions came through social contacts, 
multiplied through the communities in which they participate, through the genuine esteem in which 
they are held. The authors recommended that developing a community around such champions 
makes practical sense for organisations and will potentially initiate further innovative practices.  
 
4.1.2 The concept of a ‘community of practice’  
Svinivki and McKeachie257, 258 proposed that working in a group was more dynamic and motivating 
than working alone. The authors concluded that the opportunity to work alongside peers, promotes 
the individual’s ability to restructure their knowledge and understanding of concepts259. Furthermore, 
it has been identified that group work facilitates the critical discussion of an idea in a way to advance 
problem solving and conceptual understanding260.  
Lave and Wenger261 used the term ‘communities of practice’ in conducting research on 
apprenticeships. A brief definition is that communities of practice are groups of people who share a 
concern or a passion for something they do, and learn how to do it better as they interact regularly262. 
Other terminology cited in the literature has been used encompassing a similar philosophy; 
collaborative learning communities and professional learning communities appear most frequently. 
Collaborative learning communities have been described as small groups of individuals who encourage 
each other to enhance their own and each other’s learning with the purpose that sharing ideas and 
responding to others, enhances thinking and deepens understanding263. Li et al. built on this definition 
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in describing the four fundamental aspects of a collaborative learning community; namely: 
empowering others, building communities, continuing support and being patient263. Similarly, 
professional learning communities, as described in the literature, highlight seven aspects which 
resonate with the values of the HLC group. Hord and Sommers264 describe these components as: a 
shared belief, set of values and vision; shared and supportive leadership; collective learning; applying 
the knowledge; supportive conditions and shared personal practice. Wick265 more narrowly defines a 
community of practice (CoP) as a group of professionals with similar task responsibilities, who 
promote learning through membership communication. This type of CoP affords members the 
opportunity to share professional practices and tools.  
The author proposed that the group of HLCs could be considered as a CoP261. This group of healthcare 
professionals formed soon after the initiation of HLPs in Portsmouth and became a key feature in the 
implementation of the project.  
The term community of practice will be used in the context of the investigations carried out in this 
chapter of the thesis,  as this is consistent with the literature citing Lave and Wenger’s261 notion of a 
CoP. Three characteristics of a CoP have been proposed (Figure 4.1): the domain, the community and 
the practice. The domain refers to the community having an identity, a shared interest, a commitment 
and shared competence that sets them apart from other communities or groups. The community 
works towards their interests: members engage in joint activities and discussions, help each other, 
and share information. They build relationships that enable them to learn from each other262. Finally, 
the members of a CoP are practitioners. They develop a shared repertoire of resources to share 
practice and highlight the embedded nature of practice266.  
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Figure 4.1 The three inter-related key elements of a community of practice (COP) 261 
 
 
Within the context of this study, the three characteristics as described by Wenger262 relate to the 
group work that is central to the role of the HLCs and is fundamentally about dialogue and 
collaboration (practice) .The community members are the HLCs and the domain is the activities 
comprising the HLP project.  
Lave and Wenger’s initial work acknowledged that the concept of CoP was through investigating the 
learning of apprenticeships where they identified a set of social relationships through which learning 
took place261. Expecting to find that the learning would reflect the novice/master type relationship 
usually associated with apprenticeships, they were surprised to observe that learning predominantly 
took place with colleagues and more advanced apprenticeships. Once communities of practice were 
identified, they could be seen in a variety of settings from healthcare through to industry and 
education.  
 
4.1.3 Community of practice in healthcare 
Improving productivity was one of three strategies put forward as a means of addressing the funding 
shortfall projected for the NHS in the UK for 2011-2017267. Funding shortfalls are not exclusive to the 
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NHS; health services across the world are faced with the need to deliver high-quality care within 
economically constrained environments268. Improving productivity in the healthcare sector means 
adding value to how resources are used to deliver high quality healthcare that meets the needs of the 
people; that is, to deliver high-quality healthcare effectively. In an attempt to meet this challenge, 
other industries have explored strategies which have the potential to enhance organisational 
performance. One such strategy has been the promotion and fostering of communities of practice 
that have gained recognition in the business sector for improving organisational performance269, 270.  
In business, CoPs are promoted as drivers of knowledge management, as a mechanism for the sharing 
of tacit knowledge, sparking innovation, reducing the learning curve for new staff, and as a means of 
creating social capital and adding organisational value270, 271. These claims have led to communities of 
practice being promoted in healthcare as a tool to enhance knowledge and improve practice272. It 
appears, they provide a means for knowledge to cross boundaries, generate and manage a body of 
knowledge to draw on, promote standardisation of practice, and “innovate and create breakthrough 
ideas, knowledge and practices”271.   
To date, there have been two systematic reviews focused on the application and effectiveness of 
communities of practice in the context of healthcare. The first review explored the role of 
communities of practice in improving the uptake of best practices and mentorship of new 
practitioners273. The authors also identified and compared existing CoP descriptions from the health 
and business literatures and common themes of social interaction, knowledge sharing, knowledge 
creation and identity building were identified.  
Andrew and Ferguson274 provided the most contemporary definitions and descriptions of CoP in the 
context of nursing. In a report on a CoP of academic healthcare instructors and healthcare clinicians, 
the authors offer a description that captures the essence of Wenger’s275 definition and also shows the 
application of the concept to a healthcare setting: “The contemporary interpretation of communities 
of practice promotes a dynamic social participative approach to learning and discovery”. The authors 
provide clarification of how a CoP promotes learning by affirming that communities of practice result 
from “an integrated approach to learning, achieved through a combination of social engagement and 
collaborative working in an authentic practice environment”, in which “skills and talents of like and 
unlike diverse populations can be harnessed to challenge and develop professional practice”. The 
learning involved in communities of practice is elaborated further; hypothesising that learning in a 
CoP occurs through a “deep interest of their members, encouraging them to share personal histories 
and journeys, weaving a narrative to contextualise professional practice development”.  
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Whilst the authors of the review searched for both quantitative and qualitative studies, no 
quantitative studies for healthcare were found. The authors concluded that the actual structure and 
function of healthcare communities of practice varied greatly, restricting the evaluation of their 
effectiveness; therefore this review was only able to shed light on the first objective of comparing CoP 
descriptions with the actual effectiveness remaining unclear.  
The effectiveness of communities of practice in healthcare was the aim of a further systematic review 
by Ranmuthugala et al. 276. This review looked at how and why communities of practice have been 
established in healthcare with the aim of informing the development of a framework to systematically 
evaluate communities of practice effectiveness in sustaining improved practice initiatives. The authors 
found the emergence of CoP terminology in healthcare research to be a very recent phenomenon. 
Whilst improved outcomes reported included improvement in guideline development, patient 
assessment, reduced frequency of insurance liability claims received by hospitals and improved 
adherence to evidence based processes, the multifaceted nature of the interventions made it difficult 
to differentiate the impact of the CoP intervention from other variables.  
CoP studies in healthcare found in these two systematic reviews mostly focused on specific speciality 
areas of healthcare practice rather than practitioners themselves, with the aim of facilitating 
interdisciplinary collaboration to improve healthcare delivery and outcomes. There are no specific 
published studies relating to the involvement of the pharmacy workforce in CoPs.  
Despite this, there are important conclusions that can be drawn from the literature regarding 
communities of practice within healthcare; one of which includes what constitutes a functioning CoP 
within a healthcare setting. It has been recognised that each element of the CoP (community, practice 
and domain) has prerequisites necessary for the formation and success of the CoP. The literature 
described the antecedents to community to include the initiative, interpersonal skills, and work ethic 
of the community members. Furthermore, community members must join the CoP voluntarily 
(without coercion) as a show of personal commitment to the domain and self-motivation to improve 
practice277-280. Necessary for the formation of relationships within the community, strong 
communication skills promote meaningful collaboration and mutual engagement 246, 280. Meaningful, 
sustained relationships and shared ways of engaging are viewed as two core elements of a CoP 274, 275, 
281. In addition, trust among the community members is necessary for the development of sustained 
relationships that promote accountability and a culture of independency277, 280, 281.  
A supportive work environment has been identified as providing an important antecedent to practice. 
Employers and organisations that foster communities of practice must be willing to invest in members 
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who participate in the CoP. Community members must be granted time away from their work to 
participate in the CoP278, 280, 282. It has been reported that communities of practice flourish in an 
environment that is “ripe for growth, propelling the person from individual level dependence to team 
focused levels of trust, potency, and commitment”283. The CoP must also be supported both 
structurally with physical spaces in which members can meet and technologically, with means to 
record their activities277, 280. 
In order to achieve a sustained interest in the domain, it has been recognised that CoP members 
should have an appreciation of the context, content and importance of the domain, as this has been 
shown to facilitate their commitment274, 277, 278, 280, 281, 284. The domain must instil in the members a 
sense of unity of purpose within the practice environment. For the domain of interest to be considered 
an element of a healthcare CoP, the domain must be a practice-centred problem, concern, or 
interest274.   
In the absence of one or several of the aforementioned conditions, strategies have been employed to 
support communities of practice. For example, in recent times, varying forms of online technologies 
have been employed to support collaborative knowledge sharing and learning within and between 
groups of healthcare professionals through the development of Virtual Communities of Practice 
(VCoPs)285-287.  
 
4.1.4 Virtual Community of Practice (VCoP) 
VCoPs primarily describe a network of individuals who share a domain of interest about which they 
communicate and share experiences, problems and solutions online; with the aim of improving the 
knowledge of each participant and the overall domain288. VCoPs support interaction, collaboration and 
learning among professionals especially where face-to-face interactions are limited due to geographic 
spread, organisational boundaries, costs and time differences286. Studies in healthcare research reveal 
that VCoPs potentially support and enhance how healthcare teams that may not normally work 
together, might use online interaction.  It has been reported that VCoPs may facilitate interaction 
between healthcare professionals, in order to collaborate, share, debate, resolve, integrate and 
implement different perspectives on practice to improve and inform evidence-based decision 
making286.  
VCoPs have also been noted as being capable of extending healthcare practitioners’ learning beyond 
face-to-face opportunities by promoting distributed and continued learning285, 286. Other studies have 
also explored how collaborative conversations in VCoPs can help to strengthen intra-professional ties, 
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enhance information access and improve support that would otherwise be unavailable to healthcare 
teams287.  
Despite evidence revealing that VCoPs can improve informal peer support and networking, improved 
shared decision making and overcome professional isolation amongst geographically dispersed teams 
of health professionals289-292, research also suggests that many VCoPs developed for health 
professionals fail because rates of online interaction are very low293. Explanations for this have been 
cited in the literature. Online interaction may be conditioned by whether an organisation sanctions 
the use of a VCoP by its employees for its potential for improving practice; whether members may feel 
their contribution is important and useful to share and whether members trust that the information 
being collectively shared in the community is not misleading or overtly critical294, 295. In addition, busy 
schedules, topic relevance of the online community, Information and Communications Technology 
literacy of participants, presence or lack of moderation and appropriate tasks to enhance 
participation, lack of feedback/responses to posts and forgotten passwords and usernames, can all 
have an effect on online interaction295.   
The potential for using a VCoP with the HLCs has not been explored; this is the topic of research 
described later in this research.  
 
4.1.5 Aim and objectives 
The aim of the research reported in this chapter was to investigate the role of HLCs and explore the 
significance the HLCs attribute to attending HLC meetings.  
The research had the following objectives:  
1. Investigate the self-reported activities of HLCs  
2. Explore the influence attending HLC meetings has on the HLC role 
3. Assess the consensus of opinion amongst HLCs on the significance of meetings towards the 
sustainability of HLP activities 
4.2 Methodology 
 
As a general description, qualitative research aims to be subjective, inductive and non-
generalisable296, it investigate how people behave in a particular social setting and explore what 
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meanings people actually wish to convey when describing personal experiences297. Qualitative 
methods have been applied in the investigation described below.  
 
4.2.1 Qualitative methods 
Different qualitative methods are applied to research depending on the theoretical and practical 
consideration of the study296. As discussed in Chapter 3, qualitative research has its origins in social 
sciences and humanities, where the theoretical approach used by researcher aims to provide 
conceptual understanding of social interactions, societal ‘norms’ and relational phenomena298.  
The approach to undertaking qualitative research can vary at different levels including the ‘systems of 
enquiry’ available for data collection methods. They are usually applied through observations, 
interviews (either individual or focus group), or analyses of documents and other written materials299. 
The study reported in this chapter of this thesis involved focus groups.  
 
4.2.1.1 Focus groups 
Focus groups have their origin in four separate traditions: social science, organisation research, 
community development and market research197. In medical education research, focus groups have 
been commonly used to develop items for inclusion in questionnaires or in hypothesis generation300-
302. The definition of what constitutes a focus group varies between reported studies. One definition 
is “a group discussion exploring a specific set of issues”303. 
As a research method, Sim304 outlined that focus groups can have four broad advantages:  
1. They provide information on the ‘dynamics’ of attitudes and opinions in the context of the 
interaction that occurs between participants.  
2. They may encourage a greater degree of spontaneity in the expression of views than alternative 
methods of data collection.  
3. They can provide a ‘safe’ forum for the expression of views. 
4. Participants may feel supported and empowered by a sense of group membership and 
cohesiveness.  
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As focus groups are a form of group interview, many of the issues applying to one-to-one interviews 
also apply to the sampling, data collection, analysis, theory and ethics of these groups. Researchers 
using this method must decide whether the topic would benefit from the discussion, interaction and 
comparison between groups. Some subjects, such as deeply personal issues, may be better explored 
in a safer and more productive way through one-to-one interviews. Ideally, sampling should aim for 
enough heterogeneity within the group to stimulate discussion but sufficient homogeneity to facilitate 
comparison between groups197. There is no defined number of subjects who have to be present to 
form a focus group, although numbers of between eight and 12 have been suggested as ideal; 
although studies involving between four and six participants are also acceptable304. The group is co-
ordinated by a moderator or facilitator, who may be assisted by a fellow researcher acting as an 
observer. This assistant’s role will most often be to take notes during discussions to give added 
information and meaning to the group interaction, non-verbal cues and discussion305.  
As with one-to-one interviews, focus group studies need to consider venues when planning meetings. 
Meetings need to be confidential and undertaken in a venue with appropriate facilities to ensure 
adequate recording of data. Although there is ‘no such thing as a neutral or ideal location’, the 
venue(s) chosen should aim to optimise participation303.  
Analysis of data should recognise that focus groups can overemphasise consensus and can be 
dominated by either influential or opinionated group members306. In addition, analysis should include 
the dynamic interactions within the group. This is particularly important, as it is problematic to 
generalise from a focus group. This is partly because participants, as previously described, are usually 
selected through a process of non-random sampling and, in addition, there may be a tendency for 
more self-confident and articulate individuals to agree to take part in a focus group307. Moreover, as 
focus groups are contextualised, it cannot be assumed that the information given by a subject in that 
group is a predictor what they may say or do in a different social situation304.  
 
 
 
 
  
4.2.3 Description of methods employed 
In explorative studies, such as this, the interview is the main method of data collection308. The 
interview facilitates the illumination of participants’ descriptions of the phenomenon of interest309. 
Furthermore, from a CoP perspective, the meanings the HLCs assign to their experiences could be 
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accessed through dialogue. Thus in this study, as the area of interest was the descriptions of the HLCs’ 
experiences in meeting and networking with each other, the focus group was the data collection 
method of choice. Two focus groups were conducted with the study participants available.  
 
4.2.3.1 Methodology of the focus groups 
The pharmaceutical advisor (PA) was contacted for permission to attend the next HLC meeting. An 
outline of the study objectives was sent to the PA, which was followed-up by an email including a copy 
of the study information sheet and a copy of the study consent form (Appendix 4.1). A request was 
made to include these documents alongside communications to HLCs for the next HLC meeting.  
 
At the HLC meeting, before each focus group, a copy of the topic guide was reviewed and a digital 
tape recorder was prepared, to audio tape the interview. The recordings can be transcribed verbatim. 
The disadvantage of recording is that they can make participants uneasy. However this effect generally 
disappears after the first few minutes when participants are preoccupied in conversation310.  
 
The interview schedule was created iteratively during the research process based on the substantive 
literature around communities of practice. Having an understanding of the factors associated with the 
functioning of a CoP allowed the researcher to develop the interview schedule. The interview schedule 
used during the focus group can be broadly classified into different sections, which focused on:  
 Identifying the self-reported roles and activities undertaken by HLCs, 
 Exploring the HLCs’ motivations for attending the HLC meetings, 
 Investigating individuals’ experiences in attending the HLC meetings, 
 Assessing the consensus of opinion amongst HLCs on the significance of meetings towards the 
sustainability of HLP activities. 
 
A semi-structured interview schedule (Appendix 4.2) was developed by the author to enable the 
discussion to flow and to allow probing with regard to areas identified as potentially relevant to the 
specific research questions.  
 
As the HLC s arrived at the venue they were provided with a copy of the study information sheet and 
a copy of the consent form, which they were requested to read prior to consenting to participate in 
the study. Further to this, brief profiling of the individuals was conducted, to identify place of work, 
current job role, age and years of experience working in community pharmacy. This information was 
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gathered to obtain further information on the profile of individuals undertaking the HLC role. 
Individuals consenting to participate in the focus groups were then issued with a name badge. 
 
Two focus groups were arranged. The 20 HLC attendees (representing 15 pharmacies; 5 of the 
pharmacies sent two HLCs) were split into two groups, each of 10 volunteering participants. An 
attempt was made to divide the HLCs into heterogeneous groups and to avoid persons who work 
together from being in the same group. The HLCs were allocated a group to equally divide the number 
of persons working for multiple-group pharmacies and independently owned pharmacies into the two 
groups. Further to this, the focus group interview was conducted in a separate room away from the 
meeting area, so that the second group of HLCs could not overhear communications.  
 
The researcher acted as moderator. An assistant was present acting as an observer and taking field 
notes during discussions and keeping time. The assistant was able to attribute the audio 
communications to the appropriate individual by reading their name badge. Following the two focus 
groups, the audio was transcribed verbatim by the research into a Microsoft Word file.  
 
4.2.3.2 Data analysis  
Open-ended questions usually provide qualitative data and there are several methods used to analyse 
qualitative data. Dawson311 presented four methods. The first is thematic analysis: themes usually 
emerge from the data and are not imposed by the researcher. Also, in this type of analysis, the 
researcher does not need to wait until he or she completes the data collection, so analysis can start 
once any part of the data is available. The second method is comparative analysis, which involves 
comparing and contrasting information that is obtained from the different participants, until the 
researcher is sure no more issues are identified. The third method is discourse or conversational 
analysis, which focuses on speech patterns, the frequencies of these patterns and their implications. 
The fourth method is content analysis, which is defined as ‘any technique for making inferences by 
systematically and objectively identifying special characteristics of messages’312.  
The content analysis approach is one of the most popular approaches to analyse open-ended 
questions answers313, 314. It is commonly utilised in health research to improve interpretation of data315, 
316. Content analysis may be undertaken in an inductive or deductive way317 .  
An inductive approach to the qualitative analysis was employed, applying methods described by 
Krueger and Casey318. Following the focus groups, and prior to transcription, a written summary was 
made by the researcher to record an outline of the main ideas that emerged during the discussion. As 
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advocated by Pope et al.319, content analysis of the data from the focus group transcripts occurred in 
between the two focus groups in order to improve moderation techniques and maximise the 
information gained. Principles from Heidegger’s hermeneutic circle320 were adopted for data analysis, 
whereby the researcher read and re-read the discussion transcript in detail, identifying and coding key 
concepts and ideas by highlighting discrete words, sentences and series of sentences relevant to the 
research objectives320, 321. These quotes formed the basic meaning units for analysis, which were 
categorised through a process of comparing and contrasting. Preliminary themes were then identified 
to organise and understand the data322.  
To enhance trustworthiness, an additional researcher independently analysed the transcripts from 
each focus group, reading and re-reading the transcripts to confirm the emerging concepts, ideas and 
themes323. Finally, a further discussion, involving the researcher and the assistant took place during 
which data from the two focus groups were integrated, discussed and clarified. Factors including 
frequency, specificity, emotional expression and extensiveness of the comments were also considered 
during the process318, 324. Through on-going interrogation of the data, maps and diagrams were 
developed in order to accurately depict the perspectives of the HLCs. Differences in opinion were 
considered with further discussion until consensus was formed on the constructs and themes to be 
included in the analytical model.  
 
4.2.4 Ethical approval  
This research received a favourable opinion from the Portsmouth NHS Local Research Ethics 
Committee (ref 10/H0501/6) 22/01/10 (Annexe 1). 
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4.3 Results  
4.3.1 Focus groups  
Twenty of the 33 HLCs employed in Portsmouth community pharmacies agreed to participate in the 
focus groups, all but one of whom were female. Each focus group lasted between 40-50 minutes. Table 
4.2 details the characteristics of the participants. 
Table 4.1 Characteristics of the focus group participants 
Participant 
identifier  
 
Focus group 
(FG) 
Age (years) Years of 
experience 
in CP 
Job role Place of 
work 
FG1 P1 1 54 12 MCA MC 
FG1 P2 1 59 21 MCA MC 
FG1 P3 1 48 16 MCA SC 
FG1 P4 1 53 9 PT SC 
FG1 P5 1 23 4 PT SC 
FG1 P6 1 39 4 MCA MC 
FG1 P7 1 63 12 DA IC 
FG1 P8 1 58 20 DA IC 
FG1 P9 1 47 10 DA SC 
FG1 P10 1 49 17 PT SC 
FG2 P1 2 55 20 MCA MC 
FG2 P2 2 55 12 PT SC 
FG2 P3 2 58 4 MCA MC 
FG2 P4 2 21 2 MCA SC 
FG2 P5 2 33 6 MCA MC 
FG2 P6 2 41 7 MCA SC 
FG2 P7 2 62 19 DA MC 
FG2 P8 2 47 6 DA SC 
FG2 P9 2 53 14 MCA IC 
FG2 P10 2 58 11 PT IC 
 
(n= 20; CP: community pharmacy, Job role MCA: Medicines Counter Assistant PT: Pharmacy Technician DA: 
Dispensing Assistant, Place of work MC: Multiple Chain. SC: Small Chain IC: Independent Contractor)  
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The average age of the participants was 49 years (range 21-59) and the average number of years of 
experience within community pharmacy was 11.3 (range 2-21).  Ten of the participants were MCAs 
(mean age: 46, mean years’ experience: 11), five were PTs (mean age: 48, mean years’ experience: 
11), and five were DAs (mean age: 55, mean years’ experience: 13).  
Seven of the HLCs were employees from five MC pharmacies, nine from six SC pharmacies and four 
from four IC pharmacies.  
The meaning units (the key quotes derived from the content analysis) comprised 203 quotes, which 
were relevant to the HLC meetings. These varied in length from one word, to a sentence, to a 
paragraph. Identified concepts and ideas were representative in both focus group discussions; thus 
the findings were integrated for analysis.  Fourteen constructs were established, clustering into four 
themes, reflecting participants’ perceptions and thoughts regarding the HLC meetings (Figure 4.2). 
The following themes emerged from the analysis: role and activities performed by HLCs; perceived 
benefits of attending HLC meetings; setup and content of the HLC meetings; and suggestions on 
developing the HLC network to support sustained delivery of HLP activities. Quotes illustrating these 
themes and constructs are described in the following section.  
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Figure 4.2 Analytical model of the issues relating to HLC meetings discussed in the focus groups  
Constructs Themes Phenomenon 
Supporting and motivating 
Leading HLP initiatives 
An opportunity to network 
A source of motivation to 
engage in HLP activities 
A platform to discuss health 
promotion campaigns 
Sharing practice of patient 
recruitment and promoting 
services 
Initiating relationships for 
collaborative projects in the 
local community 
A sense of community 
working together with a 
common goal 
Central location and 
convenient time are 
essential  
The educational element 
deliver by the practitioner 
contextualises HLC role and 
is a valued inclusion 
Updates of pharmacy’s 
service activity and success 
motivate further service 
delivery 
A facility to allow 
communications to 
continue between meetings  
Formation of group 
committee to manage 
communications  
Role and activities 
performed by HLCs 
Perceived benefits of 
attending HLC meetings 
Thoughts on the setup 
and content of HLC 
meetings 
Suggestions on 
developing the HLC 
network to support 
sustained delivery of 
services  
HLC 
meetings  
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4.3.1.1 Focus group analysis – derived themes 
In the following section the following abbreviation is used to identify the respondents, FG1 P1: Focus 
Group 1 Participant 1. Further characteristics of the respondent can be found in Table 4.2.  
Role and activities performed by the HLCs 
The HLCs reported their role in supporting the delivery of HLP activities in the community pharmacy 
in which they were employed. They described their responsibility in training and motivating members 
of the community pharmacy team they worked with in recruiting and supporting customers involved 
in the HLP activities. The following statements reflect this.  
 “It’s me who tells the other staff about the new campaigns we are running and how they can get 
involved and the advice we should be giving to customers.” FG1 P1  
“I think that it’s also my role to encourage everyone else in the team because not everyone is always 
motivated and keen to talk to customers and try to recruit them to what we are doing at that time in 
the pharmacy.” FG2 P1  
The HLCs detailed their role in leading the HLP accreditation process in ensuring service activity is 
recorded in an online database to share with the commissioners (PharmOutcomes), communicating 
service targets to their team and making necessary arrangements to introduce new HLP initiatives.  
“We are the ones in the pharmacy who are always looking out for the new things that come out. Like 
now, the Men’s Health Audit; we have to try to fit that in to what we are doing and make sure all the 
staff know about it and what to do and how we can promote it.” FG2 P3 
“I do have to do a lot of the paperwork like putting all the figures on PharmOutcomes and making sure 
all the details are right and then checking to see that we got paid.” FG2 P5 
The dissemination of important information discussed in the HLC meetings was also identified as an 
important function of the HLC role. After attending HLC network meetings, the HLCs reported that 
they routinely disseminated amongst their team the ideas of good practice, useful signposting 
resources and new community pharmacy referral pathways discussed at the meeting. This was in most 
cases communicated verbally. However, it was also mentioned by a number of respondents that 
distributed material including leaflets and other printed resources containing this information would 
be added to the pharmacy’s sign-posting resource.  
“I consider going to the meetings as professional development and a chance to get useful information 
that I can bring back to the pharmacy…..When you meet with the other girls (HLCs), you talk about 
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work and you share your ideas; I’ve learnt so much just by talking to them….It was XXXX (HLC) who 
told me about the Alcohol Interventions team and the referrals they make and she also said about the 
scratch cards (Alcohol brief intervention scoring cards- contains information of local referral services) 
you get for the pharmacy” FG1 P4 
Two of the HLCs discussed their role in “supporting the process of change” (FG2 P2) within the 
pharmacy to help with the implementation of the HLP project, and mentioned that they had sought 
advice from their peers and from the local pharmaceutical advisor (PA) on strategies to influence their 
colleagues in the pharmacy to participate further in HLP activities.  
“I know that its my job (as a HLC) to try and make HLP work and make everyone (colleagues in the 
pharmacy) as passionate and driven and keen as I am to help the customers and get involved (in HLP 
activities)…..the hardest thing is changing people; one day they will be fine and ‘dabble’ with talking 
to customers but I have to keep trying with them; XXXX (the local PA) said I should get them to come 
to these meetings (HLC network meeting)… I think I’m going to bring them along next time” FG2 P3 
Within one of the focus groups it was proposed by one HLC that, managing internal communication 
with regards to HLP activities and developments, ensuring consumables for HLP services were well 
stocked and monitoring the level of service provision were all responsibilities of the HLC; to which 
there was agreement from the other HLCs present.  
 
Perceived benefits of attending HLC meetings 
This theme, comprising of six constructs, reflects HLCs’ opinions of the benefits they perceive to 
acquire from attending the HLC meetings.  
It was evident that the majority of HLCs were in favour of regular meetings and perceived them as 
opportunities to network with other HLCs working in different pharmacies. The overriding feeling was 
that the meetings, first and foremost, provided a platform for attendees to discuss current health 
promotion campaigns and to share ideas around customer recruitment and service promotion. The 
HLCs perceived the meetings as a rare opportunity to meet face to face and network with other HLCs; 
and was widely valued by the participants. 
“I really look forward to these meetings, I think they are great and I think they are a great way for us 
to network and keep us motivated with the all the services” FG1 P3 
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“I find them (the meetings) really useful because it gives me a chance to see and hear what everyone 
else is doing in their pharmacy and it gives me ideas for what I can do” FG1 P4 
After attending the meetings, HLCs stated they returned to their workplace with greater motivation 
possessing a “feel good factor” (FG2 P7), which acted as a "boost"  (FG1 P3, FG2 P4) in their desire to 
help more customers. Attending the meetings with other HLCs added “something new and exciting” 
(FG1 P11) to the job role; this acted as a source of motivation for attendees to continue to engage in 
HLP activities.  
“I go back to work (after the meetings) and feel more motivated and I find out that others like me are 
working hard and trying to do the same things.“ FG2 P12 
“Once you hear about something working well in one place it gives me confidence to try it in our 
pharmacy” FG2 P6  
Furthermore, a significant number of the HLCs agreed that attending the meetings and hearing of 
others’ success with HLP activities, provided a source of “healthy competition” (FG2 P6) in comparing 
service activity figures, for example smoking cessation quit rates. The HLCs would use the meetings as 
an opportunity to elicit advice from other HLCs on health promotion campaigns and strategies to raise 
public awareness to boost customer recruitment.  
“XXXX branch are doing really well with their health checks and quitters (smoking cessation) and that 
is something that when I hear about, I feel that maybe there is more we can be doing.  So I try to have 
that conversation with them to see what I can be doing differently” FG2 P5 
“We get to hear about other pharmacies and how many services they are doing; I listen and find out 
who is doing more than us and find out how they are doing it….. because getting the patients isn’t easy 
(customer recruitment to HLP services) and there’s lots of ways you can do so I try to ‘pinch’ their 
ideas” FG1 P3 
Groups also discussed the opportunity the meetings provided in facilitating support for a range of 
other issues encountered within the pharmacy, such as IT solutions, sources of purchasing service 
equipment and sharing communication techniques in supporting customers involved in health and 
well-being services within the pharmacy.  
“Sometimes I just wait to come to these meetings with all my questions because I know there will be 
someone here who can help me….. I needed help with putting the figures on PharmOutcomes (service 
information database) and I didn’t know where to get the inhaler devices from to show the patients” 
FG1 P1 
 114 
“I found out (from the meetings) where I can get all the smoking stuff (posters and display materials) 
from for the health promotion table so I just ask here now” FG1 P7 
The meetings had served to initiate working relationships between individuals employed at differing 
pharmacies and led to collaboration of HLCs from different pharmacies.   
“We didn’t use to talk to each other, we would just say ‘Hi’ even though she only works down the road 
from me…. We decided at one of these meetings that we were going to do the health promotion stand 
at the college together, so we planned it together and it was brilliant, it went really well.“ FG2 P3 
Both focus groups discussed the importance the education element of the meetings is to their 
professional development. Whereby a practitioner affiliated to one of the HLP services (e.g. a local 
asthma nurse or a locally employed dietician) delivered a presentation, explaining their role and the 
remit of the service they provide as well as the how community can contribute to specific patient 
groups (e.g. appropriate dietary advice to offer during a weight management service).  
“The speakers who come along and present are brilliant…. They really help me to know who are the 
right patients to refer and they tell us how best we can refer patient to them. I learn so much from 
them” FG1 P4 
 
Thoughts on the setup and content of the meetings 
The HLCs identified that a local venue and the specific time the meetings were held were important 
factors in being able to attend. Further discussions regarding the content of the meetings and the way 
in which they are structured, revealed the HLCs’ feelings towards the meeting agendas.  
The inclusion of the PA’s presentation on local and national developments in the area of HLP with 
regards to new initiatives being considered and the references to recognition in the press of the 
success achieved in the Portsmouth HLP project promoted a “feeling of shared identity” (FG1 P2) and 
“sense of pride” (FG1 P3). 
The training element incorporated into the meetings through the presentation of the invited 
practitioner was acknowledged to be a valuable source of learning and helped in contextualising the 
HLC role within the provision of specific services. A typical comment from participants is highlighted 
below. 
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“The speakers (trainers) are really good and I learn so much from them…….. Because they are involved 
in the same service, they can tell us exactly what we can do to help and what we should be telling 
customers who we think need to be referred on” FG1 P7 
HLCs generally held negative views toward the correspondence publicising meetings, as invitations 
were addressed to the pharmacy and not specifically the HLC. This often resulted in invitations 
received late or in many cases, not at all.  
Individuals, who had been unable to attend past meetings, expressed their frustration at missing out 
on these discussions and updates included in the meeting not being circulated afterwards.  
 
Suggestions on developing the HLC network to support sustained delivery of HLP activities  
The HLCs acknowledged the positive affect attending the HLC meetings had on their understanding, 
enthusiasm and confidence in the process of their pharmacy meeting the criteria in becoming HLP 
accredited. There was also a voiced belief that continuation of the HLC meetings will be central for 
continued motivation, collaboration and sense of community amongst the HLCs in sustained delivery 
of HLP activities.    
“These meetings give us an identity that we did not have before and we are recognised here (at the 
HLC meetings) for what we do with our customers; that’s not something we’ve had before and I think 
that’s what’s keeping us interested” FG1 P4 
The HLCs discussed how the meetings could be designed and delivered to improve the variable 
attendance, which was likely to limit the benefits of the meetings. The HLCs cited the lack of means 
for direct communication between meetings and the absence of an advanced timetabling schedule. 
The lack of HLCs attending was seen as detrimental to enhancing exchange of ideas. It was also 
proposed that with greater attendance, a leadership committee could be formed to share the 
responsibility of arranging meetings, collating important information and disseminating 
communications within the group. This idea received numerous positive comments.     
“We should have a small committee in charge of collecting everyone’s ideas and then before each 
meeting the committee can meet up or talk on the phone about what topics we want to cover and then 
send out the invitations to everyone” FG1 P5 
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“It would be great to have more of us here at every meeting, so we can share more ideas and that 
would help as well to make a committee of regular people who can organise sending out the meeting 
information” FG2 P3  
To facilitate improved communication between meetings, participants spoke of introducing a platform 
to allow direct interaction between HLCs; an online forum and a Facebook group were mentioned as 
possible solutions to facilitate this.  
“We need something that everyone can use (in between meetings), and it would be good if we can use 
it from work; that we don’t have to give too much personal information…. It has to be simple and have 
it so that we can talk to each other” FG2 P7 
“We need something that you can send messages and pictures and chat about what we’re doing in the 
pharmacy…that gives us the same ‘buzz’ that we get from these meetings.” FG2 P6 
 
4.4 Discussion 
 
The aim of the work undertaken was to investigate the role of HLCs and explore the significance the 
HLCs attribute to attending HLC meetings.  
In addition to achieving the study objectives set out in this chapter of the thesis, the work carried out 
provided profiling detail on community pharmacy support staff, adding to the sparse published 
literature around this population of healthcare professionals.  Only one of the HLCs involved in the 
study was male; indicating an overwhelmingly majority female orientated role. The participants were 
either MCAs, DAs or PTs, however MCAs made up half of the participants; this observation was not 
investigate but a plausible reason for this could be that MCAs are often the first point of contact within 
community pharmacy thus were deemed most suitable for the HLC role99. The average age of 
participants was 49 years old, with an average of 11 years of community pharmacy experience; these 
findings are similar to the findings of two earlier reported studies108, 114. There was little difference in 
the age and level of experience between MCAs, PTs and DAs, except that the DAs average age was 55 
years old compare to 48 and 46 years old of the PTs and MCAs respectively.    The participant data 
collected do not indicate a specific age group, level of experience nor specific job role for undertaking 
the role of HLC. Furthermore there does not seem to be a correlation of HLCs working at specific types 
of pharmacy (e.g. independent contractor versus multiple); the place of employment for the HLC 
population resembles that of the pharmacy types within Portsmouth.   
 117 
This study reported on the role and activities of HLCs involved in delivering the HLP project; there has 
been two further similar studies published which have reported findings in line with those of this 
work325, 326. The self-reported activities conducted and reported by the HLCs in this study included: 
training and motivating staff, leadership responsibilities, internal communications, organising 
supporting conditions for services, networking, updating resources and service monitoring. These 
activities are consistent with those cited in the related literature pertaining to the ‘champion role’ 
(refer to Section 4.1.1). Furthermore the findings identify that HLCs perceive their role to be one of 
influencing and implementing change within their workplace as detailed in Rogers’ Diffusion of 
Innovations model238, in which the concept of champions is described as an individual who “influences 
clients’ innovation-decisions in a direction deemed desirable by a change agency”.  Since this research 
has been conducted, further reports evaluating the role of HLCs in HLP projects elsewhere in England 
have been described. These include the evaluation of the implementation and impact of HLPs in 
Birmingham327, which revealed the HLCs’ role in the delivery of HLP activities and identified HLCs to 
be highly motivated in supporting the HLP objectives. However, the diversity of HLC activities, as 
reported in this study, was either not evident or not reported on. In this report, HLCs reported peer 
support for their role was non-existent and there were no communications amongst HLCs working in 
different pharmacies. This was despite it being recorded that the HLCs perceived that peer networking 
would be valuable in enabling transfer of knowledge and sharing of best practice amongst HLCs to 
facilitate continued improvement of service delivery in HLP activities. Furthermore, the report exposes 
the lack of recognition and support the HLCs received from their employers and the local 
commissioners. This contrast may be explained by Coakes et al.’s research256, which suggests that in 
order for individuals to succeed in championing innovations in organisations, they need both 
procedural and resource support, and social and cognitive support. The authors recognise that the 
influence of innovation champions came through social contacts, multiplied through the communities 
in which they participate, through the genuine esteem in which they are held. 
This study also specifically identified the perceived motivators and benefits of HLCs attending HLC 
meetings. These were reported to include: peer learning, increased motivation, enhanced confidence, 
source of advice, opportunities for collaboration, professional development, and sharing ideas. The 
findings of this part of the research resonate strongly with the work of Lave and Wenger261 in 
describing communities of practice. The Lave and Wenger definition emphasises the opportunity for 
collaborative learning opportunities communities of practice create through sharing personal practice 
and regular interaction.  
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The three characteristics described to comprise a CoP can be clearly identified through the narrative 
of the HLCs:  
1. the domain being the HLC shared interest and commitment to progress with the HLP agenda; 
2. the community being the network of HLCs who meet periodically and engage in joint activities 
and discussions; 
3. and finally the practice element whereby all HLCs contributing to the meetings are 
practitioners working towards a achieving a shared goal.  
A more recent study by Rutter and Vryaparj identified similar themes325; HLCs involved in the HLP 
project in Dudley, UK were interviewed to explore their views on their role. The research identified 
that HLCs held positive views towards their new role and were motivated through a sense of personal 
development and a desire to enhance their practice in helping their customers. However, unlike in 
Portsmouth, the study did not identify the formation of a CoP but did include the introduction of 
networks between HLCs as a recommendation to support the skills development and practice of HLCs.   
Analysis of the focus group discussions suggests that there are some key factors that influence the 
development, functioning and maintenance of the HLC meetings.   These factors can be summarised 
under the following broad headings: commitment, enthusiasm, infrastructure and resources. These 
four factors, amongst others, have been cited in related literature as influential for encouraging 
collaboration and knowledge sharing within communities of practice328, 329. Moreover, on reviewing 
the recent publications evaluating the HLP projects elsewhere in the UK325, 330, 331, the factors which 
have been cited to influence the successful implementation and delivery of the HLP project can be 
categorised into the aforementioned headings. 
The four factors mentioned can be attributed to the HLC, the pharmacy in which the HLC is employed 
and/or the wider structure supporting the HLP initiative (e.g commissioners, project team), 
summarised as follows:   
 The HLC demonstrates their commitment and enthusiasm in attending the HLC meetings, 
contributing to discussions, sharing ideas, disseminating information to their team in the 
pharmacy and continuing to promote and deliver HLP activities.  
 The community pharmacy demonstrates commitment through supporting the attendance of 
the HLC at HLC meetings, which provides the social and cognitive support; and being receptive 
to change and innovation through championing HLP initiatives and providing the procedural 
and resource support to the HLC256.  
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 The wider support structure (e.g commissioners, project team) manifests their commitment 
in continuing to commission resources and services in developing the HLP initiative, funding 
and facilitating the HLC meetings, sanctioning the local Pharmaceutical Adviser (PA) to lead 
HLC meetings and resourcing HLP communications.   
Further to this, in discussing the contribution of the HLC meetings in supporting the sustainability of 
HLP service delivery, the HLCs saw improved communications in between meetings and the formation 
of a committee to take on the leadership of the group in managing communications and 
administrative functions, as a facilitator for tackling some of the challenges mentioned above.  
  
4.5 Conclusion  
 
There is increasing evidence indicating that the HLP project is an effective platform through which 
community pharmacy’s role in delivering health public health services can be realised; this has been 
achieved through improved utilisation of pharmacy staff330-332. The author’s research has identified 
effective team working and staff motivation as key enablers and facilitators in supporting the HLP 
initiative. This study has identified a CoP developing amongst the HLCs; this is evidenced by the 
reported contribution of the HLC meetings in providing HLCs with professional development, 
networking opportunities and continued motivation. It thus offers recommendations to develop and 
sustain the CoP to support the sustainability of delivering HLP activities.   
In the next part of this study, the literature will be explored to inform the design, implementation and 
evaluation of a strategy to support the emerging HLC CoP. 
 
 
 120 
Chapter 5 : Supporting the HLCs’ community of practice 
 
5.1 Introduction 
The work conducted in Chapter 4 identified a Community of Practice (CoP) developing amongst the 
Portsmouth HLCs; further to this the HLCs proposed recommendations to develop the existing 
networking opportunities to support the sustainability of delivering HLP activities.  
This chapter reports a review of the literature for evidence based strategies employed to support 
CoPs. This, together with the analysis of HLCs’ recommendations informed a strategy to support the 
emerging HLC CoP, which was subsequently implemented and evaluated. 
 
5.1.1 Supporting CoPs 
CoPs are entities that emerge and evolve for the purposes of learning and solving authentic 
problems265, 275. Current trends in knowledge management cite the implementation of CoP in 
organisations as a way to advance knowledge333. For this reason, enabling and cultivating their 
emergence and continuation should be a priority among organisations270, 333. 
For the healthcare professions, one of the greatest advantages of CoPs as a collaborative learning 
environment, is being able to respond to the dynamic nature of medical knowledge and its relationship 
with clinical practice273. In recent years, varying forms of online technologies have been employed to 
support collaborative knowledge sharing and learning with and between groups of healthcare 
professionals, in order to improve standardisation and spread best practices. One strategy that has 
been employed to achieve this is the development of a virtual community of practice (VCoP). A VCoP 
describes a network of individuals who share a domain of interest about which they communicate and 
share experiences, problems and solutions online, with the aim of improving the knowledge of each 
participant and the overall domain288. 
In a VCoP, knowledge can be continually shared in context with meaning, and can be changed through 
a collaborative nature; the members have the opportunity to pattern their behaviour based on current 
opinions and beliefs. Furthermore, healthcare practice can change quickly, and a virtual online 
community can be responsive enough to change with it334.  
It has been argued that the ideal technology to support a CoP does not exist. Although many products 
have been designed with relevant features which are useful in facilitating CoP functions, a single 
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platform enabling the recognised beneficial activities of a CoP has yet to be developed and reported 
on335. Meanwhile, the attributes of an ideal technological platform to support a CoP are being 
recognised:  
 easy to learn and use since involvement in a CoP is not usually one’s main occupation;  
 uncomplicated access and integration with other software that members of the CoP are using 
for their regular work so that participation requires as few extra steps as possible;  
 affordable; if the technology requires a large initial investment, potentially CoPs will not be 
able to take advantage of the platform.335  
  
5.1.2 Virtual Community of Practice (VCoP) 
Whether an optimum VCoP exists, or what defines one remains controversial. It has been questioned 
whether or not a community can exist in an online or virtual environment because many associate the 
concept of a community with common physical space and history shared by its members336. However, 
others agree that VCoPs do exist and maintain the same functions as regular communities336, 337. 
Moreover, it has been claimed that one of the Internet’s largest successes is connecting people to 
share knowledge or advice. It has been estimated that in 2005, one third of all adult internet users 
used virtual social networks to make a key decision in their lives338. 
The literature recognises the concept of VCoPs and alludes to their capacity to support interaction, 
collaboration and learning among professionals, especially where face-to-face interactions are limited 
by geographic spread, organisational boundaries, costs and time difference339.  
Preece and Maloney-Krichmar340 sum up five important characteristics of VCoPs. These five 
characteristics are:  
 members have a shared goal, interest, need or activity;  
 members engage in repeated, active participation;  
 members have access to shared resources;  
 exchange of information, support, and services; and, 
 members have a shared context of social conventions, language and protocols.  
 
The literature discusses the advantages of VCoPs. Palloff and Pratt341 stress that because of the large 
amount of information shared, VCoPs offer a greater amount of acquired and shared knowledge than 
could be collected on an individual basis. They add, that the excitement and synergy of an online 
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community can offer greater collaborative benefits than any other medium through the sharing of 
resources and offers the capacity to support community members. Furthermore, it has been reported 
that engaging in a VCoP enhances the learning environment. Johnson concluded the learning that 
evolves from VCoP is collaborative, in which the concerted knowledge of the community is greater 
than any individual knowledge342.  
Fontaine and Miller’s review of the literature pertaining to VCoPs343 concluded that it is possible to 
identify three types of benefits of VCoP, depending on the recipient: individual benefits; community 
benefits, and organisational benefits. Regarding individuals, VCoPs can affect both professional 
activity as well as the personal lives of those individuals. Furthermore, being members of a VCoP can 
also influence how relationships are established at a group level. While in relation to an organisation, 
the impact can be upon activities, output, value and business results.  
 
5.1.3 VCoPs in healthcare 
Research focussing on identifying the various benefits that VCoPs offer healthcare institutions has 
revealed that their use of VCoP has progressed knowledge management within health institutions344, 
345.  
There is also evidence to suggest that VCoPs can support practitioners to change practice to 
implement evidence-based practice, or to enhance performance276. Further research reports on 
observed improved quality of care 346, 347; reducing diagnostic time, or the establishment of new 
treatments and protocols in emergency situations348, following involvement in a VCoP.   
Evidence for the contribution of VCoPs to generating ideas for healthcare services, practice and 
products has also been published349, 350.  Moreover, it has been indicated that VCoPs can address 
complex dilemmas, such as improving quality and safeguarding high standards of care by fostering an 
environment for clinical care346, 351.  
VCoP benefits directly linked to activity and the outcomes of health institutions, such as increasing 
productivity and saving time and economic cost have been identified350-353. Moreover, the literature 
recognises the positive impact of VCoPs at the strategic level of healthcare services in developing 
intellectual capital354, 355 and  relationships with important constituents356-358.  
Lesser and Stock concluded from their research that belonging to a VCoP of healthcare professionals, 
favoured the creation of social capital, derived from the network of people who make up the 
community. This creates trust, co-operation and behavioural changes that enhance performance269. It 
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has also been suggested that the stronger the emotional links between community members, the 
greater propensity for knowledge sharing359. Furthermore, it has been observed that with more 
established VCoPs, a sense of belonging and identity through shared activity and purpose, is 
created356. 
These claims have led to VCoPs being promoted in healthcare as a tool to enhance knowledge, 
improve practice, and in general increase the individual and organisational performance272.   
 
5.1.4 The use of social media amongst healthcare professionals  
‘Digital natives’ is a term which has been used to describe a generation of people who have grown up 
in the time of online digital technologies, with a large majority of people using them frequently in their 
everyday lives360. Individuals use social media for both personal and professional purposes. There are 
reports indicating that commercial organisations favour the use of social media as a means to improve 
performance, knowledge and relationships361.  
More specifically, healthcare professionals are using social media tools in a variety of innovative and 
creative ways – to build and improve social and professional networks and relationships, to share 
health-related information and to engage with the public, customers and colleagues in shaping future 
health policies and priorities. Closed online groups are also commonly used for education and peer 
support. One such study reports on how social media can bring a new dimension to healthcare as it 
offers a medium to be used by the public, customers and health professionals to communicate about 
health issues with the possibility of potentially improving health outcomes362. Further works have 
explored the impact of healthcare professionals employing social media within the care of cancer and 
diabetic patients363-365.  
 
Facebook is one such online social media networking site, widely used to share information and 
communicate with friends, family and colleagues366. The use of Facebook has grown rapidly and as of 
June 2014, there were over one billion monthly active users worldwide367. The use of smartphones 
and tablets has also increased significantly368; both of which facilitate instant access to many social 
media platforms.   Although not designed to facilitate a learning environment, recent studies indicate 
Facebook to be a valuable tool in supporting academic activities369, 370 and share academic 
resources370. Facebook offers facilities enabling interaction via ‘profiles’, ‘groups’ and ‘pages’ and 
communication with individuals or groups using online chat, video chat and inbox messaging. User 
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profiles are personal spaces through which personal information, photographs and videos can be 
shared with an online community. The group facility allows a dedicated space for small group 
interaction about shared pursuits or interests. Groups can be formed by any registered user with the 
option to modify privacy settings. Pages are visible to the public and permit official entities such as 
public figures, businesses and organisations to communicate broadly with members who register their 
support for them371.  
The use of Facebook groups and pages has also been recognised in effectively supplementing 
academic course material372, 373.  Further studies report on the additional uses of Facebook in creating 
online environments to motivate learning374, 375, cope with stress376, facilitate collaborative peer 
learning377, 378 and encourage evidence-based practice379.  
In a study conducted by Panahi et al.369, doctors were interviewed to identify their personal use of 
social media for professional purposes, the perceived benefits and the challenges its use presented. 
All of the 24 participants revealed their frequent use of at least one social media platform for reasons 
of networking amongst peers, sharing knowledge, engaging in medical education, benchmarking and 
branding. The main challenges of adopting or greater usage of social media by physicians were cited 
to be: maintaining confidentiality, lack of trust, workplace acceptance and support, and information 
anarchy.  
 
5.1.5 VCoP design and the factors influencing user involvement 
Kondratova and Goldfarb380 believe the challenge of a VCoP is at least three-fold: 1) it has to provide 
content for users, 2) it has to encourage participation in the community and 3) it needs to facilitate 
communication and interaction among the practitioners.  
A recognised issue for a VCoP involves the technology and its usability. The literature suggests that 
measures should be taken to ensure participants have the technological provision and necessary 
information technology (IT) skills to support mutual engagement275. Difficulties with access and 
information and communications technology (ICT) skills in relation to online discussion and virtual 
learning are widely cited in related studies381-385.  
Technology needs to be regarded as an accepted and transparent means of communication386. The 
evolution of a CoP is reliant upon the effective communication of the members; this has been 
recognised to be most simply realised through face-to-face meetings387, 388. Billings acknowledges that 
there is a need for designing training for the use of VCoP including special attention to addressing 
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significant gaps in computer and information literacy skills between members389. McCartney et al.’s 
research involving healthcare professionals agrees with this. The authors conclude that a practical 
consideration to have in mind with VCoPs for health professionals is the need to ensure that potential 
members have the necessary skills training to understand the features of the virtual environment in 
order to use it effectively390.  
BHP Billiton, a leading global resource company, have invested in many technologies to support and 
develop CoPs throughout its organisation. A report evaluating their usage indicated that the differing 
styles and cultures across CoPs will often dictate the specific design and functionality of the support 
tool they will seek. Furthermore, it was recognised that face-to-face meetings between community 
members are essential to successfully implement and sustain a VCoP; it was concluded that the value 
of the use of technology may simply be in sustaining activity between meetings. The report also alludes 
to CoPs employing a mix of technologies, driven by what is pragmatic for the group overall. To ensure 
that no member is disadvantaged they will often choose the most widely used and understood form 
of technology e.g. e-mail or telephone391.  
The need for a community facilitator has also been discussed in the literature. Brennan and 
McGowan392 conclude that it is the moderator or facilitator’s role to choose to seed discussions where 
possible in order to keep online interaction vibrant and to ensure that networks and connections are 
developed by community members. Further, the author identifies that in large distributed groups 
interacting online, a lack of moderation increases the possibility of having unconnected networks, 
since participants may be too different and lack the social awareness and trust to develop connections 
around a shared perspective.  Stuckey and Smith393 argue that the presence of “leadership” within the 
VCoP is the most significant factor implicated in the ability to sustain the community and this may be 
in the form of a moderator, facilitator or list owner. 
 
The barriers to VCoPs have been recognised in the literature. Smith et al.394 identified that high 
collegiality, for example a strong community of members who are physically co-located, can have a 
negative impact on the sharing of information and knowledge within a VCoP. Another barrier involves 
the shifting membership of a VCoP, which Wenger et al.279 distinguish to be fluid in its composition. 
As a consequence, VCoPs are faced with the challenge of maintaining interest to encourage 
participation. Individual members of a VCoP must engage with it in order that it may develop and grow 
and have meaning395-397.  
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Trust is also a barrier, which has been recognised to influence whether individuals engage in a VCoP. 
The VCoP lacks the opportunity for face-to-face interaction and socialising, which can consolidate 
group membership. Trust is essential for collaboration and sharing information and primarily develops 
through face-to-face interactions396-399.  In a virtual environment, identities can remain hidden and 
members may adopt different personas400, 401. 
It has been cited in the literature that trust at an institutional level can also pose a barrier. Crossing 
virtual boundaries between organisations or institutions can have legal consequences involving 
disputes over intellectual property and data protection402-405.   
Ikioda et al. examined the relationship between the structuring characteristics of VCoPs and the rate 
of online interaction among health visitors and subsequently made suggestions for how to improve 
interaction339.  The study considers how the group size, geographic dispersion and topic relevance 
influence rates of online interaction. The study’s key findings are summarised in Table 5.1.  
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Table 5.1 Factors that influence healthcare professionals’ online interaction in a VCoP339 
Factor influencing 
VCoP online 
interaction 
Study finding 
Number of 
participants in the 
VCoP on online 
interaction 
Overall online contribution of posts increased as new members joined. 
With the joining of new members, new issues, good practice points, 
comments and resources to support existing and previously posted 
evidence pieces were added and re-energised posting activity in the VCoP, 
were observed.  
Contribution and overall participation stagnated until new members joined 
and re-invigorated the discussions. 
 
Geographic 
dispersion of VCoP 
members on online 
interaction 
Within professionally diverse and geographically spread groups, the degree 
to which a sense of community can be initiated and facilitated in order to 
make online interaction sustainable is highly dependent on facilitation of 
the VCoP. Moderation can provide a great deal of nurturing towards 
helping virtual interaction, however homophily (the degree to which 
participants of similar backgrounds  will only interact with each other) 
increases the tendency of disconnected networks, which in turn results in 
less online interaction.  
 
Topic relevance on 
online interaction 
High topic relevance facilitates more engaging online interaction among 
participants because the VCoP’s topics mirror the discussion that directly 
draws on practitioners’ experiences. High topic irrelevance can result in 
low online interaction because participants’ interests will not be 
stimulated to encourage interaction.  
 
 
Support for the findings observed in Ikioda et al.’s study can be derived from the literature. Tarmizi et 
al.406 recognised that the size of the group has a strong relationship with the stability of membership 
when considering the effect of member numbers on online interaction. The study recognised that 
there is an increased chance that the VCoP will thrive with larger group numbers and an open 
membership because new discussions and suggestions will be added by potentially more enthusiastic 
newcomers. Further to this, it has been recognised that new members will join a VCoP because they 
associate a substantial number of people using it; thereby augmenting online interaction through 
increasing numbers of users407.     
Regarding the influence of geographic dispersion, it has been reported that a potential issue with 
online and computer-mediated communications is that it is less personal and often diminishes social 
presence and cues present in face-to-face communication408. As a result, in VCoPs where there has 
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been little or no prior face-to-face interaction, there is a lower social presence which can lessen the 
sense of community, thereby reduce the level of interaction409. Thus, derived from these findings, one 
may hypothesise that where geographic dispersion of VCoP members is greater, the opportunities for 
members to meet face-to-face are fewer, which in turn can reduce online interaction.  
To overcome this potential barrier, the literature alludes to a strategy of facilitating the VCoP with a 
moderator to encourage the flow of information and interaction410, 411. Studies have demonstrated 
that the moderator may be the single most important point in a VCoP, whose departure or absence 
can result in unconnected networks amidst the diversity of members410. 
The literature pertaining to topic relevance recognises that the day to day topics that members may 
want to discuss in a VCoP arising from their experiences; may not be relevant to all the VCoP members, 
and can result in low online interaction292. The authors conclude that VCoPs for health practitioners 
must accommodate topics that bear most close semblance to issues that are most relevant to 
participant’s daily practice and as much as possible, aggregate less relevant topics under broader 
themes to enhance online interaction.   
  
5.1.6 Evaluation of VCoPs  
Online communities are dynamic, evolving and constantly changing412. Understanding what makes 
such systems successful is therefore complicated. As discussed, there are factors that significantly 
contribute to the success of an online community other than the specific technology employed. 
Maloney-Krichmar413 argues that designing the online community technology to achieve only optimal 
usability is inadequate; the design should consider how the technology can best support social 
interaction for optimal sociability. Sociability is concerned with developing software, policies and 
practices to support social interaction online. Preece identifies three components implicated in 
achieving good sociability414 which resonate strongly with Wenger’s three domains of CoP275 : 
 Purpose. A community’s shared focus on an interest, need, service or support that provides a 
reason for individual members to belong to the community.  
 People. The people who interact with each other in the community who have individual, social 
and organisational needs.  
 Policies. The language and protocols that guide people’s interactions. This can include policies 
for registration and code of behaviour.  
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De Souza and Preece412 consider the aforementioned components of an online community in their 
online community framework. (Figure 5.1)  
Figure 5.1 The key components and factors of the online community framework412. 
 
Purposes  
 
 
 
SOFTWARE 
 
 
People 
 
Policies 
 
 
SOCIABILITY USABILITY 
 
The usability is concerned with how intuitive and easy it is for individuals to use and interact with a 
product415. The main usability issues for online communities cited in the literature are similar to those 
for most web-based software; but the following four components are particularly important because 
they are concerned with the software’s role as a medium and a place for social interaction416.   
 Dialogue and social interaction support. This relates to the prompts and feedback that support 
interaction, the ease with which commands can be executed and spatial relationships in the 
environment.  
 Information design. This relates to how easy to read, how understandable and how 
aesthetically pleasing information associated with the community is.  
 Navigation. This relates to the ease with which users can move around and find what they 
want in the online community. Many online community users have suffered from the 
inconsistencies of data transfer and differences in interaction style between imported 
software modules and websites housing the community.  
 Access. Requirements to download and run online community software must be clear. In 
addition, if the community can be accessed from portable devices such as smartphones and 
tablets, clear instructions should be made available about how to obtain it.  
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The online community framework provides a basis for identifying characteristics and measures that 
can help to describe success of online communities. Table 5.2 provides examples of determinants and 
measures of success for each of the components included in the framework. These have been derived 
from the literature and reported on by Preece in research aiming to provide a strategy to determine 
and measure the success of online communities. 416 
Table 5.2 Examples of determinants and measure of success of online communities416 
Framework Design 
criteria 
Examples of determinants of success 
Sociability 
 
  
Purpose How many and what kinds of messages or comments (or comments 
per member) are being sent? How on-topic is the discussion? How 
much interactivity is occurring? How much and what kind of 
reciprocity occurs? What is the quality of the peoples’ contributions 
and interactions?   
People How many and what kinds of people are participating in the 
community? What do they do and what roles are they taking? How 
experienced are they? What are their ages, gender and special needs? 
Policy What policies are in place? For example, registration and moderation 
policies to deter unprofessional behaviour. How effective are the 
policies? How is relationship development being encourage? For 
example, what kinds of policies encourage trustworthiness and how 
effective are these policies?  
Usability Dialogue and 
social support 
How long does it take to learn about dialogue and social support? How 
long does it take to access or send a message, or perform some other 
action etc.? Are users satisfied? How much do users remember about 
the dialogue and social support?  
Information 
design 
How long does it take to learn to find information (e.g. help) or to 
achieve a particular information-oriented goal? How satisfied are 
users?  
Navigation How long does it take to learn to navigate through the communication 
software and/or web site to find something? Can users access the 
desired information/activity in a reasonable time? How satisfied are 
they?  
Access Can users access all the components they need? Can they download 
desired information? Are response times reasonable? Does the 
software/web site protect their privacy? What problems do they 
encounter using the resource?  
 
The author commented on the application of these determinants and measures in evaluating online 
communities, suggesting that used individually, some measures can be misleading; so several different 
determinants and measures are needed to gain an accurate assessment of a community.  
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More recent studies have attempted to investigate the factors influencing VCoP members’ on-going 
contribution to the knowledge-sharing within a VCoP. User satisfaction is one such factor that has 
been explored for its influence on the knowledge creation and sharing process of VCoP417. Generally, 
satisfaction is measured by subjective user assessments of any outcome or experience regarding a 
specific technological tool or information system418. User satisfaction has also been recognised as a 
determinant of the use of a technological tool419. 
It been reported that VCoP members contribute to knowledge creation, motivated by factors related 
to their personality and the perceived satisfaction is attributed to sharing knowledge and collaborating 
with peers347. Further studies have revealed factors such as an individual’s standing within a VCoP, 
internet usage habits and the specific technology to influence VCoP user satisfaction271, 420. 
Jimenez-Zarco et al. developed a theoretical model incorporating the factors recognised in the 
literature to influence VCoP user satisfaction (Figure 5.2 and Table 5.3)421.  
Figure 5.2 Theoretical model of factors influencing VCoP user satisfaction421.  
 
 
 
Table 5.3 Factors recognised to influence VCoP user satisfaction 
Factors influencing 
VCoP user 
satisfaction 
Literature summary 
User involvement Research indicates that usage is directly linked to enhanced satisfaction419, 422. 
It has also been argued that VCoP usage and user’s satisfaction affect each 
other simultaneously and the relationship is reciprocal 80. 
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Efficiency VCoP have been reported to facilitate the processes of knowledge creation and 
knowledge sharing in a quick, simple and inexpensive manner422. The level of 
efficiency that the VCoP user perceives positively influences the degree of 
satisfaction421 
Effectiveness Research indicates that the VCoPs are highly effective and efficient means of 
creating and sharing knowledge423. Moreover, VCoP have demonstrated to be 
an effective means to address professional isolation424, 425.  The level of 
effectiveness that the VCoP user perceives positively influences the degree of 
satisfaction421.  
Utility The perceived usefulness and perceived ease-of-use are two factors 
demonstrated to play a significant role in the degree of VCoP user 
satisfaction418, 426.  
Knowledge The research indicates that with increased knowledge and understanding of 
the potential benefits of the VCoP, a higher level of activity can be observed 
within the community417, 427, 428.  
Frequency of use The degree of user involvement in the VCoP has been shown to be largely 
determined by the frequency of use and the accessibility of the ICT. The related 
studies indicate that individuals who routinely use technology and have 
experience of VCoP membership are likely to be more involved in the VCoP420, 
429. 
Place of use Reports indicate that VCoP users make greater use of the VCoP in the 
workplace278. This is especially relevant in workplaces where access to the 
VCoP may be restricted by time-pressures or lack of adequate facilities.  
Gender There are conflicting studies indicating a difference between gender in the use 
of technology, and the associated levels of satisfaction430, 431.  
Workplace Studies have indicated that the workplace of VCoP users can influence their 
professional skills and their need and desire for new knowledge278, 356 . These 
factors have been demonstrated to determine user level of involvement in the 
VCoP.  
Professional 
specialisation  
The user profile, in particular the degree of specialisation, has a significant 
impaction on the reasons for participating in the VCoP and in the level of 
satisfaction339.  
 
 
Online interaction is often measured by the level of contribution, which includes posting questions 
and providing feedback; however it has been argued that postings represent only one side of the 
vibrancy of a VCoP and it has been suggested that there are other ways of depicting online interaction, 
for example, whether people are visiting the VCoP295, 432.  
Kimball and Ladd reported that measuring outcomes of a VCoP can be problematic. Membership, 
activity levels and relationship maps have all anecdotally, provided useful proxy measures for VCoP 
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value. However, the authors suggest that specific “stories and anecdotes” appear to be the most 
useful type of communication for users of a VCoP to benefit from391.  
Social network analysis has been employed in studies to examine whether professional connections 
and relationships are being developed by health practitioners as they interact and share knowledge in 
a virtual environment339, 433.  
 
5.1.7 Social Network Analysis (SNA)  
SNA can used to quantify the connectivity and stability of online communities by measuring degree, 
closeness and “betweenness” centrality, reciprocity of relationships, and multiplexity434.  
Social networks consist of webs of social exchanges that people share between each other. Each social 
network consists of individual actors as nodes, (these can be individuals or organisations) and relations 
between actors as ties (or links) between nodes. These relations can take many forms; they may 
represent the exchange of information, resources, money or support435. Not all nodes in a network 
are equal; rather, the degree, closeness and “betweenness” centrality, and multiplexity of 
interpersonal ties between each node affect the network’s structure and their position within it.  
Degree centrality is the number of persons (or nodes) to which a particular person is directly linked; a 
higher score indicates a well-connected person436. This measure helps to identify key persons in a 
community, with the facilitator likely to score highly. A high average density score, indicates a high 
level of direct links or interactions between members of the community.  
Closeness centrality recognises the importance of indirect connections for exchange of resources 
(such as knowledge) and measures the shortest path connecting a key node (community member, in 
this case) to any other node437. Betweenness centrality also takes into account the importance of 
indirect links in maintaining links between nodes not otherwise connected437. This, too, is relevant in 
terms of examining the flow of resources (such as information or knowledge)436. A community scoring 
highly in the knowledge exchange relationship would indicate high connectivity with little threat to 
knowledge exchange due to lost links. Reciprocity of each relationship can also be examined to identify 
bidirectional links, with suggestions that a high level of reciprocity is characteristic of a more stable 
network438. 
Multiplexity can be examined as an indication of the strength of the link between members; with 
members linked by more than one relationship said to have stronger ties than those linked by one 
relationship436 439. 
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Various softwares maybe be used to create visual representation of SNA in the form of graphs, one 
software commonly used in undertaking research in social science is NodeXL440. In employing such 
software, the graph density may also be calculated; this is a measure of how many members of a 
network interact with other members compare to the maximum number of interactions.441 For 
example if there are two persons in a network and the only connection made is person 1 speaking to 
person 2 and person 2 does not respond, then the overall graph density is 0.5. i.e.(1) connection 
divided by (2) possible connections. The resultant figure represents how well connected a network is 
(maximum figure is 1).  
The author used guidance from the literature to design, implement and assess the impact of a VCoP 
to support the HLCs’ CoP identified in Chapter 4. 
 
5.1.8 Realist evaluation 
It has been suggested that a realist evaluation is well suited to explore complex interventions like CoPs 
where outcomes are determined through stakeholder action and interaction, which in turn is likely to 
be influenced by social and cultural norms.410  
A realist evaluation is a qualitative approach for testing and refining programme theories by exploring 
the complex and dynamic interaction between a given context, mechanism and outcome442. It is a 
theory-driven evaluation; it aims to outline and provide: the context in which the intervention applies, 
the mechanism by which it works, and the outcomes which are produced443. A realist evaluation goes 
beyond focussing purely on inputs and outputs; it involves exploring and identifying the mechanisms 
by which the inputs are converted into outputs, and recognises the need for particular conditions 
(contexts) to be present for the causal mechanisms to be triggered and yield a particular outcome444.  
A realist evaluation technique (RET) begins with the development of a middle range theory, which 
establishes the relationship between contexts, mechanisms and outcomes to generate a potential 
CMO (Context, Mechanism, Outcome) configuration445. RETs do not set out to make a judgement 
about whether or not an intervention is effective.  
Since CoPs are influenced by the social and cultural norms of participants, Ranmuthugala et al. 
proposed that RETs are most appropriate in their evaluation410.  The authors argue that when 
employing a realistic evaluation for a CoP, the contexts are the connections, interactions and 
knowledge flow, membership, level of maturity and activities of members. The mechanisms are 
 135 
factors and resources that collective participation potentially offers members to influence change. The 
outcomes are not predefined in RETs.  
Figure 5.3 illustrates how the RET links context and mechanism to outcomes. 
Figure 5.3 Realist evaluation theory446 
 
 
5.1.9 Aim and objectives 
The aim of the research conducted in this chapter of the thesis was to describe the development of a 
platform to establish and host a VCoP to support the HLC CoP and evaluate its subsequent success in 
achieving this. 
The research had the following objectives:  
1. Development and implementation of a literature-informed online platform to support the 
existing HLC CoP 
2. Exploring the HLCs’ use and experiences of the platform using realist evaluation techniques to 
determine whether a VCoP has been established.  
5.2 Methodology 
 
5.2.1 Designing and implementing the VCoP 
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Following a review of the literature and consideration of the HLC recommendations for development 
of the existing networking opportunities (Chapter 4), a platform was developed and introduced to 
create a VCoP to support the existing HLC CoP.  
A brief summary of the steps taken in developing the platform and the rationale for these steps, is 
outlined in Table 5.4.  
Table 5.4 The rationales for the steps taken in designing and implementing the platform to support 
the HLC CoP. 
Elements of  
development and 
introduction of the 
platform   
Rationale  
 
Facebook employed to 
support HLC CoP. 
The literature indicates that a platform to support the CoP should be: easy 
to learn and use, uncomplicated access, affordable335; Facebook offers 
these advantages367, 368.  
Facebook facilitates dedicated space for small group interaction and 
settings to allow for confidentiality of personal information371. 
Reports on the use of Facebook to successfully support CoP activities374-
378.  
A communications 
officer was employed to 
deliver Facebook 
training and provide a 
user guide. 
Measures should be taken to ensure participants have the necessary IT 
skills to support mutual engagement in a VCoP275.  
There is a need to ensure that potential members have the necessary skills 
training to understand the features of the virtual environment in order to 
use it effectively390.  
Demonstration on 
accessing Facebook on 
portable devices 
If the community can be accessed from portable devices, clear 
instructions should be made available415.  
Appointment and 
training of community 
facilitator 
It is the community facilitator’s role to choose to seed discussions where 
possible in order to keep interaction vibrant392.  
A lack of moderation increases the possibility of unconnected networks393.  
Face-to-face interactive 
training  
Trust is essential for collaboration and sharing information and primarily 
develops through face-to-face interactions396, 398.  
Non-attendees sent a 
copy of the illustrated 
user guide containing 
instructions on how to 
join the Facebook group 
With a larger community size, new discussions and ideas will appear more 
frequently, augmenting online interaction407.  
Online interaction increases as new members join339.  
Facebook was used as a platform in supporting the VCoP. The local commissioners (Portsmouth City 
Council) were approached to obtain the contact details of the Marketing and Communications Officer 
(CO), whose role includes leading on behaviour change marketing for public health within Portsmouth 
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City Council, developing and delivering creative and engaging campaigns that play a role in improving 
the health of Portsmouth residents and supporting the City's regeneration. 
 A meeting was arranged between the CO and the author to design the content of a HLC training event, 
which was used to launch the HLC Facebook group.  
Postal invitations were sent to all HLCs employed within Portsmouth’s community pharmacies, inviting 
HLCs to the VCoP launch event.  
In an attempt to encourage attendance, the VCoP launch event was arranged at a local community 
centre at a time during the week when HLCs would usually have their network events scheduled. The 
training event was led by the CO who used a PowerPoint presentation to demonstrate how to join the 
HLC Facebook group and carry out functions such as corresponding with other members, initiating 
discussions and posting media files onto the group page. The Facebook specific facilities such as like, 
add a friend, privacy settings and building a personal profile were also introduced. Instruction was also 
provided on how to access the Facebook group via a smartphone or tablet. 
An illustrated guide was printed and provided to all attendees containing the instruction provided in 
the training session (Appendix 4.3).  
The presentation also included direction on how, through interaction on the Facebook group, the 
existing HLC network can benefit. Following this, the role of the group facilitator/moderator was 
introduced and attendees were given the opportunity to volunteer to assume this role. Three 
individuals volunteered to perform this role; each of whom were referred to a specific section within 
the illustrated guide containing information relating to the moderator’s role in a VCoP.  
 
After the event, the illustrated guide was sent by post to all HLCs who were unable to attend the event, 
and an electronic version was made available on the HLC Facebook group.  
  
 
 
5.2.2 Evaluating the VCoP using a realist evaluation 
Four stages make up the RET as shown in Figure 5.4; each stage corresponds to a component of the 
realist evaluation cycle (theory, hypothesis generation, observations and programme 
 138 
specifications)446. The stages are carried out in sequence such that the findings from each stage will 
inform the next stage, and the final stage will involve reviewing the findings from stage three to 
confirm, modify, or reject the theory-based hypothesis generated in stage two447. 
 
Figure 5.4 The realist evaluation cycle446 
 
 
 
In this study, both qualitative and quantitative methods were employed to collect data for inclusion 
in the RET. The data was collected over a nine month period and included semi-structured interviews, 
an online survey and observation of online interaction, through social network analysis. 
A summary of the methods employed in each stage of this study is shown in Table 5.5. 
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Table 5.5 Four-stage approach to the realist evaluation employed in evaluating the HLC Facebook 
group 
Stage Activities Analysis  Purpose 
 
 
 
1. Theory 
 Literature review 
 
 Semi-structured 
interviews with 
HLCs 
 
 
 Formulate CMO 
configurations 
 
Qualitative 
 Framework analysis – 
identify themes and 
categorise as 
outcomes, 
mechanisms, and 
contextual factors 
 
 Formulate potential 
CMO configurations 
 
 
Provide the theoretical basis 
for the realist evaluation  
2. Hypothesis 
generation  
 Generate 
hypothesis based 
on CMO 
configurations 
Rephrase CMO 
configurations into 
hypothesis  
Formulate hypothesis to be 
tested during stage three 
 
 
3. 
Observation 
 
 Online survey of 
HLC Facebook 
group members 
 
 Observation of 
Facebook group 
activity by HLCs 
 
Quantitative 
 Identify CMO 
configurations that 
occur with regularity 
 
 Social Network 
Analysis  
Test and accept, reject, or 
modify hypotheses.  
 
Examine structure of 
professional and social 
relationships and flow of 
information and knowledge 
within the HLC Facebook 
group  
 
4. Program 
specification  
 
 
 Review analysis 
from stage three 
 
Refine theorised CMO 
configurations based on 
testing hypotheses 
Specify CMO configurations 
that explain how, when and 
why the HLC Facebook group 
can improve healthcare 
practice  
 
 
5.2.2.1 Stage 1: Theory 
To underpin the realist evaluation, the literature on the role VCoPs play in supporting the practice of 
healthcare practitioners was explored (as reported in Sections 5.1.3-5.1.7). This was done to identify 
characteristics of VCoPs, factors recognised to influence user involvement and outcomes achieved. 
The literature review provided adequate information to formulate contexts and potential mechanisms 
by which VCoPs support practice. A brief summary of these findings are presented in Table 5.6.  
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Table 5.6 Brief summary of the literature findings of the characteristics of VCoPs, factors recognised 
to influence user involvement and outcomes achieved. 
Characteristic Findings from the literature  
Membership and 
practice 
 Members have a shared goal, interest, need or activity340. 
 VCoP can support practice change and evidence-based practice276.  
 Membership and group size is not fixed339, 412. 
 VCoP can establish a sense of professional identity356.  
 Users join voluntarily through requesting access from the community 
facilitator(s)339.  
 Membership can cross professional and or/organisational boundaries339. 
 
Activities and 
communication 
methods 
 
 
 Members engage in repeated, active participation and have access to 
shared resources. Members exchange information, support and services. 
The existence of a shared context of social conventions, language and 
protocols between members340. 
 Interaction is an important feature of VCoP identity420, 429. 
 
Origin 
 
 A strategy to support CoPs, enhance professional networks, to share 
information and to engage with stakeholders362-365. 
 
Determinants of 
success 
 
 
 A committed facilitator410. 
 Shared purpose414. 
 Commitment and enthusiasm from the members419, 422. 
 Workplace acceptance and support369. 
 Confidential information protected369. 
 Users receive specific ICT training to support engagement275, 388, 389.  
 Uncomplicated access381, 382. 
 Technology needs to be regarded as accepted and transparent means of 
communication386, 416.   
 Trust between members is essential and can develop through face-to-face 
interactions396-399. 
 Regular communication and interaction between members403. 
 Topic relevance292. 
 Infrastructure to support the access and integration of the VCoP into 
everyday practice278, 356. 
 
Based on the literature findings, an interview protocol was designed with the objective of identifying 
CMOs that were used to develop potential theories on CMO configurations explaining the role of the 
HLC Facebook group in supporting HLCs’ practice.  
The interview protocol consisted of two main parts: part one was designed to determine the user’s 
motivation for joining the Facebook group and part two was to explore the users’ experiences of using 
the group. A pilot with two community pharmacy teacher practitioner staff employed at the University 
of Portsmouth took place to establish if the interview protocol was clear and understandable. Minor 
linguistic changes were made following this.   
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 It should be mentioned that within three months of the launch of the HLC Facebook group, 
commissioner funding to support the HLC network meetings was withdrawn. Furthermore, the 
pharmaceutical advisor employed by the commissioners, who had contributed significantly to the HLC 
meetings, reduced her working hours and was no longer able to support the HLC networking 
opportunities. Consequently, the HLCs ceased their face-to-face meetings and were no longer able to 
benefit from the advantages these meetings provided.  
Six months following the implementation of the HLC Facebook group, an invitation for participation in 
a telephone interview with the researcher, was posted on the group’s Facebook page. The invitation 
detailed an outline of the intended study.  This invitation was re-sent after seven days to identify any 
further potential participants.  
The telephone interview was selected in these circumstances since the HLCs no longer routinely met 
face-to-face, which would have made arranging focus groups challenging; the telephone interview can 
be used with minimum disruption and permits considerable flexibility448. The researcher was aware of 
limitations of employing telephone interviews, in that the separation between the interviewer and 
interviewee can present challenges for interpersonal communication, specifically in the formation of 
trust449 and with interviewees typically providing less detail and elaboration than in face to face 
interviewing450.  
Following the recruitment of participants, individuals were contacted by the author via the Facebook 
instant messenger to arrange a suitable time and date to conduct the telephone interview. A study 
information sheet was sent to each participant prior to the telephone interview, which also informed 
participants that their responses would be anonymised and kept confidential (Appendix 4.1).   
After an introduction and confirming the identity of the participant on the telephone, the interview 
commenced. The telephone interviews were digitally recorded and professionally transcribed 
verbatim through the online academic transcription service, Way With Words. Transcripts were 
imported into NVivo10. The highly structured nature of the qualitative data lent itself to Framework 
Analysis, which the author used to systematically code and analyse the data, using a matrix to 
summarise and compare the transcripts by participant and theme213. The framework was informed 
but not mandated by the aforementioned literature review of VCoPs and their employment in 
healthcare. The value of this approach is that the data were ordered into descriptive ‘chunks’ which 
aided theme focused analysis; the analyst looks down the columns to examine all interviewees’ 
responses in relation to a particular issue, while the matrix maintained the context of the data and 
aided the search for explanation by looking across the rows. The themes were partly drawn from the 
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topic guide and later refined to include emerging and unexpected material in the data. The author 
identified and coded the data which was then reviewed by a second member of the research team; a 
discussion then took place between the two researchers to agree on how the data should be 
interpreted. Through these discussions, the data were categorised into contexts, mechanisms or 
outcomes.  
The end product of this stage was possible CMO configurations that explained the role of the HLC 
Facebook group in supporting the practice of the HLCs.  
 
5.2.2.2 Stage 2: Hypothesis generation  
This second stage involved rephrasing the CMO configurations theorised in stage one ready for testing 
in stage three. The hypotheses were framed around the theoretical associations between specific 
CMOs that could contribute to different outcomes of VCoPs, depending on the context in which the 
VCoP operated.  
 
5.2.2.3 Stage 3: Observation   
The hypotheses developed in stage two were used to generate statements for wider testing as part of 
an online survey to all HLCs employed in Portsmouth’s community pharmacies during stage three. 
These statements were converted into a set of twelve questions by the author and were then reviewed 
by a second member of the research team. The twelve questions required the HLCs to indicate their 
level of agreement on a Likert scale about their participation in the HLC Facebook group (1= Strongly 
disagree – 5= strongly agree). Testing the hypotheses was intended to help identify CMO 
configurations that appeared regularly, and provide possible explanations for the role of the Facebook 
group in supporting the HLCs. The survey also collated information of the context of the HLC’s 
participation in the VCoP; for example, the length of time being a member of the VCoP, age, practice 
setting, and frequency of use. The questions were piloted with two community pharmacy teacher 
practitioner staff employed at the University of Portsmouth, to establish if the questions were clear 
and understandable; minor grammatical and wording changes were made to the questions.  
The survey was posted via the HLC Facebook group for all registered members to access.  
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The second part of the third stage involved obtaining contextual information on the connections, 
relationships and knowledge exchange that occurred within the HLC Facebook group. These are 
essential elements of a VCoP and form the context in which the hypotheses were tested.  
Social Network Analysis (SNA) methods were utilised to explore the contextual information about 
connections, relationships and knowledge exchange within the Facebook group, represented by the 
strength of ties410. SNA was also used to visualise the nature of cohesiveness, the formation of sub-
groups and cliques and the density of the overall methods of interaction amongst the Facebook group 
users in order to document the development of the VCoP.  
In facilitating the SNA, the author undertook the following process:  
1. A NodeXL440 spreadsheet was generated of the names of the persons who had posted on the 
Facebook group (either an initiating post or a response to a posted item)  since it was 
introduced (November 2015) until the end of the study period (August 2016). Each person 
was assigned a number and the Facebook group was also attribute an identified within the 
spreadsheet. (The purpose of this was to record posts to the Facebook page rather than a 
communication between persons) 
2. Each post was then recorded on the NodeXL spreadsheet, this included details of who initiated 
the post and recorded all individuals who had responded. For example Person 1 posts a picture 
on the Facebook page would be recorded as an interaction between  “person 1 and Facebook 
page”; if person 2 decided to respond to the picture, this would be recorded as an interaction 
between “person 2 and person 1”. This process was carried out for all of the posts that took 
place during the study period. (This was checked for accuracy by a second member of the 
research team) 
3. Using the NodeXL functions, a SNA graph was plotted, whereby all of the interactions that 
took place are presented in a visual format; each individual is represented as a circle of a 
specific size. The size of the circle represents the level of activity within the Facebook group 
and the lines connecting the circles represent specific interactions that took place.  
4. The SNA chart was then analysed to identify key knowledge brokers (i.e. those individuals who 
significantly contributed to interaction within the group) and active members who were 
connecting in the community451. Further NodeXL functions were employed to quantify the 
connectivity and stability of the community by measuring degree, closeness and 
“betweenness” centrality, reciprocity of relationships and multiplexity.  
5. Further analysis of posts took place to categorise the posts according to specific themes, count 
the number of interactions per month and to collate the “seen” data for each of the posts (the 
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“seen” data identifies how many of the group members have seen the post). This information 
was collated and was repeated by a second member of the research team for accuracy.  
 
5.2.2.4 Programme specification  
The final stage of the evaluation involved reviewing the theorised role of VCoPs in supporting 
healthcare practitioners and potential CMO configurations derived from stage one, in light of the 
findings in stage three. The CMO configurations that were supported with regularity were used to 
form possible explanations for the role of the HLC Facebook group in providing support to the HLCs.  
 
5.2.3 Ethics approval  
This research received a favourable opinion from the Portsmouth NHS Local Research Ethics 
Committee (ref 10/H0501/6) 22/01/10 (Annexe 1). 
 
5.3 Results and discussion 
 
The HLC Facebook group launch event was attended by 22 HLCs in November 2015. During the session, 
attendees were able to access Facebook and join the Facebook group via their personal electronic 
devices. As of the end of November 2015, there was 29 registered users in the group.  
 
5.3.1 Stage 1 results: Developing theory - HLC Semi-structured interviews   
Six HLCs volunteered to participate in telephone interviews to discuss their experiences using the HLC 
Facebook group; one of these individuals had also volunteered for the group facilitator role at the 
launch event. Interviews lasted between 25-40 minutes.  The six interviews were conducted between 
August and October 2016.  
The following major themes were identified from the interview transcripts.  
 
Motivations for membership 
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All respondents explained that a significant motivation in joining the HLC Facebook group was to 
experience feeling part of a professional community. This was illustrated by the following quotations.  
“I really enjoy meeting and networking with the other HLCs at the meetings and we have made our 
own little community now, we learn about new services and talk about what we do together- which I 
am really happy to be part of. So, joining the Facebook group was to make that feeling stronger and 
to stay in touch more often” HLC1 
“Going to the meetings and working with the other champions (HLCs) was what it was all about, that’s 
what made me feel like I was a HLC and made me think what I should be doing, that’s why I joined, to 
be part of the group and know what I should be doing” HLC2  
“I just feel that we have our own little group going; we all help each other, and I really like that, so I 
joined the group even though I don’t really use Facebook” HLC3 
The aspiration that the Facebook group would facilitate further learning to help HLCs improve their 
practice was identified as a common theme in the HLCs responses.  
 
“I know that there are some of the champions who have been doing this a lot longer than I have and 
have more experience at doing the services and talking to the customers, so I wanted to see what I can 
learn from them” HLC2 
“We’ve only got a small team in the pharmacy and there isn’t time to read up on the new things that 
are happening or time to do some extra reading; at least with Facebook you can see what everyone 
else is doing and what they are talking about and you can ask questions and learn from that” HLC4 
“I am always looking to learn and whenever I go to the meetings I am always asking how I can try new 
things to see if I can sign-up more patients (to pharmacy services), XXXX always spends time to give 
me some advice, on Facebook I can see if there is anyone else who can help me” HLC5 
Further motivation which was mentioned was a desire to build closer relationships with local HLCs to 
develop opportunities in designing collaborative health promotion campaigns. It was also alluded to 
that on occasion, HLCs are not able to attend the face-to-face meetings; thus Facebook could be used 
to communicate important information relevant to the HLC role. 
These findings are consistent with the literature which suggests that shared interests are the main 
purpose VCoPs exist452. It is also proposed that community members can deepen their expertise by 
closely working with other members undertaking similar roles453. Porter introduces the idea that 
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interactions in such communities create a sense of belongingness, shared values, and mutual 
understanding454; this resonates strongly with the HLCs’ motivations for joining the Facebook group.  
The research confirms that VCoPs are often used as knowledge management tools and hold significant 
value in facilitating the sharing of ideas to enhance practice279, 295; the HLCs interviewed seemed to 
recognise this in articulating their motivations to join the Facebook group.  
 
Activities and communication 
The HLCs discussed their personal usage of the Facebook group by describing the activities and 
communications they had been involved in.  
It was evident from the HLCs’ responses that they perceived the Facebook group to be useful in sharing 
information and resources related to community pharmacy services, which respondents report they 
access for further learning.  
 
“If I’m ever stuck because I don’t know where to get the stock for the smoking cessation equipment or 
the alcohol awareness scratch cards then I can quickly ask on the group and I will get an answer the 
same day, sometimes someone local will pop round and deliver what I need” HLC4 
“I’ve used it (the Facebook group) for getting local signposting information when I can’t help the 
customer myself, and I want to know where I can send them for help” HLC3 
“I will check it regularly (the Facebook group)… the articles and educational material is useful to me 
and I would say I do learn quite a lot from the stuff that is posted on there” HLC1 
All of the HLCs spoke of their use of the Facebook group to stay up to date with HLP developments 
and checking for posted information of communications relating to impending meetings, health 
campaigns (both nationally and locally-initiated) and media reports relating to HLPs and the wider 
community pharmacy profession.  
“XXXX (HLC Facebook group facilitator) posts a lot of stuff about what’s happening with HLP in other 
areas of England which is interesting to read, and she puts stuff up whenever there is a national health 
promotion project to try to get us all doing something together in our pharmacies” HLC6 
“I always check when somebody has put something up because a lot of the time it’s really useful, like 
when the next meeting is (HLC network meeting) and what it’s going to be about. Also some of the 
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girls (HLCs) post news articles about pharmacy and tells us what we could be doing to help things like 
obesity and drinking problems” HLC2 
“I use it mainly to check what people have posted on the group. I don’t always get the information in 
the post but XXXX (HLC Facebook group facilitator) always puts up important information about what 
is happening locally and how community pharmacy can get involved” HLC5 
A further theme was that of using the Facebook group to seek advice and ideas of peers in designing 
and raising awareness of a pharmacy health promotion campaign. Two of the interviewees cited this 
to be a reason for accessing the HLC Facebook group.  
“I’ve been in touch to see what everyone else was doing with Stoptober (National Quit Smoking 
campaign). I know that some of the pharmacies do really well with that and I was looking for ideas……. 
I got some really good ideas back on getting more people signed up and what I should say (recruitment 
process)” HLC3 
“I’m quite new to the HLP stuff, but I saw the photos on Facebook of what other pharmacies have done 
with the health promotion stands and putting up posters and I wanted to something similar” HLC2 
Interestingly, questioning individual HLCs on how often each of them posted an item or initiated a 
discussion on the Facebook group revealed that three of the six interviewee’s activities comprised of 
responding to initiated discussions or commenting on posted items; and one of the interviewees 
admitted that they only access the Facebook group to read information and do not contribute at all.  
Further to this, it was commented on that in more recent months, the HLCs had not accessed the 
Facebook page as often as before due to a reduced online activity within the group. The interviewees 
discussed possible reasons for this later in the interviews.  
“Over the last few months, I’ve noticed less and less people are posting things and that’s a shame 
because I think people (HLCs) will lose interest if there’s nothing happening and will not bother 
anymore” HLC1 
“I think it’s since XXXX (the local pharmaceutical advisor) retired and we stopped having the meetings, 
and I know that XXXX (HLC Facebook group facilitator) went off sick, it seems as though not many 
people are using it anymore….. I still check it (HLC Facebook group) occasionally just in case I’ve missed 
something but recently nobody has posted anything” HLC2 
In discussing the use of the Facebook group to access information, the literature recognises that VCoPs 
provide two types of information. The first type is described as explicit which includes documents such 
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as journals, media reports and conference papers. The second type is described as implicit 
information, which is information provided by the community members, gathered through their 
experience and expertise455.  In the author’s study, community members shared both types of 
information with other members by interacting with them, for the purpose of enhancing knowledge 
and keeping up to date with developments in the area of HLP. In other words, this study has 
demonstrated that members of VCoP can learn from, discuss about, and contribute to the 
community’s explicit information, and they can share their implicit information for the purpose of 
enhancing knowledge. Similar observations have been reported in related studies456, 457.  
Further, Allen et al.455 provided ten reasons why individuals chose to join and participate in a VCoP, all 
of which were identified to an extent, in the responses of the HLCs. These reasons are: asking and 
answering questions; chatting with experts; solving problems; making connections with other 
community members; creating sub communities around a special interest topic; participating in 
collaboration; networking; construction of knowledge baseline and sharing best practices.  
The HLCs’ reference to user participation in the Facebook group is also discussed in the literature. 
Herring458 indicated that online communities should comprise a core of regular participants, actively 
engaged with each other through what he refers to as “self-sustaining participation”. Preece and 
Maloney also allude to this in identifying five important characteristics of virtual communities. The 
five characteristics they refer to are: members have a shared goal, interest, need or activity; members 
engage in repeated, active participation; members have access to shared resources; exchange of 
information, support and services; and members have a shared context of social conventions, language 
and protocols340. In the analysis of the HLC interview transcripts, the first four characteristics can be 
recognised; however no reference to a shared context of social conventions was mentioned. Despite 
this, it does not necessarily mean that this was not a characteristic of the virtual community; it has 
been reported that such an attribute may remain unrecognised or unreported by community 
members although clearly evident in the analysis of their interaction459.  
To explain the variable level of participation, the literature suggests that VCoPs are composed of both 
observers, who are persons still considering whether the community is a right fit for them, as well as 
participants, who have begun to reflect on what they have to contribute to the community460. 
Blanchard and Markus452  further identify two types of distinctive online participants in virtual 
environments. They claim that there are active participants who embrace activities related to posting 
and responding to messages and passive participants who primarily focus on the reading of messages. 
Wang and Yu432 use the term lurkers to classify participants who not only just read posts but also to 
apply to those observers who may not be ready to join the community yet. This lack of visible presence 
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may leave the researcher and indeed other community members, unaware of the extent of 
involvement of all the community members.  
In essence, these studies indicate that any VCoP is likely to be composed to varying degrees of lurkers, 
observers, passive and active contributors. More particularly, because online interaction is often 
measured by who contributes, posts questions and provides feedback at the expense of other types 
of behaviour, like reading and viewing posts, having a high number of lurkers/observers and passive 
contributors (when compared to active contributors) who read but do not post, might imply that 
online interaction is low432.  
Strategies to compensate for this effect of “participation inequality” have been suggested in the 
literature; extending membership criteria and continued communication to attract new members are 
two strategies recommended461. Work on participation inequality reveals that it is common to observe 
a 90-9-1 rule where 90% are lurkers, 9% are contributors who post from time to time and 1% post very 
often461.  
 
Barriers and facilitators  
The HLCs reported what they perceived to be the challenges in utilising the Facebook group in a way 
that could support their role in continued involvement in the HLP project.  
Several of the challenges discussed were mentioned by all six of the interviewees. These included the 
absence of a strong facilitator or leader to promote continued regular interaction through the posting 
of relevant material, the loss of face-to-face meetings and the lack of endorsement from employers 
of the HLC role. These aspects were exemplified by the following observations. 
 “Its not easy, especially when there aren’t many people in the group who say much, XXXX (HLC 
Facebook facilitator) seemed to bring everyone together and get people talking, we did have some 
interesting conversations about electronic cigarettes and people were posting articles and information. 
But I’ve noticed that XXXX isn’t posting stuff anymore, I don’t know why, but things have got a lot 
quieter recently” HLC3 
 “It’s a real shame they stopped the meetings (HLC network meetings), I don’t think the Facebook group 
can replace the meetings. The meetings gave us time away from the pharmacy and time to spend 
talking about our ideas and we could focus on HLP stuff for the time we were there. I remember I would 
come away from those meetings feelings motivated with lots of ideas….. The Facebook group can work 
but we need to have the meetings too” HLC5 
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 “Since the meetings have stopped I do feel that the HLC role has become less important; we’ve lost 
focus. My manager in the pharmacy says that HLP has passed and doesn’t give me time away from 
dispensing and serving customers… we are short-staffed, but we have always worked this way and I 
would be given some time to change the health stand (health promotion stand in the pharmacy) but 
now it does feel that there is less support for HLP” HLC2 
“I’ve tried to use the computer at work to log onto the Facebook group because I had some questions 
and I wanted to see about arranging a visit to our local church group with XXXX pharmacy down the 
road, but my manager said that I shouldn’t use Facebook at work because we would get in trouble” 
HLC6 
These thoughts of the HLCs strongly reflect findings from McDemott’s analysis of online 
communities462. He recognised four factors to be community challenges. The first factor is the 
involvement of thought leaders; these are individuals who either have important specialised 
knowledge or who are well-connected and influential members of the network. These individuals can 
build energy in the community and encourage the involvement of other members. The concept of 
thought leader can be compared with great similarity to Brennan and McGowan’s work392. They 
describe the community’s moderator or facilitator’s role, as someone to choose to seed discussions 
where possible in order to keep online interaction vibrant and to ensure that networks and 
connections are developed by community members.  
Stuckey and Smith393 also recognise that the presence of “leadership” within the VCoP is the most 
significant factor implicated in the ability to sustain the community and this may be in the form of a 
moderator, facilitator or list owner. Significant to the observations reported in this study, 
Ranmuthugala concluded that the moderator may be the single most important point in an online 
community, whose departure or absence may result in the break of flow of information and 
interaction410. 
The second of the factors discussed by McDermott is that of personal relationships between 
community members. He concludes that the key for ongoing interaction and collaboration through an 
online community is the contact members have with each other, and the social connection that comes 
paired with it. It is evident from the HLCs’ responses that since the face-to-face meetings were de-
commissioned, the level of interaction and contribution of activity on the Facebook group had 
diminished.  
Thirdly, McDermott mentions the development of an active passionate core-group is important in 
helping to support the creation of a VCoP. In introducing the Facebook group, an opportunity was 
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provided for HLCs to take on the role of group facilitator; the rationale for permitting numerous 
individuals to volunteer for this post, was to enhance the prospect of creating a core-group of 
influential members. Three HLCs volunteered to accept this role, and were provided information on 
the role of a facilitator in an online community. However, despite this attempt to create the core-
group of community members, it was later identified in the interviews that although there had been 
significant efforts to promote interaction in the Facebook group by these facilitators, illness and 
change of employer meant that two of three appointed facilitators were no longer contributing 
activity to the Facebook group.  
The final factor reported by McDermott was the creation of forums of thinking together as well as a 
place to share information. In discussing this factor, McDermott emphasises the need for community 
members to not only share information with each other, but also communicate regularly. Through the 
HLCs’ responses, it is clear that the lack of regular communication within the Facebook group was a 
reason for reducing their involvement.  
The topic of employer support is one that has been recognised in the related literature. Allen455, in 
identifying the factors that determine the success of an online community alludes to the amount of 
time permitted by organisations for users to access the community. Similarly, McDermott462 reports 
that the organisational support in terms of time and encouragement for participation can be a 
challenge to the functioning of an online community. This factor was made evident in the HLC’s claims 
of not being permitted usage of the computer at work to access the Facebook group and the lack of 
support from the manager in not allocating time to update the health promotion stand and carry out 
other specific HLP activities.  
 
 
5.3.2 Stage 2 results: hypothesis generation  
The coded data derived from the interview transcripts were categorised into contexts, mechanism or 
outcomes. Table 5.7 presents a list of possible CMO configurations that potentially explain the role of 
the HLC Facebook group in supporting HLC practice.  
Table 5.7 Preliminary list of CMOs that potentially play a role in the HLC Facebook group supporting 
HLC practice. 
Contexts: 
 A common goal is shared amongst the members of the HLC Facebook group 
 Members are committed to supporting the HLP project 
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 Varying levels of expertise is represented in the membership 
 
Enabling mechanisms: 
 Creating social capital  
 Uncomplicated and supported access to the Facebook group 
 Fosters trust and respect through frequent face-to-face interactions 
 Facilitate access to more experienced community members 
 Facilitates knowledge exchange between members 
 Alleviates sense of professional isolation 
 Endorsement and support from the organisation 
 Supportive sponsoring agent(s) 
Disabling mechanisms:  
 Lack of opportunity to meet face-to-face and establish/maintain connections 
 Lack of clear focus among group members on specific goal 
 Lack of contribution of community members 
Outcomes-  
 Introduced a new approach or method in work practice 
 Developed a new method or approach to solve a work-related problem 
 Decreased time to problem solving 
 Developed a new system or approach to improve services.  
 Reduced professional isolation  
 Intra-professional collaboration 
 Encourage evidence-based practice 
 
 
 
5.3.3 Stage 3 results: Observation (Online survey and Social Network Analysis of Facebook 
activity) 
Fifteen responses to the online survey were received from the HLCs. Table 5.8 indicates the CMO 
configuration statements (derived from the preliminary CMOs Table 5.7) tested as part of the online 
survey exploring users’ experience of participating in the HLC Facebook group. The median score and 
interquartile range was calculated for each of the statements, the results of which can be found in 
Table 5.8.  
Table 5.8 CMO configuration statements tested as part of an online survey exploring users’ 
experience of participating in the HLC Facebook group. 
Participating in the HLC Facebook group has allowed me to do the 
following: 
Median 
score (n=15) 
Interquartile 
range 
1. Introducing a new method or approach to solving a problem 
that I experienced in my practice 
4 2 
2. Providing me with expertise to progress my learning  4 2 
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3. Allow me to keep abreast with the latest developments to my 
role as a HLC 
4 2 
4. Being able to bounce ideas/good practice with other HLCs 4 2 
5. Supporting me to share issues in practice 5 1 
6. Getting access to a wide range of evidence based resources to 
aid my professional practice 
3 1 
7. A positive impact on my career development 3 2 
8. Helping on at least one occasion in my ability to solve a work-
related problem 
4 2 
9. Attending the HLC face-to-face meetings helped to establish 
links with other HLCs 
5 2 
10. The commitment of the other members of the Facebook group 
encouraging my contribution to the group 
4 2 
11. Access to a trusted colleague that I can turn for advice when 
needed 
4 2 
12. Getting access to information that demonstrates success of 
evidence-based practice makes it more likely that I will adopt 
evidence-based practice in my own work 
4 1 
 
Of the 12 CMO configurations derived from stage 2, all but three of the statements scored a median 
of 4, indicating that HLCs ‘agree’ with the majority of the statements. The statements regarding 
whether the HLC Facebook group has provided access to a wide range of evidence based resources to 
aid professional practice and whether the HLC Facebook group has had a positive impact on career 
development reported a median score of 3. This indicates that the respondents had a close to neutral 
opinion with regards to these two statements. Furthermore, the interquartile-range of all of the 
statements reveal a score of 2 or less thus indicating a consistent level of agreement amongst the 
HLCs.  
Apart from the online survey, a NodeXL spreadsheet was generated of the HLCs’ activity on the 
Facebook group. This included posts that each HLC had made to appear on the HLC Facebook group 
as well as interactions that took place between HLCs.  
Over the nine month period, 19 HLCs had contributed 203 distinct items, in the form of posting 
information or interacting with other HLCs.  
The relationship in Figure 5.5 shows how 19 of the 29 registered HLC Facebook group users (each user 
is represented as a number) posted and replied to each other in the Facebook group. The circles with 
a larger diameter indicate that these members contributed a greater interaction in the Facebook 
group.  
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Figure 5.5 HLC Facebook activity generated from a NodeXL spreadsheet 
 
 
Overall the emerging community had an overall graph density of 0.234 (maximum score = 1), thus 
indicating a lack of connections made between members of the Facebook group. This figure suggests 
that despite a relatively high level of activity of over 200 items in the Facebook group, few connections 
and relationships have developed among users in the community in its first nine months, with informal 
clusters of HLCs becoming evident within the group. Despite the limited connection, three users (3,4 
and 8) had the greatest betweenness centrality measures of 32.6, 25.8 and 17 respectively (NodeXL 
analysis). Significantly, two of these individuals were HLC Facebook facilitators.  
In Figure 5.5, these betweenness measures show the users with the greatest number of persons (or 
nodes) to which they have interacted. These users are 3 and 4, both of whom were HLC Facebook 
facilitators. The literature indicates that these individuals are key persons in the community and are 
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important to identify because their activities are likely to challenge the development of knowledge 
silos and help create broader connections across otherwise disconnected communities436. 
Table 5.9 provides information of the items and activities posted on the HLC Facebook group 
categorised by theme.  
Table 5.9 Items and activities posted on the HLC Facebook group by the HLCs 
Description of item or activity posted on the HLC Facebook group 
 
Number of posts 
Information relating to developments of the HLP project 6 
Information relating to local or national health campaigns  6 
Request for help with regards to a work-related problem 13 
Seeking collaboration to run health campaign  7 
Seeking advice on a practice-related issue 8 
Advertising of local training events 5 
Media reports relating to the community pharmacy profession 4 
Posting of guidelines for professional practice 3 
Seeking ideas to run health promotion campaign  5 
Multimedia (photos, videos, press article) of HLP recognition in Portsmouth.  3 
 
The HLC Facebook group was used for diverse purposes by the HLCs, consistent with those reported 
in the HLC interviews and subsequently discussed is Section 5.4.1.   
The SNA only captured the communication that took place between individual members and that 
which was posted onto the Facebook group page. Facebook also records the number of ‘likes’ 
attributed to a particular activity, which is a function that expresses one’s agreement or positive 
relationship463 as well as the number of users who have accessed the group and seen a particular 
activity (recorded as ‘seen’). Significantly, it was evident that the number of ‘likes’ and ‘seens’ 
attributed by users to specific HLC Facebook posts are markedly greater than written responses 
(attributed to the 203 distinct items there were 484 ‘likes’ and 756 ‘seens’) . This suggests that there 
are community members who access the Facebook group to read posted information and view 
activities but do not contribute to the interaction with their fellow community members. This 
observation is consistent with Nielsen’s proposal to explain ‘participation inequality’ within an online 
community and the presence of lurkers, observers, passive and active contributors461.   
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Further observations of the level of activity on the HLC Facebook group revealed a gradual dwindling 
since April-May 2016, approximately six months post-introduction (November 2015-April 2016, mean 
number of 31.4 items/month posted on the Facebook group, May – August 2016, mean number of 
5.4 items/month posted on the Facebook group).  This observation is consistent with the reports of 
the HLCs and also coincides with the de-commissioning of the HLC meetings as well as the departure 
of the group facilitators.  
These findings may be explained by observations made in previous studies which have demonstrated 
that technology itself will not make a VCoP successful464. Further, it has been proposed that the 
facilitator, and also the core-group of VCoP community members, need to guide the community at 
least for the first four months after implementation, which can be a commitment of approximately 
one hour a week333.  
 
5.3.4 Stage 4 results: Programme specification   
The theorised role of VCoPs in supporting the practice of HLCs and potential CMO configurations 
derived from stage one were reviewed in light of the findings in Stage Three of the evaluation.  
The observations reported in the SNA of Stage 3 resonate strongly with the results of the online survey. 
There is evidence present in both sets of data that HLCs have used the Facebook group to support 
their practice in delivering HLP activities; namely conducting community pharmacy services and 
arranging health promotion promotions and activities.  
However, it should be recognised that a limitation of the SNA software utilised in stage three of the 
evaluation was that the data captured was a ‘snapshot’ of the activity recorded on the Facebook group 
over a nine-month period.  The SNA software did not demonstrate how the level of activity varied over 
time. Consequently, the data included in the realist evaluation may not accurately represent the 
current activity of the VCoP.  
The literature attempts to explain the variable activity of a VCoP in proposing the five phases that can 
be applied to the establishment of a successful VCoP279. The following make up the five phases: 1. 
Beginning; 2. Growing; 3. Maturing; 4. Maintaining, 5. Transformation.  
There is strong evidence from the findings reported in this chapter, that the HLC VCoP has entered 
phase 4 – The Maintaining Phase of the VCoP five phase model, which has been attributed the 
following description:  
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The VCoP enters into this stage when there is a significant change to the environment in which the 
VCoP was introduced. This could come about in the following circumstances: end of project, 
discontinuation of funding or completion of intended project outcomes. In these circumstances it has 
been acknowledge that it can be challenging for the VCoP to continue to function. In order to continue 
to function, efforts should be made to enhance user motivation by setting goals, attracting new 
members through face-to-face events and disseminating newsletters279.  
 The VCoP was launched and attained 29 registered members; this included a core-group of 
community members who interacted frequently and benefitted from their involvement. However, the 
observed recent dwindling of activity following a number of challenges faced by the VCoP appeared 
to contribute to its reduced benefit.  
 
5.3.5 Summary  
This study describes the development of a platform to establish and host a VCoP to support the HLC 
CoP and evaluating its subsequent success towards achieving this.   
Informed by the literature, a virtual platform was created through the employment of a designated 
HLC Facebook group.  By means of realist evaluation techniques, this study identified some of the 
benefits that the designated Facebook group can offer to support knowledge sharing and networking 
for its members. The final stage of the realist evaluation provided evidence for the establishment of a 
VCoP. 
However, this study recognised that a VCoP is a fragile concept and changes to the environment in 
which the VCoP developed can significantly affect its functioning.  
This study described a protocol that uses mixed methods to examine systematically and understand 
how and why a Facebook group can support a HLC CoP. Realist evaluation is being used increasingly 
in the healthcare sector, recognising the fact that programs and interventions requiring behavioural 
change operate within a complex social and cultural context and that the operating context plays an 
important role in determining impact. In such circumstances, the traditional approach of evaluating 
success based on whether or not a pre-defined outcome is achieved does not provide decision makers 
with sufficient information to assess the value of a program outside the context in which it was tested. 
There is a need for methods that are able to tease out the mechanisms by which a program results in 
change, and study the interactions between these causal mechanisms and context.  
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5.4 Conclusion 
 
This study is the first to report on an attempt to introduce a VCoP to support HLCs, who are often 
professionally isolated and lacking networking opportunities. The study comes at a time of looming 
financial cuts to community pharmacy designed to make the sector more “efficient” through changes 
in the roles of community pharmacists and pharmacy teams. This imminent environment of change is 
likely to result in new responsibilities for pharmacy staff, yet potential support strategies have yet to 
be reported465.  
The realist evaluation which the findings of this study are drawn from, suggests that it is possible to 
establish a VCoP capable of sustaining commitment to deliver HLP activities and provide a platform 
for HLCs to share advice and ideas in the scope of their practice. The results after nine months of 
online interaction were promising and demonstrate that with proper facilitation and opportunity for 
face-to-face meetings, a designated Facebook group can become a mechanism that can equip HLCs 
with the motivation and knowledge to support their practice in delivering HLP activities.  
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Chapter 6 : Investigating the sustainability of the HLP project 
in Portsmouth’s community pharmacies  
 
6.1 Introduction  
 
In Chapter 3 the implementation of the HLP project within Portsmouth’s community pharmacies was 
investigated. The stages and activities of the implementation process were identified and discussed 
within the context of the concepts included in the General Implementation Framework (GIF). The 
findings indicated that few pharmacies had entered a stage of sustainability, whereby provision of HLP 
services had become embedded into daily practice. It was concluded that a possible reason for this 
was that insufficient time had passed since the introduction of the HLP project for pharmacies to reach 
the sustainability phase of implementation.  
In this chapter, the community pharmacies were re-visited four years after the study in Chapter 3 was 
conducted, and a method consistent with that described in Chapter 3 was used to explore the 
sustainability of the HLP project within Portsmouth pharmacies.  
 
 6.1.1 What does sustainability mean in the context of HLPs? 
   
The 2014 NHS England report, “Sustainable, Resilient, Health People and Places”466 recognised that 
the NHS, public health and social systems are not sustainable without radical transformation. 
Supporting the strategies proposed to address sustainability challenges, is the development of new 
models of care implemented at a local level; and designed with a sustainable development plan. The 
report recognises sustainability as a factor underpinning high quality care and encourages service 
commissioners to develop criteria that recognise innovative approaches of delivering care that costs 
less and reduces inequalities. The HLP project is one such model of care that will be required to 
demonstrate its sustainability.  
It is well established in the literature that implementing innovative practices can be challenging467. 
Moreover, it has also been recognised that many innovations that are initially successful, fail to 
become part of routine practice of host organisations or communities.  
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Significant resources have been invested by Government agencies and community organisations to 
research into evidence-based practices, implementation of clinical guidelines and quality-
improvement innovations182, 468. To date, the majority of studies in this area have focused on 
identifying the factors essential for successful initial implementation. More recently, stakeholders and 
policy makers are increasingly concerned with the sustainability of innovative programmes and 
complex interventions.  
Within the context of healthcare, sustainability has been described as falling into one of three 
components: (1) continued benefits to those who received health services when the programme 
started and to new participants when the supporting funds are discontinued; (2) continued 
implementation of a programme activities in an organisation following the discontinuation of the 
programme financial support; and (3) community empowerment to improve their own health by 
continuing the activities of a finished programme469. Due to the complexity of this area of 
implementation science, researchers have argued that the concept of sustainability should be studied 
as a distinct and dynamic phenomenon469, 470. Although the literature identifies a series of factors that 
generate favourable conditions for successful implementation (discussed in Chapter 3), it has been 
observed that their presence or influence may become less prominent as time passes471-473. This can 
result in innovations, which demonstrated successful implementation, later failing to continue as 
originally implemented.  A number of factors that may contribute to the discontinuation of a particular 
intervention have been proposed. The development or discovery of more effective, efficient, or 
compatible practices may render an intervention redundant156.  Adaptations, partial continuation of a 
programme or intervention, or integration of new practices may occur following the introduction of 
an innovation. These may occur in response to new evidence, changes in priorities or resource 
availability, or other contextual influences; all may play a significant role in whether an intervention 
remains valuable. Alternatively, the challenge to sustain an effective intervention at an adequate 
standard of quality, intensity, or scope once implemented, may be at odds with the original goals and 
intentions of the adopting organisations474-476. New ideas may be incorporated into existing 
interventions rather than undergoing full integration477; this can leave the intervention susceptible to 
erosion over time478.  Unintentional disengagement may transpire should local conditions change; this 
could result from issues relating to staffing, resources, or competing demands470. Should failure to 
obtain the desired outcomes result from these processes, the value of the intervention may be 
undermined which may make discontinuation a greater possibility479. Consequently, consideration of 
these processes at the design stage has been recommended to promote the sustainability of 
interventions at a level that is sufficient to achieve the desired outcomes236.   
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6.1.3 The sustainability of interventions in healthcare settings 
 
The main challenge that exists in studying the literature pertaining to sustainability is that often 
interventions do not continue through the process of implementation unchanged. Adaptations to the 
design are made to enhance their suitability for different contexts; these contexts may differ 
significantly from those in which the intervention was originally designed and developed236, 469. 
Consequently, an intervention may undergo multiple adaptations and serve a purpose other than that 
initially intended. This observation has been identified within the healthcare literature232, 236, 480.  
Models of sustainability have been put forward that attempt to incorporate differing priorities and 
perspectives on this issue232. Some of the models proposed, focus on the intervention and articulate 
the series of factors or influences that enhance the prospects for the sustainability of a particular 
intervention481.  Whereas within other models, emphasis is placed on the relationships between the 
wider environment factors, contextual influences, and the characteristics of the intervention482, 483. 
For example, employing the former approach may focus on the factors contributing to preservation, 
fidelity, or discontinuation of an intervention. Whereas the latter approach would attempt to explore 
ways in which the intervention and the local context mutually adapt and evolve and how this process 
impacts sustainability484.  
Many studies have investigated interventions, procedures, or programmes that were implemented to 
achieve specific programme-, patient-, or population-level benefits. Stirman et al.232 reviewed this 
work and identified those studies where sustainability outcomes were discussed or where influences 
on the sustainability of these interventions were reported232. The authors identified that most of the 
studies included in the review did not provide an operational definition of sustainability, which did not 
allow for a consistent interpretation of study outcomes. In many cases, “partial sustainability” was 
reported whereby only some elements of the original intervention continued to operate. The authors 
also revealed that in order to assess sustainability, many studies attempted to identify the 
employment of “sustainability strategies”232 at the provider level, such as training and supervision, 
audit and feedback, building triggers into the process of care, checklists, or reminders and efforts to 
align the intervention and setting 485-487. 
Further to Stirman et al.’s work and with the increasingly important challenge facing commissioners 
around sustainability, Schell et al. conducted a similar review but focussed on public health 
interventions488. The study also identified that over time, a programme can sustain various elements, 
including its activities, community-level partnerships, organisational practices and benefits to 
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customers. These were termed sustainability outcomes and the authors suggested that each of these 
may be investigated to assess sustainability, since they reflect the various ways that a programme can 
continue to have its intended effects. But further to this Schell et al. investigated the literature to 
identify how a programme can position itself to best ensure that these sustainability outcomes can be 
realised. The authors introduced the term sustainability capacity to demonstrate this concept which 
recognises the existence of structures and processes that allow a programme to effectively implement 
and maintain its activities.  
Following the review of the public health literature, Schell et al. identified nine core influences of an 
intervention’s capacity for sustainability488.  These are illustrated and defined in Figure 6.1.  
Figure 6.1 Graphic framework for sustainability of public health programmes/interventions488. 
  
 
Schell et al. propose that sustainability capacity is a critical element of a public health programme and 
without it, money and resources will be wasted, trust between the programme (or programme 
providers) and the community may be damaged, and the programme may be limited in its ability to 
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achieve its public health goals. They suggest that programmes with a higher capacity for sustainability 
may be better prepared when faced with threats such as funding cuts or infrastructure changes.  
 
6.1.4 Sustainability capacity of the HLP project 
 
The literature has begun to report the various benefits of adopting the HLP project326, 330, 331, however 
the sustainability capacity of the HLP project has yet to be investigated. 
Following Schell et al.’s initial work in developing the conceptual framework, researchers have 
produced an assessment instrument to measure the capacity for programme sustainability, the 
Programme Sustainability Assessment Tool (PSAT)489. The tool has since undergone consistency and 
reliability testing in a sample of 592 respondents representing 252 public health programmes, and it 
was proposed that the PSAT has the capability to capture the distinct elements of programme 
sustainability as articulated in the Framework for Sustainability of Public Health Programmes (Figure 
6.1).  
The assessment tool is administered as a paper instrument and comprises of 40 items organised within 
eight domains, (each domain having five items). The eight domains being political support, funding 
stability, partnerships, organisational capacity, programme evaluation, programme adaptation, 
communications and strategic planning. (The PSAT used in this study can be found in Appendix 6.1)  
Respondents rated the extent (1, no extent to 7, a very great extent) to which a programme or 
intervention has or does what the items describes. Table 6.1 illustrates an example. 
Table 6.1Example of one of the 40 items included in the Programme Sustainability Assessment Tool 
Organisational 
capacity 
domain 
Not at 
all 
 
To a 
very 
little 
extent 
To a 
little 
extent 
To a 
moderate 
extent 
To a 
good 
extent 
To a 
great 
extent 
To a very 
great 
extent 
Not 
able to 
answer 
 1 2 3 4 5 6 7  
The HLP project 
is well 
integrated into 
the operations 
of the 
pharmacy. 
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The Program Sustainability Assessment Tool is a copyrighted instrument of Washington University, St 
Louis, United States. All rights reserved and is licensed under a Creative Commons Attribution-
NonCommercial- ShareAlike Licence. This licence allows researchers to adapt, tweak, and build upon 
the initial study non-commercially, as long as Washington University is credited. Further, the use, 
download, reproduction, reprint, or modification must be for non-commercial, educational or 
personal use only.  
The PSAT has since demonstrated its utility in evaluating sustainability capacity in the eight specified 
domains490, 491. 
6.1.5 Aim and objectives  
 
The research reported in this chapter explored whether the HLP project was a sustainable intervention 
within Portsmouth’s community pharmacies and to investigate the factors that influenced its 
sustainability.  
The research had the following objectives:  
1. Administering the Programme Sustainability Assessment Tool (PSAT) to community pharmacy 
staff to evaluate the sustainability capacity of the HLP project across eight specific domains.  
2. Investigating the reported challenges, and the strategies employed by community pharmacy 
staff to enhance the sustainability efforts of the HLP project.  
 
 
6.2 Methodology 
This study investigated the experiences and opinions of the community pharmacy staff employed 
within Portsmouth’s accredited HLPs, to address the research objectives stated in Section 6.1.5.  
The PSAT was adapted by the researcher to be used within this study in the context of evaluating the 
sustainability capacity of the HLP project. Since the second objective of the study objectives was to 
investigate the reported challenges and strategies, exploratory qualitative interviewing and thematic 
framework analysis were deemed as the most appropriate approach to collect this data.  In addition, 
qualitative interviewing are the most appropriate method to allow exploring participants’ views and 
experiences in depth,205-207 in order to better understand the sustainability capacity of HLP in 
community pharmacy, with data being collected over a relatively short period of time.  
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Other methodological approaches were also considered but later discarded, deemed as inadequate 
to meet the objectives of this research. These approaches included ethnography, grounded theory 
and phenomenology. An ethnographic approach was inadequate for this research, as it would have 
involved observing pharmacists in their natural environment (i.e. pharmacies) over a long period of 
time, and using the observational data collected as evidence to explain the phenomenon under 
investigation188-189. Not relying on explicit accounts from the participants, it would not have been 
possible to capture participants’ individual accounts and viewpoints about their workplace in order to 
investigate the sustainability capacity of the HLP project.  
A grounded theory approach was also deemed as inadequate as it involves collecting data when there 
is little or no evidence about the phenomenon under investigation, and without any theoretical 
assumptions previously established192. This research draws on the assumption that a series of factors 
influence whether or not innovations implemented within healthcare settings become sustainable, 
based on previous evidence collected by a review of the literature.  
A phenomenological approach was initially considered as it is also concerned with individual 
perspectives and experiences, using a small sample size over a long period of time194. However, 
similarly to grounded theory, this approach does not follow pre-established theoretical assumptions, 
and data is difficult to analyse as it does not necessarily fit into categories. In addition, participants are 
expected to be invested in the research for extended periods of time and on several different 
occasions, in order to draw meaning from the data. Given the limited time frame to collect data for 
this research, qualitative interviewing and thematic framework analysis were deemed as more 
adequate when compared to phenomenology, as participants were only needed to participate once.  
Regarding data collection, semi-structured qualitative interviews were deemed as the most adequate 
method for this research, as they provide flexibility in terms of the data collected205.  
 
6.2.1 Overview of the study method 
A semi-structured interview protocol was designed to supplement the items in each domain of the 
PSAT. Both the adapted PSAT and the interview protocol were piloted prior to use with two 
community pharmacy staff involved in delivering HLP activities.  
Pharmacy staff were contacted by phone and via the HLC Facebook page. A paper-copy of the PSAT 
was posted to participants, to complete prior to carrying out one-to-one, semi structured interviews.  
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Descriptive statistics were used to categorise then summarise the data obtained from the completed 
PSATs. Interviews were transcribed verbatim and subject to framework analysis using the conceptual 
framework of public health programmes. Figure 6.2 illustrates an overview of the study methodology.  
 
 
 
 
 
 
 
 
 
 
 
 
 
6.2.2 Data collection  
The sample population for which the research questions were appropriate were staff employed at HLP 
accredited community pharmacies in Portsmouth.  
A written version of the PSAT was used to assess the perceived sustainability capacity of the HLP 
project in the eight domains. However, due to the tool’s brevity and simplicity, previous studies 
utilising the PSAT have encouraged as well as administering the PSAT, to discuss the domains with the 
respondents to capture nuances in local settings490, 491. Therefore, open-ended questions were 
developed by the author for each domain to address this limitation e.g. Describe the strengths and 
weaknesses you see in terms of funding stability to maintain the HLP project”.  These questions formed 
the interview schedule and were set around elements of the sustainability of interventions; developed 
and informed by the related literature (Sections 3.1 and 6.1).  
The interview schedule and PSAT were piloted in an interview with a pharmacist and a HLC involved 
in delivering HLP activities. There were no major changes to the questions following the pilot 
Literature review: Examination of previous research in evaluating sustainability of public health 
interventions. 
Development and piloting of the data collection instrument: The PSAT was adapted to use 
within the context of this study and a semi-structured interview schedule was developed to 
supplement the PSAT. 
Sampling and recruitment: Recruitment of participants; employees from the HLP-accredited 
pharmacies in Portsmouth  
Data collection: PSAT sent one-week prior to 
undertaking audio-recorded, semi-structured, one-to-
one interviews 
Data analysis: Descriptive statistics of 
the PSATs. Verbatim transcripts were 
subject to Framework analysis using 
NVivo. 
Interpretation of results: Gathering of 
themes and categorising; identification 
of common issues.  
Figure 6.2 Overview of study methodology to investigate the sustainability of the HLP project 
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interview, although the term ‘political champion’ was recognised to cause potential confusion with 
the HLC role so was replaced with ‘political advocate’. Consequently, these data were included in the 
data analysis.  
A list of HLP-accredited community pharmacies was obtained from Portsmouth CCG. Despite this 
study taking place four years after the initial implementation study (Chapter 3), the list of HLP 
accredited pharmacies had remained the same with no further additions.  
The reason for excluding non-HLP accredited community pharmacy employees was that it was very 
unlikely that there were pharmacies actively involved in the HLP project who had not yet achieved 
accreditation in the six years since the introduction of the project. Moreover, the aim of this study was 
to investigate sustainability of the HLP project within community pharmacy, thereby effectively 
excluding non-HLP accredited pharmacies from the study criteria.   
Contact was made with each of these pharmacies via telephone. A study invitation was also posted 
on the HLC Facebook group. In each case, a mutually convenient time was arranged to conduct the 
interview with willing respondents and a study information sheet (Appendix 6.2) was sent by mail 
prior to visiting the pharmacy. A paper copy of the PSAT was also mailed to respondents one week 
prior to the interview, inviting them to complete the closed-ended questions and to consider their 
responses to the open-ended questions (Appendix 6.1).  
Interviews were carried out face-to-face in the private consultation room or staff room of the 
community pharmacy. The interviews were audio-recorded; respondents were asked to state their 
role and the number of years since HLP-accreditation. Respondents then reported their responses to 
the PSAT items and then responded to the open-ended questions.  
Following the interview the paper-copy of the PSAT was collected from the respondent. Interviews 
were transcribed verbatim and checked for accuracy by a second member of the research team.  
 
 
 
6.2.3 Data analysis  
The responses to the interviews were grouped under the eight domains of the PSAT and were 
subjected to framework analysis (see Table 3.7, Chapter 3). 
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The completed PSATs were collated. Microsoft Excel was used to insert all of the PSAT scores and to 
calculate mean values for each of the 40 items from each of the respondents. An overall domain score 
was obtained by averaging the scores for the five items associated with each domain.  
To determine cross-site domain scores, an average of the domain scores collected from each of the 
PSATs was calculated; standard deviation was also calculated to assess variability by domain.  
Mean and standard deviation descriptive statics were utilised in analysing the PSAT scores in this study 
in line with the designer’s recommendations and its use in previous studies490,491. 
 
6.2.4 Ethical approval  
 
This research received a favourable opinion from the Portsmouth NHS Local Research Ethics 
Committee (ref 10/H0501/6) 22/01/10 (Annexe 1). 
 
 
 
 
 
 
 
 
 
 
 
6.3 Results 
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Staff from 12 of the 17 HLP-accredited community pharmacies in Portsmouth agreed to be 
interviewed. Interviews took place between November 2016 and January 2017.  Those HLP-accredited 
pharmacies which declined to participate in the study cited the following reasons: no longer pursuing 
involvement in the HLP project (three pharmacies) and the staff who were involved in supporting the 
project no longer employed at the pharmacy (two pharmacies).   
A total of 12 interviews (one member of staff per pharmacy) were conducted with pharmacy staff 
(eight HLCs and four pharmacists). All 12 of the interviewees had contributed to the initial study 
investigating the implementation of HLP in Portsmouth community pharmacies (Chapter 3). Five of 
the respondents were employees of different independent pharmacies and seven were employed at 
multiple chain pharmacies; all of the pharmacies had been HLP-accredited for 3-4 years.  
The interviews ranged in length from 30 minutes to 40 minutes.  
 
6.3.1 PSAT domain scores 
 
All 12 staff completed the PSAT prior to undertaking the individual interviews. Figure 6.2 presents the 
mean domain scores and the standard deviation of the PSAT responses received from participants 
employed in Portsmouth’s HLP-accredited pharmacies.  
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Figure 6.3 The Mean PSAT Sustainability Capacity scores by domain, as attributed by the pharmacy 
staff employed in Portsmouth’s community pharmacies (n=12). 
 
 
The domains of Organisational Capacity (mean = 3.8) and Programme Evaluation (mean =3.6) 
produced the highest scores and Partnerships (mean =1.4) produced the lowest score. The mean score 
across all eight domains was 3.0, thus indicating that respondents perceived that the HLP project to 
be sustainable to a little extent. The consistency of the responses to the PSAT was high, as indicated 
by a standard deviation (SD) of less than one in all but one of the domains (Funding stability SD = 1.1).  
Presented below are the responses to the interview questions, which were designed to provide an 
opportunity for respondents to expand on their responses. Further, the responses facilitated further 
investigation into individual implementation factors and strategies employed within the HLP 
accredited pharmacies to promote sustainability.  
 
Political support (cross-site mean, 3.4, SD = 0.6) 
One of the biggest challenges to political support for sustainability was the change in the 
commissioning structure of the Primary Care Trust, from when the HLP project was first introduced, 
to the CCG and Local Authorities- a change that took place in April 2013. Respondents claimed that 
3.4
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the change resulted in a loss of influential community pharmacy advocates and that the new 
organisational structure of the commissioners reduced the potential influence of advocates of the HLP 
project to garner resources. With the loss of advocates for the HLP project, it was reported that there 
was a lack of an external group increasing the awareness of the project within the local community 
and amongst other local stakeholders. The scrutiny of funding for HLP services seemed to increase 
with the new commissioners; it was perceived that the commissioning arrangements became more 
focussed on targets, and that community pharmacy services no longer had their own designated 
funds, exemplified by the following observations:  
“when it first came out (the HLP project), I remember that there was XXX (local pharmaceutical 
advisor), XXXX (HLP project team lead), XXXX (PCT communications officer) and XXXX (Local Pharmacy 
Committee lead) all involved in making this happen; they were always there at the events and we 
would get newsletters telling us what is being done locally to get this off the ground and how it’s going 
to change community pharmacy, but after the offices changes and the funding became more of an 
issue (introduction of service tendering); its fallen by the wayside (the HLP project) and I know people 
have retired, but they haven’t been replaced; it’s a real shame because I thought we were going 
somewhere with this (the HLP project)” Pharmacist 1.  
Further to this, other healthcare professionals and community groups were commissioned to provide 
services which were included in the HLP project (e.g. smoking cessation), which reduced customer 
demand through increased competition. It was felt that the change in commissioners had an impact 
at the organisational level. Pharmacy management soon recognised the potential for instability of HLP 
services and therefore shifted its focus from marketing and target-setting to supporting more secure 
funding streams such as recruiting customers to the Electronic Prescription Service, flu vaccinations 
and Medicines Usage Reviews (MUR).  
“the fact that a lot of the services are being offered everywhere else doesn’t help… we don’t have the 
same number of people coming in interested in the services, but I have to say that e-cigs (electronic 
cigarettes) probably has something to do with that” HLC1 
“it’s not really secure anymore (the HLP project)… ‘like’ you can’t be guaranteed that services are going 
to continue and there’s so much else that we are told to focus on with these electronic sign-ups and 
MURs and in the winter it’s the flu jabs…. I don’t thinks it a priority anymore for XXXX (name of the 
pharmacy)”. HLC 2 
 
Funding stability (cross-site mean, 3.0, SD = 1.1) 
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The current funding situation of community pharmacy was discussed as a challenge to the 
sustainability of the HLP project. Since the HLP project was introduced into Portsmouth’s community 
pharmacies, some HLP services had been de-commissioned, other initiatives had been introduced and 
later de-commissioned (such as the HLC meetings) and payment structures for the re-imbursement of 
services had been altered on a frequent basis. It was perceived that this lack of funding stability has 
influenced the organisational support to the HLP project in terms of resources and staffing hours.  
“I guess it’s difficult for the owners because when you are running a business you need to forecast for 
these things (HLP project), you can’t say that you will employ extra staff to do X, Y and Z if you don’t 
know if X, Y and Z are going to continue… and there is that feeling with the services (HLP services” 
Pharmacist 2 
The reduced revenue to community pharmacy through national funding and high number of new 
pharmacies opening which added extra competition for the NHS prescription aspect of the business, 
were also identified as contributors to a reduced emphasis on organisations investing resources into 
supporting HLP services and focussing efforts to securing prescription business.  
“I know that the cuts (national cuts to the pharmacy contract) have hit hard and its worrying because 
there is a lot of competition around us… a lot more than before…. and I think we’ve taken the approach 
that we have to do our best to protect what we’ve got and what brings us the most money (referring 
to the NHS prescription revenue)” HLC 4 
Partnerships (cross-site mean, 1.4, SD = 0.2) 
Respondents reported that following the introduction of the HLP project, there was a sense that 
community pharmacy was becoming better integrated with local stakeholders and community 
organisations. This came about through shared training sessions, a HLP marketing strategy to increase 
awareness of community pharmacy services, and the community outreach events that were initiated 
by the local commissioners and facilitated by local community pharmacy staff.  These opportunities 
provided the chance for community pharmacy staff to develop a greater understanding of the local 
health services structure and meet staff involved in delivering these services. Furthermore the 
community outreach activities provided staff the opportunity to work alongside their peers from other 
pharmacies in a context which improved their knowledge of health inequalities within their local 
community (e.g. providing health checks within commercial centres, organising health promotion 
stands at local events).  
Despite this, respondents reported that very few similar opportunities had been arranged in recent 
times, and local restructuring of services, of which staff felt poorly informed,  had created confusion 
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amongst community pharmacy staff regarding the continuing remit of local services. Consequently 
staff felt that they had returned to a situation in which they were professionally isolated.    
“I feel that I had a good understanding of what services there are around us, and I was confident that 
if a customer came into the pharmacy and we didn’t have the help they needed, I could point them in 
the right direction and I knew what sort of service they’d receive…. I can’t say the same now…. So many 
changes have happened locally that we are not told about, we seem to have been forgotten….. and 
I’ve had customers that I’ve try to refer on to different services; they’ve come back and told me that 
they (the service) don’t take referrals or that it’s not available any more” HLC 1 
Few respondents were able to identify other organisations or individuals who had invested in the 
success of the HLP project. Although it was perceived that the contribution of General Practitioners 
(GPs) may assist the sustainability efforts of the HLP project through appropriate patient referral and 
raising awareness of the project, respondents recognised that GPs are often too busy or lack interest 
and/or awareness.  
“GPs can help but they don’t or they won’t…. I know they are so busy and there’s so much else for them 
but it’s the same old story, customers listen to their doctors and if we had them on our side (GPs) I 
think it would solve half the problem” Pharmacist 2 
The HLCs involved in the interviews stated that the cessation of HLC networking meetings had also 
contributed to the perception of isolation and reduced interaction with community organisations as 
well as the collaborative work HLCs undertook in the community.  
“They stopped the meetings (local commissioners decommissioned the HLC network meetings) and it 
felt like we were back to square one… we don’t get out of the pharmacy anymore (reference to lack of 
networking opportunities)” HLC 6 
 
Organisation capacity (cross-site mean, 3.8, SD = 0.6) 
Respondents described numerous organisational strengths promoting implementation and 
sustainability, including the free provision of material resources to deliver HLP services from 
commissioners (e.g. carbon monoxide meter for the smoking cessation service and various 
consumable items) and support from branch managers in attempts to integrate the provision of HLP 
services into workflow. HLCs also commented on the recognition of their role from branch pharmacists 
and managers, indicating that this was demonstrated through increased autonomy in managing and 
delivering HLP services and being included in branch strategic planning discussions.  
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“In terms of the owners and the manager and the pharmacist, they’ve always been supportive and 
encourage me and XXXX (a second HLC) to take the lead on HLP and even let us dictate how best to 
run the services and the promotions with things like training and staff meetings (to inform the 
pharmacy team of HLP implementation plans)” HLC 5 
Respondents from all pharmacies spoke of the on-going challenge of organisations’ multiple 
competing priorities. Commonly cited challenges were a lack of staff coupled with on-going 
recruitment freezes, lack of internal funding for HLC training and a lack of support from an 
organisational level. Further, nearly half of the respondents reported a higher staff turnover, since the 
introduction of the HLP project, whereby long-serving staff had become unwilling or unable to extend 
their role from the traditional activities of providing advice and recommending OTC remedies.  
“To be honest you’ve got your two types of staff, the ones who are motivated and get excited by talking 
to customers and learning new things, and I have to say that that is most of us here, and there’s the 
other ones who have sort of taken this job part-time to wind down their career but haven’t coped with 
all the change and new bits to the job that weren’t there when they started…. A lot of the time, they 
end up leaving” HLC 6  
A strategy discussed to help in overcoming some of these challenges, was that HLCs proactively trained 
new members of staff within the pharmacy in customer recruitment and the process for delivering 
HLP services.  
“It hasn’t been easy but we love what we do so we get on with it and when someone new joins the 
team, it doesn’t take them long to learn because we all pitch in (providing training)…. nobody asks us 
to but that’s where the enjoyment is; watching people learn and then seeing them help the 
customers…. It’s very rewarding when you see that” HLC 2 
 
Programme evaluation (cross-site mean, 3.6, SD = 0.5) 
Programme evaluation was carried out in most of the pharmacies through collecting customer 
feedback and seeking regular input from staff; the results of which informed planning and 
implementation of services.  
“We use the feedback slips to collect patient feedback after they’ve been through a service with us, 
and if there is anything we can use to improve the service and make it better for the patient, then we 
usually discuss it as a team and put things in place…. Although if I’m honest, it was XXX and XXX (the 
HLCs) who starting this idea and they get on and make the changes themselves” Pharmacist 1.  
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Commissioners, to streamline service claims, introduced PharmOutcomes, a web-based platform for 
pharmacies to record service data. The software facilitated access to data relating to historical and 
current levels of specific service provision for the local community pharmacies. Respondents indicated 
that they accessed these data to obtain service reports and compare their performance to other local 
pharmacies. HLCs mentioned that during the HLC network meetings they sought advice from HLCs 
employed at pharmacies where they had noticed strong service provision data, to inform their own 
service evaluation.   
HLCs felt that the HLC network meetings provided a form of quality evaluation through the 
presentations from practitioners affiliated to specific HLP services (e.g. a member of the local Alcohol 
Awareness team delivered informal training and a presentation on the potential role of community 
pharmacy to recognise and signpost suitable customers to their service, and described the planning 
and implementation of the pharmacy Alcohol Awareness Service). However since the cessation of the 
HLC network meetings, these activities had not continued.  
There was no evidence of a mechanism whereby evaluation results were shared with local 
stakeholders or the public; which was of concern to some respondents who commented that this 
could limit the effectiveness of evaluation on sustainability.  
“I don’t know if there is any sort of HLP monitoring still happening, if there is, it’s not really shared with 
us…. I hope there is because we need that data as evidence to show what community pharmacy is 
capable of” HLC 6 
 
Programme adaptation (cross-site mean, 3.4, SD = 0.4) 
The adaptability of the HLP project was discussed both at the project design and service delivery level. 
At the project design level, respondents agreed that periodically, the project adapted to the health 
needs of the local population with the introduction of new services. However, it was suggested that 
commissioners could provide further support to pharmacies struggling with the delivery of specific 
services, to identify strategies and propose specific adaptations that may enhance customer 
recruitment and service delivery.  
“I think they (commissioners) could do more to help us with patient recruitment…. Whether its training 
or suggesting way that we can offer the services in a more flexible way… like maybe helping us to go 
out to a local community centre and setting up a stall once a week” HLC 3 
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Many respondents had taken it upon themselves to adapt services to boost customer engagement 
and accommodate workflow, thereby promoting sustainability of HLP services. Examples of this 
included introducing an appointment based system for customers to attend regular service 
appointments e.g. weight management, smoking cessation, and a text message reminder system to 
customers enrolled on specific HLP services to alert them of their next appointment.  
 
Communications (cross-site mean, 2.2, SD = 0.6) 
The communications domain recorded the lowest but one score of all the domains. Respondents 
expressed their frustration at the lack of a continued communication strategy to disseminate key 
information relating to developments of the HLP project to pharmacy teams and to raise awareness 
of the project to local stakeholders as well as the local community. Further, respondents were 
unaware of communications of the project’s success to stakeholders at a regional or national level.  
“Communications seem to have dried up (relating to HLP updates), the marketing of HLP was short-
lived anyway, but recently I don’t feel that we have been kept updated with what’s happening in 
Portsmouth and I can’t say that I’ve noticed anything happening at a national level” Pharmacist 4 
Communication was seen as having the potential to enhance sustainability, primarily by enhancing 
political and financial support for the project. Although, it was reported, that over the past 18 months, 
the level of communication from the commissioners regarding the project had reduced; before this, 
it was felt that greater efforts were made by the commissioners to raise local awareness of the project. 
One respondent described how specific communications describing the success of the project had 
garnered national recognition, which had increased the internal political support to continue efforts 
with the project.  
“I think going forward if we want to make this work, which I think we can (HLP project), because we 
are starting to realise that community pharmacy has so much to offer, I think we need to get everyone 
on board, GPs, community groups, and other local services and have a strong marketing campaign to 
make a lot of noise to the local community….. and then I think success will bring more success, we will 
(community pharmacy) be noticed again locally and nationally and it will get them (policy makers) 
thinking about community pharmacy again” Pharmacist 3 
 
Strategic planning (cross-site mean, 3.0, SD = 0.1) 
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Two pharmacies claimed that considerable resources had been invested into the strategic planning 
for the sustainability of the HLP project. A second private consultation room was installed in one 
pharmacy to accommodate the delivery of HLP services; various equipment was bought to support 
HLP services e.g. a networked laptop to access pharmacy Patient Medication Records; and multiple 
staff were sent to undertake the HLC training course. However, the overriding impression of 
respondents was that sustainability was not considered from the outset of the project and although 
attempts were made by the commissioners to implement strategies to promote sustainability earlier 
in the implementation process, their effectiveness was short-lived and poorly disseminated.   
“The HLP is a great idea, and I don’t think the planners thought it would be the success it has been 
because there doesn’t seem to be a continuation plan…. OK so we get everybody accredited as a 
Healthy Living Pharmacy, but then what? Where are the public awareness campaigns? Don’t get me 
wrong, they (local commissioners) have tried to keep it going, first with the champions meetings, which 
were good but you only found out they were happening at the last minute, and then there is still talk 
of using the HLPs in Portsmouth in some way but nobody quite know how” Pharmacist 2 
Two of the respondents discussed the potential for periodic self-reaccreditation against the HLP 
project criteria. They said that any such effort would need to be integrated into a holistic sustainability 
strategy since they perceived that many of the local pharmacies, due to a lack of local attention given 
to the project, had recently lost focus or interest in the project. Consequently other activities had 
taken priority within pharmacies and public awareness of the project was lacking, therefore it would 
be unlikely that the HLP branding would play a significant role in differentiating one pharmacy from 
the next.  
“I know there’s been talk of self-accreditation, which I think is still in the pipeline… but I think there is 
more to it than that because it doesn’t mean much if you’ve got the sticker (HLP branding) on your 
window but nobody knows what it means…. And I think as well there’ll probably be a bit of scepticism 
because a lot of the pharmacies put the work in to be recognised as an HLP and it seems they have 
been forgotten about……. I think some of them would have lost interest” HLC 2 
 
 
6.4 Discussion  
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The PSAT was used to evaluate the sustainability capacity in eight domains of the HLP project in 
Portsmouth’s accredited HLPs with added open-ended questions for further investigation.  
The analysis revealed that many of the pharmacies involved in this study had undertaken activities 
associated with the sustainability stage of the implementation process; these included activities 
relating to monitoring, adaptation, and training and supervision. However, it became evident through 
further discussion that these activities in most cases, were no longer part of routine practice and 
consequently the supportive conditions to promote consistent service outcomes had deteriorated.  
The relative strengths of each domain were similar. All eight domains across the pharmacies scored 
less than 4, indicating a perceived deficiency in all the domains and suggesting that the HLP project 
demonstrated poor sustainability capacity.  
The partnerships domain was rated with the lowest score in this study. This finding indicates a lack of 
established links between the HLP project and the local community and stakeholders. This finding is 
consistent with findings of a recent (April 2016) NHS England commissioned review of community 
pharmacy services150. The report discusses the identified barriers to providing clinical services in 
community pharmacy and cites poor integration with other parts of the NHS and weak relationships 
between GPs and pharmacy, as two of the three most important barriers.   
The third barrier identified in the report related to specific issues around commissioning and 
regulation; a finding, which resonates strongly with the data obtained in this study, particularly 
relating to political support and funding stability domains. However, it could be argued from the 
qualitative analysis of the open-ended questions that the issue of commissioning influenced all of the 
domains. This observation that multiple domains seem to be connected is consistent with the 
empirical literature on sustainability232 and supports conceptual models of interactive relationships 
among influences on sustainability492. Gruen et al.482 and Greenhalgh et al.169 report that the 
sustainability of an intervention is dependent on a complex set of inter-relationships between various 
organisational, social and political systems impacting broad scale change, which is evident in the 
findings of this study.    
The domains which achieved a marginally higher score in this study were organisational capacity and 
programme evaluation. The analysis revealed that staff initiative and motivation was strongly linked 
to both of these domains. Staff proactively sought means of evaluating their performance through 
requesting customer feedback, viewing service provision data, and seeking advice from other staff. 
They also sought to enhance organisational capacity by undertaking staff training and adopting 
increased responsibility within the pharmacy. The motivation and commitment of pharmacy staff 
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towards the HLP project has been recognised elsewhere within the thesis (see Chapter 3), and is 
consistent with recent HLP evaluations elsewhere in the UK327, 331; however also in line with the 
content of these reports is the recommendation that pharmacy staff need to be supported and given 
the tools and training to sustain their involvement in the project.  
The analysis of the data revealed that pharmacies had at some point been involved in undertaking 
implementation activities (monitoring, adaptation, and training and supervision) and had employed 
strategies to promote the sustainability of the HLP project within the pharmacy. However it became 
clear through further discussion that these activities were no longer routine practice. It should be 
noted that this study took place five years after the introduction of the HLP project in Portsmouth and 
four years after the initial investigation of the implementation of the HLP project (Chapter 3). This is 
significant because, although it has been advocated that sustainability is the final phase in an 
intervention’s implementation process 480, 493. Moulin et al.’s Generic Implementation Framework 
(GIF) proposes that the implementation process is non-linear and recursive in nature, (illustrated by 
the double arrows and overlapping circles in Figure 3.1). This would suggest that similar to other stages 
of the implementation process, should interventions reach the sustainability stage and then be subject 
to particular influencing factors, the intervention may begin to demonstrate characteristics consistent 
with the preparation or operation stages.  
 
Strengths and limitations 
The PSAT was designed to be used in a wide variety of public health programmes and robust studies 
have demonstrated its reliability in assessing a programme’s capacity for sustainability489, 491; however, 
the tool has been used only with the assessment of chronic disease programmes. This study is the first 
to employ the PSAT in a community pharmacy setting and to assess the sustainability capacity of a 
community pharmacy intervention.  
Secondly, all data were self-reported by a small number of individuals employed at 12 of the 17 HLP-
accredited community pharmacies in Portsmouth. Self-reported assessments can be inaccurate494, 
and these individuals did not represent all stakeholders. Inclusion of other stakeholders in this study, 
such as commissioners, organisational leaders, programme leaders and community representatives 
may have revealed additional strengths and weaknesses in each of the domains. The perspectives of 
such stakeholders may vary from those of individuals immersed in the work, and they may provide 
insight on other aspects of the project.  
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Thirdly, the data collected represents a period during which HLP services continued to be 
commissioned; however the funding to support the development of the project, e.g. the HLC meetings 
and local HLP marketing, had ended. Ideally, research on sustainability is conducted at multiple time 
points232 both before and after the end of funding but due to time constraints of the researcher, this 
study could only be carried out at one point.  
Finally, although the PSAT has been used in this study in primarily a descriptive manner, the findings 
indicate the potential for PSAT to be used prescriptively to determine weaker areas of sustainability 
capacity, which may inform targeted strategies to remedy them.  
 
6.5 Conclusions 
 
The findings of this study demonstrate the usefulness of the PSAT for guiding a mixed-methods 
evaluation of sustainability capacity. Although the authors used open-ended probes during the 
development of the PSAT, the published tool consists of only likert-scale style questions however the 
qualitative questions added to this study facilitated a more insightful investigation. Evaluators and 
researchers have used the PSAT in similar way to assess the design of an intervention and also the 
strategies employed to promote sustainability during the implementation process.  
This study has shown that despite the attempts of commissioners and community pharmacy teams to 
maintain the HLP project as a successful programme to tackle local health inequalities through 
designated activities, the goal remains elusive.  
This study provides further evidence of the poor integration of community pharmacy into the wider 
NHS as well as demonstrating the impact of contractual issues and commissioning constraints on 
community pharmacy.  
Study findings may inform policy makers, commissioners, organisational leaders and practitioners that 
from the outset, interventions should consider sustainability in their design. Specifically, with 
community pharmacy interventions, which need to be designed and delivered in a way that is 
integrated both in terms of the NHS and public health systems and structures.  
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Chapter 7 : Overall discussion  
 
7.1 Focus of the study 
The work undertaken has successfully achieved the intended aims of this project in investigating and 
reporting on the implementation and sustainability of the HLP project in community pharmacies 
within Portsmouth.  
 
7.2 Summary of results 
 The use of implementation science in this study has demonstrated its potential use to guide 
formative evaluation and to enhance the implementation success of innovation within 
community pharmacy. Through the adoption of theoretical models, this study has described 
the various stages recognised in implementing innovation within UK community pharmacy, as 
well as facilitating the mapping of the various barriers and enablers to each of the stages.  
 
 This study recognised the willingness of community pharmacy teams to adopt and implement 
innovation; and to develop and participate in various strategies in order to enhance the 
sustainability of an innovation.  
 
 Through the investigations, community pharmacy support staff have demonstrated their 
potential to deliver an extended public health role and leadership activities to be considered 
as significant contributors to the implementation of innovation within community pharmacy.  
 
 Through the desire of community pharmacy staff for a professional identity and their 
enthusiasm to undertake developmental activities and contribute to the learning of their 
peers, a HLC community of practice (CoP) developed. The CoP was supported through face-
to-face meetings, which demonstrated to serve as opportunities for idea-sharing and seeking 
advice to advance with HLP activities.  
 
 The introduction of a HLC FaceBook group to support the emerging CoP presented its use as 
a central information point and as a facility for HLCs to seek ideas and advice. However, 
following the decommissioning of regular meetings and departure of key individuals 
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supporting the local HLP agenda, the use of the FaceBook group lessened and consequently 
became of less value in supporting the HLC role. 
 
  The sustainability of community pharmacy innovations should be considered within their 
development; contractual issues, commissioning constraints and the community pharmacy’s 
lack of integration in the wider NHS are key factors that should be considered.  
 
The study has shown that the HLP project was successfully adopted and implemented into the majority 
of community pharmacies within Portsmouth. Through employing the use of implementation science 
literature, the evaluation of the HLP implementation process was reported on. The Generic 
Implementation Framework facilitated the identification of the implementation concepts that were 
specific to the HLP project. The implementation stages were used as themes and thematic analysis 
was performed for the data under each stage, revealing that factors varied across the different stages 
of the implementation process. The major influences associated with the implementation process 
included those of direction and impetus, internal communication, community fit, staffing and support, 
all of which were linked to the HLC role.  
The HLC role was subsequently investigated and revealed the emergence of a community of practice 
developing, which motivated a continued involvement in the HLP project and contributed to their 
professional development. However, further investigation identified that resource support and 
leadership were required for this community of practice to remain effective and this was 
demonstrated through a HLC Facebook group, set up to supplement the activities of the community 
of practice, which became redundant following withdrawal of commissioner support. 
The HLP project’s capacity for sustainability was measured five years after it was introduced. In that 
time various restructuring of the local commissioner, increased financial pressures of community 
pharmacy and the lack of integration of community pharmacy within the wider NHS appeared to be 
detrimental factors contributing to the project’s lack of capacity for sustainability.   
  
7.3 Existing research and importance of the findings 
Appendix 7 summarises the current literature reporting on HLP. With the exception of one study 
conducted by the research team in Portsmouth, the published studies do not include service delivery 
data from community pharmacies but focus on the self-reported impact of introducing HLP. The 
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majority of the literature consists of snap shot studies involving small samples of community pharmacy 
staff conducted in specific geographical areas of England. Although, a minority of studies report on 
the barriers and facilitators of implementing HLP, there is no evidence of adopting implementation 
theory to further evaluate reported observations. Further to this, there are no reports attempting to 
analyse the potential of HLP to serve as a platform for sustained community pharmacy involvement 
in addressing local health inequalities.  
The emergence of data indicating the significant contribution of the HLCs in the implementation of 
the HLP project and exploration of their specific role adds to the limited literature on this group of 
healthcare professionals. The few previous studies describing the role and attitudes of pharmacy 
support staff towards community pharmacy services are consistent with the findings of this work. 
Furthermore, recent evaluations of the HLP project elsewhere in the UK have reported similar 
observations129, 326, 330, 331.   
There is a dearth of literature reporting the implementation of innovation within community in the 
UK. At the time of commencing this study, the author identified two other studies495, 496 and since then, 
one further study has been published497.  However in all of the studies, there was no evidence that 
implementation theory was employed to guide the evaluation which resulted in key implementation 
concepts not investigated or not reported on. Further to this, none of the three studies discussed the 
sustainability of the innovations being investigated but focussed on stakeholder’s perceived barriers 
and facilitators of implementing the innovation, which were broadly consistent to those identified 
within this study. Therefore the results within this study describe for the first time the implementation 
process of innovation within community pharmacy in the UK, articulating the overarching influences 
associated with the process, the specific factors that may be encountered at each stage and strategies 
that may be employed to enhance the process.  
Regarding the sustainability of innovations within community pharmacy, the findings confirm what 
has been reported in the recent NHS England Community Pharmacy Clinical Service Review 
document150 and further emphasises the need for sustainability planning at the development stage of 
innovation design. The findings add to those of the report by providing the perspectives of community 
pharmacy staff on the sustainability of the HLP and detailing their perception of sustainability across 
eight domains of the Programme Sustainability Assessment Tool.  
Specific to the HLP project, which has been rolled out in pharmacies across England, there is little in 
the published literature reporting on the sustainability of the project. The 2013 evaluation of the HLP 
pathfinder programme129 included the views of various stakeholders involved in HLP projects across 
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England. Project management personnel were concerned about the sustainability of the project 
following the pathfinder programme since they had recognised that support for project management 
was an important aspect of the drive for further roll out, and this support could not be guaranteed to 
continue, as indicated by the following quote:   
“Sustained managerial support for the project is essential to maintain regular contact with 
pharmacies” HLP project manager Buckinghamshire and Milton Keynes.  
Further published reports have investigated the views of community pharmacy staff, including HLCs, 
on the barriers and facilitators of performing the HLC role325 and the views and attitudes of pharmacy 
support staff on the HLP331 which have supported the findings of this work.  
 
7.4 Application to current practice  
In July 2016, Public Health England published new HLP Quality Criteria; available to community 
pharmacies to undertake self-assessment and linked to funding through the NHS national community 
pharmacy contract498.  The criteria have been revised and include the following: HLPs must:  
 show evidence of workforce development; 
 operate in premises that are fit for purpose;  
 and prove it has engagement with the local community, other health professionals, social care 
and public health professionals and local authorities.  
The dissemination of these new criteria is a recent development and therefore has not been 
investigated within this work.  
On initial assessment, it can be seen that the revised criteria attempts to overcome the challenge in 
commissioning the project, whereby the delivery of specific services is no longer a requirement; and 
funding is delivered through the NHS national community pharmacy contract, which may help to 
overcome some of the challenges pharmacies were facing with the previous criteria.  
However, Roberts et al.172 identified that within the literature of implementing community pharmacy 
services, commissioners place significant focus on remuneration as the single most important factor 
to overcome implementation challenges but often this does not make implementation more 
successful. Change management research supports the notion that recognising and understanding 
social trends and forces affecting an organisation is essential in facilitating change management180, 181.  
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This study identified and discussed important social trends and forces affecting community in relation 
to the eight domains of the Programme Sustainability Assessment Tool (Section 6.3.1) that this criteria 
does not address. An example of this is communications; the HLP sustainability study within 
Portsmouth, was conducted between November 2016 and January 2017, by which time the HLP 
Quality Criteria had been published; yet all participants were unaware of its existence, thereby 
demonstrating the need for a more effective communication strategy.  
 
7.5 Implications and recommendations for further work 
Implementation theory has proved insightful in understanding the challenges of community pharmacy 
service implementation. The theoretical models employed within this research have been developed 
from work undertaken in the fields of public health and general practice; it has not been reported that 
the area of pharmacy practice has been considered in their development. Future research evaluating 
innovation within community pharmacy may consider the application of implementation theory to 
build upon the dearth of pharmacy practice literature employing this approach.  
In the area of developing services, the findings from this study emphasise the importance of 
considering sustainability at the design stage of service development. Further, this work identifies 
specific implementation factors and strategies that may influence the implementation process within 
community pharmacy; consideration of these in service design may enhance the implementation 
process.  
Moreover, this study has identified the potential of community pharmacy support staff to significantly 
contribute to the implementation of community pharmacy services; often overlooked, this group of 
healthcare professionals should be considered and included within plans for future innovation within 
community pharmacy.  
In regards to the HLP project, further research is needed to establish the benefits of HLP accreditation 
to customers, the local health care services and the community pharmacy itself. This may include 
economic analysis of pharmaceutical care since the literature review revealed that such economically 
led data to support the development of community pharmacy services is lacking. The creation of a 
credible economic basis would help decision makers to settle on future courses of action and will 
provide a counterfactual that can be used for the evaluation of any future interventions into primary 
care.  
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Finally, the recent release of the HLP self-accreditation criteria provides an opportunity to evaluate 
the potential impact this will have on the long-term sustainability of the project.  
 
7.6 Limitations of the study 
This study has a number of possible limitations. The evaluation of the implementation and 
sustainability of the HLP project relied on self-reported evidence through collecting qualitative data 
from community pharmacy staff; however self-reports may be subject to bias and may not represent 
the extent of views and experiences of all community pharmacy staff and the various stakeholders 
involved in the project. The inclusion of stakeholders, such as other local healthcare providers or 
customers of the pharmacies, may have provided a different perspective. However, the focus of this 
work was to conduct investigations based on the views and experiences of those directly involved in 
implementing the project. Informal meetings were held with members of the HLP project team to 
obtain a greater understanding of the local political situation regarding the commissioning of the 
project. This information was used for the purpose of planning the studies included in this thesis and 
have been reported on briefly in the introduction of each of the chapters.  
The research undertaken sought to investigate the implementation of the HLP project, and therefore 
has not reported on the benefits of the HLP project to the public. Although, some of these data have 
been collated and published; early on in the research, it was identified that obtaining service provision 
data from pharmacies was challenging due to its commercial sensitivity. Furthermore, previous 
research has focussed on reporting patient outcomes and cost-effectiveness of community pharmacy 
services and the associated barriers and facilitators, yet the implementation and sustainability of 
innovation within community had not been investigated.  
Finally, with the recent development to the HLP project criteria, evaluation of its implementation and 
the subsequent impact on the sustainability using the methods employed by the author will add to 
the knowledge in this area.  
 
 
 
7.7 Overall conclusions  
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This research has revealed in detail the complexity of implementing and sustaining innovation within 
community pharmacies. The qualitative data has reported the willingness of community pharmacy 
teams to adopt and to adapt in order to provide further opportunities for their customers to access 
health and well-being activities; this was particularly evident of community pharmacy support staff 
who flourished in a champion role.  
However, a series of external factors (contractual constraints, commissioning arrangements and lack 
of integration within the NHS) have demonstrated their potential to pose significant challenges to the 
sustainability of such innovations. The consideration of these three factors, in the design stage of the 
implementation process is essential in the development of sustainable innovations. Further, this study 
has successfully demonstrated the potential use of implementation theory to address existing 
sustainability plans for the HLP project.  
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healthy living 
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includes 
PubMed, 
Medline, 
Embase, 
ResearchGate, 
Scopus, Cinahl, 
International 
Pharmaceutical 
Abstracts. 
 
 
 
 
 
 
Studies in English 
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Studies published before 1996; studies not in English 
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Authors Study objectives Method Conclusions Limitations  
Kennington. E, 
Shepherd. E, 
Evans. D, 
Duggan. C 
(2013) 
 
Explore the benefits of 
Healthy Living 
Pharmacies for 
commissioner and 
contract/employer. 
 
Content analysis of reported 
commissioner’s comments 
from the 14 pathfinder 
reports. Quantitative survey 
delivered to 
contractors/employers to 
report HLP benefits.    
Commissioners see value in the HLP 
project. Employers/ contractors perceive 
benefits to the business and staff 
productivity through HLP involvement.   
Commissioner’s data 
extracted from reports- no 
study design was 
implemented. 
Employers/contractors 
benefits were self-
reported.  
Kennington. E, 
Shepherd. E, 
Evans. D, 
Duggan. C 
(2013) 
Explore the public 
experiences of Healthy 
Living Pharmacies 
across England 
Survey delivered to 
customers of HLP-accredited 
pharmacies located in the 20 
pathfinder sites.  
HLP services are well received with 
endorsement and acceptability.  
Half of the pathfinder sites 
did not contribute to the 
study. Survey did not 
address health outcomes.  
Nazar. Z, 
Brown.  D, 
Portlock. J 
(2013)   
Qualitative analysis of 
stakeholders’ 
perspectives on the 
impact of HLP 
involvement.  
32 semi-structured face to 
face interviews with 
pharmacist and non-
pharmacist staff in 
Portsmouth.  
Successful implementation of HLP is 
dependent upon skill mix including 
introduction of the HLC role. HLP 
involvement contributed to enhanced 
motivation and improved job satisfaction.  
Only pharmacy staff were 
included in the study in 
one geographic location.  
Brown. D, 
Portlock. J, 
Rutter. P, 
Nazar. Z 
(2014)  
Assess the early impact 
of HLP in Portsmouth 
on service provision 
and staff engagement.  
Quantitative data, derived 
from pharmacy records, on 
service delivery by HLP and 
non-HLPs. 38 face to face 
semi-structured interviews 
with pharmacy staff.  
Data indicated largely successful 
introduction of HLP and the potential to 
improve customer health. Staff interviews 
suggest that successful implementation 
depend on achieving right skill mix and 
adequate funding.  
Qualitative data was 
limited to community 
pharmacy staff. 
Quantitative data provided 
a snapshot of service 
delivery but no baseline.  
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Rutter. P, 
Vryaparj. G 
(2014)  
Explore the views of 
HLCs on their role and 
to identify barriers and 
facilitators in 
performing the role.  
14 semi-structured face to 
face interviews with HLCs in 
Dudley, UK.  
HLCs held positive perceptions of the role 
and derived job satisfaction. Ongoing 
support and training were perceived as 
important facilitators.  
Study sample consisted of 
14 of the 29 HLCs in one 
geographic location.  
White. S, 
Brooks. D, 
Hopps. A 
(2014)  
Comparative study 
exploring the views of 
pharmacists versus 
non-pharmacist staff of 
HLP involvement.   
18 semi-structured 
interviews with pharmacist 
and non-pharmacist staff in 
from HLPs in Staffordshire.  
There were reported benefits to both 
pharmacist and non-pharmacist staff. HLCs 
appeared to have benefited to a greater 
extent through role expansion and 
professional recognition.  
Small sample size, no 
correlations between 
reports of benefits and 
business were made. 
Donovan. G, 
Paudyal. V 
(2014)  
Perspectives of HLP 
support staff on 
integration of public 
health activities into 
traditional pharmacy 
roles.  
21 semi-structured face to 
face interviews with HLCs 
and non-HLC staff in 
Northumberland. 
Contextualisation of fully integrating 
public health activities into the day to day 
role of support staff was lacking.  
Small sample size in one 
geographic location. Self-
reported, no reference to 
actual level of service 
provision.  
Sheket. O, 
White. S 
(2015) 
Follow-up study of the 
views of community 
pharmacy staff on HLP.  
9 semi-structured interviews 
(from the 18 staff 
interviewed 12 months 
earlier) in Staffordshire.  
Continued benefits reported with regards 
to relationships with other health care 
professionals, perceived footfall and 
enhanced job satisfaction.  
Small sample size – half 
the sample lost to follow 
up. HLP service delivery 
not investigated. Self-
reported.  
Machridge. A, 
Krska. J 
(2015) 
Investigate customer 
views on the impact of 
HLP 
Questionnaires distributed 
to community pharmacy 
customers  
Customers of HLPs are more aware of 
some pharmacy-based services, but 
pharmacy staff are not perceived to differ 
in their proactivity in promoting services.  
Low response rate (15%) 
from eight community 
pharmacies.  
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Firth. H, 
Todd. A, 
Bambra. C 
(2015) 
Explore the barriers to 
implementation and 
progression of HLP.  
26 semi-structured face to 
face interviews with 
pharmacists, HLCs and 
commissioners from North 
England.  
A key enabler identified was workforce 
development including HLC training. Low 
awareness amongst pharmacy users was 
recognised as a barrier as well as time 
investment.  
 
Limited to one area of the 
UK. Self-reported, level of 
implementation not 
investigated.  
Donovan. GR, 
Paudyal. V 
(2015) 
Explore the views of 
pharmacy support staff 
on the HLP initiative 
21 semi-structured face-to-
face interviews with 
pharmacy support staff from 
12 accredited HLP 
pharmacies in 
Northumberland.  
Involvement of pharmacy support staff 
from the outset promotes staff engagement 
and motivation. Staff perceived further 
training is required around proactive 
customer engagement.   
Limited to one 
geographical area in the 
UK. No reporting of level 
of HLP implementation.  
Kayyali. R, 
Khan. S, 
Micallef. R 
(2016) 
Investigating the 
perceived impact of 
health champion 
training on community 
pharmacy support staff 
Pre (n=354) and post (n=54) 
training quantitative surveys 
based on training content 
and knowledge.  
The training had a positive impact on 
confidence and attitude towards delivery 
of public health services as well as 
increased awareness of signposting 
opportunities. No positive impact was 
reported on public health.  
Self-reported outcomes 
collected post-training 
session, no follow-up was 
reported.  
Nazar. Z, 
Brown. D, 
Portlock. J, 
Rutter. P  
(2016)  
Investigating the 
sustainability of HLP 
from the perceptions 
of HLCs  
Questionnaire delivered to 
the HLCs in Portsmouth.  
HLCs reported that a platform to facilitate 
interaction in between face-to-face 
meetings and a designated committee 
responsible for communication and 
dissemination would promote sustained 
involvement in HLP activities.  
Limited to one 
geographical area and 
study sample included 
only HLCs.  
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White. S, 
Poole. J, 
Rutter. P, 
Cork. T, 
Visram. S 
(2016) 
Investigating customer 
views of receiving 
health interventions 
from HLP accredited 
community 
pharmacies.  
7 semi-structured face to 
face interviews with 
customers who had received 
a public health intervention 
or advice from a HLC.  
Positive opinions of the service received.  Small scale, health 
outcomes not reported.  
Kayyali. R, 
Singh Grewal. 
J, Micallef. R 
(2016) 
Evaluation of the 
delivery and content of 
health champion 
training 
22 semi-structured 
interviews with pharmacists, 
LPC & Public Health leads in 
South London.  
Positive perceptions of training provided 
was reported to improve staff confidence.  
Health champions were 
not included in the study 
sample. Self-reported 
perceived outcomes.  
Nazar. Z, 
Portlock. J, 
Brown. D, 
Rutter. P 
(2016) 
Investigate the impact 
of networking 
opportunities on the 
HLC role in 
Portsmouth.  
Two focus groups involving 
20 HLCs.  
Network meetings provided HLCs with 
professional development, continued 
encouragement and opportunities for 
collaborative work.  
Limited to one 
geographical area. Self-
reported activities- the 
impact on service delivery 
was not investigated.  
Cooper. R, 
Tsoneva. J 
(2017) 
Explore HLC 
perceptions of their 
role.  
A focus group of 7 HLCs and 
6 semi-structured face-to-
face interviews.  
Tensions with existing commercial 
business demands and lack of awareness 
amongst customers and other pharmacy 
staff were identified as barriers.  
Small study sample. 
Activities of the HLCs were 
not reported.  
Nazar. Z, 
Portlock. J, 
Brown. D, 
Rutter. P  
(2017)  
Investigate HLCs’ 
experiences of using 
Facebook to support 
professional 
development activities.  
10 semi-structured 
interviews with HLCs in 
Portsmouth.  
HLCs reported that the Facebook group 
pages contribute a positive role as an 
information point for troubleshooting and 
sharing ideas. There was little evidence to 
suggest enhanced service delivery.  
Small study sample. Self- 
reported study conducted 
only once with no 
reported follow-up.  
 
